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Complex carbocycles and heterocycles make up a large majority of natural 
product scaffolds and active pharmaceutical ingredient cores. As a result of this, 
developing methods to obtain such scaffolds in new, greener, and more modular ways 
remains an invaluable objective within the synthetic organic community. In this thesis, a 
number of exciting new methodologies have been developed to access some of these 
scaffolds, and significant progress is shown toward the application of these 
methodologies to access pharmaceutically-relevant cores: (1) a chemodivergent and 
catalytic interrupted, formal homo-Nazarov cyclization to access densely functionalized 
carbocycles, (2) the application of homo-Nazarov methodology toward the anticancer 
natural product, Propolisbenzofuran B, and (3) the application of Nazarov-like, Friedel-
Crafts methodology toward the antimalarial natural product, Flinderole A. These 
methodological transformations are tolerant of a variety of functionalities, thus giving 
broad substrate scope. These syntheses seek to have modular key transformations that 
will allow formation of a wide variety of non-natural analogs, thus providing rapid access 
to a compound library useful in the study of structure-activity relationships. 
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CHAPTER 1. INTRODUCTION 
1.1 Synthetic Organic Chemistry and Its Utility 
Organic chemistry continues to be one of the most important physical sciences to 
study, having significant impact in pharmaceuticals, agriculture, materials science, and 
other industries. Perhaps one of the most important reasons to study organic chemistry is 
its relevance in the understanding of biological systems. Quite simply, biological systems 
are nothing more than a series of self-assembling, self-replicating, organic reactions. 
When considered in this manner, understanding how to develop new small molecule 
active pharmaceutical ingredients (APIs) and drug delivery systems becomes 
considerably more simplified. Small molecule APIs are seen as simply “hands” that fit 
within protein or enzyme “gloves” to either activate or shut down biological processes. 
Physical properties of APIs are distilled down to finding an intricate balance of solubility 
in aqueous solutions and their “greasiness,” or low-polarity, in order to pass through cell 
membranes. When the desired physical properties of a drug compound are known and a 
lead is established, work can then focus on other issues, such as metabolic stability, 
toxicology, and formulations development. 
Oftentimes, biological systems produce a number of secondary molecules to their 
normal metabolic processes (called secondary metabolites) with interesting bioactivities 
ranging from antibacterial, anticancer, and anti-inflammatory to anti-parasitic and 
antiviral activities. These secondary metabolites, also known as natural products, are 
often the basis of new APIs. These natural products often have immaculately complex 
molecular scaffolds, from macrocyclic to polycyclic scaffolds, multiple stereocenters, and 
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a number of different functional groups. One major drawback of these natural products 
molecules is that they are often extracted in sub-milligram amounts from multiple 
kilograms of raw material. As a result of this, manufacturing new APIs by this extraction 
method is impractical. 
Because of the impracticality of producing new APIs from natural products by 
extraction, it is often tasked to the organic chemist to develop a synthetic route toward 
such molecules. Much more importantly, the organic chemist needs to have a large, and 
ever expanding, “toolbox” full of organic reactions to tackle these daunting molecules. 
Therefore, developing methodologies as new “tools” to take on these complex molecular 
scaffolds remains a constant focus of the synthetic organic community. As new 
therapeutics become generally more complex, they often become increasingly more 
expensive to manufacture. This leads to the first emphasis of new methodological 
developments – enhanced efficiency. Secondly, as of the 1990s, stricter regulations were 
placed upon drug manufacturers regarding the development of chiral drugs.1 Because of 
this, many drug developers have focused on progressing single enantiomers as drug 
candidates instead of racemic mixtures. As such, a need had arisen for more 
stereoselective methodologies to ease issues within the synthesis and development of 
chiral drug compounds. Lastly, APIs are often complex, densely functionalized 
molecules that present a number of significant synthetic hurdles.2 With this in mind, 
significant focus should be placed on the development of versatile, modular 
methodologies with very broad substrate scope. 
With the growing need for more synthetic “tools” in the organic chemist’s 
toolbox, especially those for constructing 5- and 6-membered (hetero)cyclic compounds, 
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two powerful methodologies remain underexplored in the literature: aza-Nazarov and 
homo-Nazarov reactions (for the construction of 5- and 6-membered (hetero)cycles). 
Nazarov cyclization methodologies have been extensively explored and well represented 
in the synthesis of bioactive molecules. However, the aza-variant of the Nazarov (for the 
construction of 5-membered nitrogen heterocycles) still remains underexplored and 
underutilized in the syntheses of natural products. Homo-Nazarov reactions, on the other 
hand, are still relatively recent synthetic methods. As such, there remains much room for 
exploration of new chemical space, the development of synthetic routes utilizing homo-
Nazarov transformations toward natural products and their core scaffolds. This thesis will 
focus on the recent advancements in these methodologies and their utilization in the 
synthesis of bioactive natural products. 
1.2 Nazarov Cyclization Reactions3 
Although unknown to its authors at the time, the Nazarov cyclization reaction was 
first discovered in 1903 by D. Vorländer and G. Schroeter after exposing dibenzylidene 
acetone to concentrated sulfuric acid and acetic anhydride, and then hydrolyzing with 
sodium hydroxide to give a cyclic ketols (Scheme 1.1A).4 In 1941, the Russian chemist 
Ivan Nazarov began investigating the rearrangement of allyl vinyl ketones, and found that 
exposing divinyl acetylenes to an acid promoter led to hydrolysis, forming allyl vinyl 
ketones, followed by isomerization of the allyl group to give a divinyl ketone, which then 
undergoes cyclization to form cyclopentenone products (Scheme 1.1B).5  
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Scheme 1.1 Voländer and Nazarov’s Seminal Reports 
1.2.1 Nazarov Cyclization Mechanism 
In 1952, the mechanism of the Nazarov cyclization was elucidated to proceed 
through a series of carbocationic intermediates (Scheme 1.2).6 The reaction proceeds first 
by exposing a divinyl ketone to either a protic or Lewis acid to activate the substrate, 
forming a pentadienyl carbocation intermediate. According to the Woodward-Hoffman 
rules,7-9 this intermediate undergoes 4π electrocyclization via conrotatory (under thermal 
conditions) or disrotatory ring closure (under photochemical conditions) to form cyclic 
oxyallyl cation intermediate, which either by loss of a proton forms cyclopentenone 
products, or by nucleophilic trapping of the oxyallyl carbocation forms cyclopentanone 
products. This nucleophilic trapping mechanism is often referred to as the “interrupted” 
Nazarov cyclization, the focus of a plethora of methodological research. A number of 
reviews have been written on variants of this reaction, including, but not limited to, the 





































Nazarov reactions,12-15 the reaction’s application toward natural products,16 combinations 
of each,17-22 and other variants.23-24 
 
Scheme 1.2 Mechanism of the (Interrupted) Nazarov Cyclization 
1.2.2 The Aza-Nazarov Reaction 
Another well-studied variant of the Nazarov cyclization is the aza-Nazarov 
cyclization. The term “aza-Nazarov” was first coined in 1997, in Ciufolini’s total 
synthesis of camptothecin.25 In this variant, when a carbon atom is replaced with a 
nitrogen atom in the 1-position (Scheme 1.3A), forming hydroxypyrrole products rather 
than the cyclopentenone products of the Nazarov. Much like the Nazarov, the aza-
Nazarov also proceeds through a concerted mechanism to form the oxyallyl cation 
intermediate through a highly exothermic process (-37 kcal/mol). However, when a 
carbon atom is replaced with a nitrogen atom in the 2-position (Scheme 1.3B), the 
reaction becomes endothermic (24 kcal/mol), and the activation barrier toward the 
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Scheme 1.3 Representative Aza-Nazarov Mechanisms 
However, this issue of high activation barrier of aza-Nazarov reactions with 
nitrogen atoms in the 2-position has been overcome in the past by the use of the highly 
reactive N-acyliminium intermediates, which, when activated by acids, become 
“superelectrophiles” (Scheme 1.4).27-28 One other major difference exists in aza-Nazarov 
substrates with nitrogen in the 2-position than those with nitrogen in the 1-position. It is 
not totally understood whether the aza-Nazarov on substrates with nitrogen in the two 
position proceeds through a concerted mechanism, such as a π-electrocyclization, or 
through a more polar mechanism, such as Friedel-Crafts-type reactivity. According to 
Baldwin’s rules,29 5-endo-trig reactions are disfavored, suggesting a more concerted 
mechanism. However, the use of these “superelectrophiles” has provided a reliable way 
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Scheme 1.4 N-Acyliminium "Superelectrophile" Aza-Nazarov Cyclization 
One other way around the issue of activation energy in the aza-Nazarov 
cyclization with nitrogens in the 2-position is the use of N-acylated heteroarenes, such as 
pyrroles and indoles. While this type of reactivity certainly does not proceed via a 
concerted mechanism, but rather instead via a Friedel-Crafts-type mechanism. In a 2011 
report, France and co-workers developed an In(OTf)3-catalyzed Friedel-Crafts cyclization 
to access pyrrolo[1,2-a]indole scaffolds found in many natural products (Scheme 1.5).30 
In this example, In(OTf)3 is used to activate the unsaturated malonamide derivative 1-12, 
inducing an intramolecular Friedel-Crafts reaction that proceeds in a Michael addition-
like fashion. As a result, the pyrrolo[1,2-a]indole products obtained resemble those of 
what might be considered a formal aza-Nazarov cyclization mechanism. As powerful as 
this methodology may be to access these scaffolds, it has been underexplored in the realm 
of natural product synthesis.  
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1.3 The Importance of Cyclopropanes 
Cyclopropanes remain an important structural motif in a number of natural 
products. A literature search of the cyclopropane structure on Reaxys yields over 6,800 
natural products and pharmaceuticals containing the three-membered ring. However, the 
smallest carbocycle is not only important in natural product synthesis, but 
methodologically as well, due to its inherently high C-C bond dissociation energy and σ-
bond p-character. Cyclopropanes are also the key structural motif found in homo-
Nazarov cyclization precursors. Because of their importance in homo-Nazarov 
cyclizations, it is important to discuss their history, properties, and reactivities to 
understand their similarities in reactivity to the previously discussed Nazarov 
cyclizations, and to continue developing these incredibly powerful methodologies to 
access 6-membered carbocycles. 
1.3.1 History and Physicochemistry of Cyclopropane 
Cyclopropane was first discovered in 1882 by August Freund upon reacting 1,3-
dibromopropane with sodium metal, which then underwent an intramolecular Wurtz 
reaction to form what was referred to as “trimethylene”.31 Cyclopropane was found to 
react with elemental bromine and hydrobromic acid to produce 1,3-dibromopropane and 
1-bromopropane respectively.32 This reactivity represented very similar reactivity to 
olefins. Cyclopropane, along with ethylene oxide, was also found to produce interesting 
C-C vibrational frequencies (1623 cm-1) similar to, but just outside, known C=C 
vibrational frequencies in known Raman and IR spectra (~1600 cm-1).33-37 From this 
point forward, cyclopropane’s true structure became a hotly debated topic in the synthetic 
community. 
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1.3.1.1 Pauling’s Proposal of “Bent” Bonds 
In 1931, Linus Pauling began investigating the nature of chemical bonds, 
proposing that chemical bonds are a hybridization of s- and p-orbitals, which, in simple 
molecules like methane, would give H-C-H bond angles of 109.5 degrees. In this report, 
Pauling also proposed that ethylene was composed of “bent” bonds in which most of the 
electron density resided outside the internuclear plane.38 Pauling later expanded upon his 
original report, quantitatively relating bond energies to the hybridization of their 
orbitals.39 Pauling’s model at the time, however, was insufficient at explaining bonding 
regimes in three membered cyclic structures, such as cyclopropanes and epoxides, having 
cyclic bond angles of 60 degrees. This angular strain combined with the torsional strain 
of eclipsing C-H bonds contribute to the high ring strain (27.5 kcal/mol) of cyclopropane. 
Using Pauling’s hybridization model, the smallest bond that could be formed are four-
membered cyclic scaffolds with C-C bonds consisting s- and p-orbitals at a minimum 
angle of 90° (composed of only p-orbitals).40  
1.3.1.2 The Coulson-Moffitt and Walsh Models of Cyclopropane 
Pauling’s hybridization theory would lead to what is known as the valence bond 
model of cyclopropane, credited first to Förster in 1939.41 In 1947, Coulson and Moffitt 
elaborated on Förster’s report, proposing a “bent” valence bond model (Figure 1.1A) of 
cyclopropane based on Pauling’s proposed quantum mechanical model of “bent” bonds 
in ethylene. In Coulson and Moffitt’s model, while the angle between carbon atoms are 
60°, the angle between orbitals at a carbon atom are 106° (indicating higher p-character, 
approximately sp5 hybridization according to Coulson and Moffitt42, calculated to be 
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sp3.46)43, much closer to the 109.5° of normal sp3-hybridized tetrahedral carbon atoms. As 
a result of this, electron density is held outside of the direct C-C bonds. Because of these 
“bent” bonds, ring strain is slightly offset, lowering the energy of the species.44 
Consequential to the carbocycle’s orbital angles, the H-C-H angles in cyclopropane are 
114° (indicating higher s-character, calculated to be sp2.62)43, and C-C bond length of 
1.512 Å, compared to typical C(sp3)-C(sp3) bond lengths of 1.535 Å. This gives some 
explanation as to why the strain energy of cyclopropane (27.5 kcal/mol) is only slightly 
higher than that of the next smallest ring, cyclobutane (26.3 kcal/mol). While this model 
provides a good explanation for most of electron density lying outside the C-C triangular 
plane, it does not explain the electron density contained in the center of the ring (to be 
discussed in following paragraphs). 
Also in 1947, a second model began to emerge; Walsh began extensively 
investigating the structure of cyclopropane molecules influenced by molecular orbital 
(MO) theory, first proposing a dative bonding model of ethylene to a methylene (Figure 
1.1B), citing the H-C-H bond angles of ~120° as evidence.45 Although this was not the 
first dative bonding model proposed,46 Walsh was met with heavy criticism,47-48 
especially due to the known Raman and IR spectra of cyclopropane and ethylene oxide 
which showed vibrational frequencies outside known C=C vibrational frequencies. Walsh 
later explained what is known today as the Walsh cyclopropane model, involving three 
sp2-hybridized carbon atoms bonding centrally and via very small overlap among the 
three carbon’s 2p orbitals (Figure 1.1C).49 While Walsh’s model was heavily criticized 
for the initial dative representation, his later corrections eventually led to a good 
explanation for the presence of electron density in the center of the cyclopropane ring. 
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Figure 1.1 Coulson-Moffitt Model vs. the Walsh Model of Cyclopropane 
Transposing Walsh’s model to a true molecular orbital model (Figure 1.2), 
cyclopropane consists of three bonding orbitals and three antibonding orbitals. The 
lowest occupied molecular orbital consists of three sp2-hybridized carbons overlapping 
directly at the center of the cyclopropane, where a large amount of electron density 
dwells. The two degenerate highest occupied molecular orbitals (HOMOs) are made up 
of two p-orbitals, pointing directly toward one another, overlapping with a node at the 
third carbon and the three p-orbitals, again pointing directly at one another, overlapping 
with a node in the midst of a C-C bond. The lowest unoccupied molecular orbital 
(LUMO) is comprised of three p-orbitals pointing directly at each other with a node 
between each of the carbon nuclei.50 Although Walsh’s MO model has been heavily 
criticized, both the HOMOs/LUMO of cyclopropane consisting of p-orbitals rather than 
the spx-hybridized bonding pattern of typical aliphatics in his model and the Coulson-
Moffitt model’s interpretation of C-C bonds having higher p-character provide good 








Figure 1.2 Molecular Orbitals of Cyclopropane 
1.3.1.3 Cyclopropane and σ-Aromaticity 
Although the dative bond model was originally proposed by Dewar,46 he later 
proposed a supplementary model to Walsh’s MO model, implying that cyclopropane is a 
σ-aromatic molecule.51 This idea was proposed as a rationalization for the very small 
difference in strain energy in cyclopropane and cyclobutane (27.5 vs. 26.5 kcal/mol, 
respectively), proposing that its aromatic character significantly stabilizes the small 
carbocycle. Using the 4n+2 equation, cyclopropane consists of a cyclic, six electron array 
in σ-aromaticity. The concept of σ-aromaticity arises by viewing the bonding electrons of 
cyclopropane as non-localized (unlike typical σ-bonds) where a two-electron “surface 
orbital” occupies the center of the three carbons.52-53 Beyond the low strain energy, this 
proposal may help explain cyclopropane’s upfield shifted protons versus normal aliphatic 
protons and its reactivity toward electrophiles.54 This model, much like Walsh’s model, 
E
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has been met with much skepticism, mostly due to the lack of consistent literature values 
for stabilization energy and no direct method of measuring stabilization energy.43  
1.4 Synthesis of Cyclopropanes 
Key to the understanding of the reactivity of cyclopropanes is the ability to 
synthesize them. While many beautiful and elaborate syntheses of these strained 
carbocycles have been accomplished both racemically and stereoselectively,55-56 most 
syntheses fall within three major paradigms: (1) synthesis via metal carbenoids from 
diazo degradation, (2) synthesis via zinc carbenoids from diiodomethane, or (3) synthesis 
via heteroatom-ylide generation.  
1.4.1 Synthesis of Cyclopropanes Via Metal Carbenoids from Diazo Degradation 
One of the most popular methods to generate cyclopropanes falls under the 
category of diazo degradation to form metal carbenoids, which then react with alkenes. 
This methodology has been extensively reviewed over the last several years.56-59 
Mechanistically, this reaction first proceeds with nucleophilic attack from the diazo 
carbon onto the impending metal center (usually CuI or RhII, though other metals have 
been used)60-62 to form a resulting tertiary diazonium intermediate. After eliminating 
nitrogen gas from collapse of the metal’s electrons, a metal carbenoid forms.63 This 
carbenoid, when in the presence of an alkene, undergoes concerted addition to the double 
bond, regenerating the metal catalyst and forming a cyclopropane (Scheme 1.6).57 
Because this reaction proceeds in a concerted fashion, a number of groups have designed 
catalysts and published methodologies to form cyclopropanes stereoselectively.55, 64 This 
is the favored method for cyclopropane formation in the following thesis due to a number 
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of characteristics: (1) high functional group tolerance, (2) low catalyst loadings (0.1 to 5 
mol % with RhII catalysts),65 (3) high reaction speed, and (4) ease of setup.  
 
Scheme 1.6 Mechanism of Cyclopropane Formation from Diazo Degradation 
1.4.2 Synthesis of Cyclopropanes Via Zinc Carbenoids from Diiodomethane 
Another popular method for cyclopropane formation is the reaction of zinc metal 
or diethylzinc with diiodomethane to form zinc carbenoids, more commonly known as 
the Simmons-Smith cyclopropanation.66 In this pathway, zinc metal (or a dialkylzinc) 
inserts into a single C-I bond of diiodomethane, forming an organozinc intermediate. 
Although the mechanism of this pathway has yet to be fully elucidated, the organozinc 
intermediate is suspected to attack via a “butterfly” transition state, releasing zinc iodide 
and the resulting cyclopropane (Scheme 1.7).67 The Simmons-Smith cyclopropanation 
can also be performed asymmetrically, due to the ability of organozinc to coordinate to 
neighboring heteroatoms and through the use of chiral ligands.68 A number of other zinc 
reagents have been developed, including those to induce reactivity for unreactive olefins 
(Shi’s modification)69-70 and bench-stable zinc carbenoids (Charette’s modification).71 
Although Simmons-Smith cyclopropanations are a very highly functional group tolerant 
method, this method was disfavored for cyclopropane generation in this thesis due to 
stoichiometric amounts of zinc dust or pyrophoric diethylzinc required and the very high 
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Lewis acidity of the zinc iodide byproduct, which could potentially promote ring-opening 
of the highly polarized cyclopropanes used throughout this thesis. 
 
Scheme 1.7 Formation of Cyclopropanes Via the Simmons-Smith Method 
1.4.3 Synthesis of Cyclopropanes Via Heteroatom-Ylide Generation 
The final major method of the synthesis of cyclopropanes that will be discussed is 
that using heteroatom-ylides as intermediates. More widely known as the Corey-
Chaykovsky reaction, this method uses a base to deprotonate a sulf(ox)onium salt to form 
the resulting sulf(ox)onium ylide. This ylide is used to nucleophilically attack highly 
polarized double bonds, such as carbonyls, imines, and Michael acceptors to form 
epoxides, aziridines, and cyclopropanes, respectively (Scheme 1.8).72-73 This 
methodology has been particularly important in natural product total synthesis, including 
Danishefsky’s synthesis of taxol.74 A number of variants of this reaction have also been 
developed, including those using ammonium ylides,75 telluronium ylides,76-78 and 
catalytic, asymmetric variants.79-82 This method was chosen for a number of 
cyclopropane substrates utilized in this thesis, especially for those in which the alkene 
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Scheme 1.8 Synthesis of Cyclopropanes Using Sulfoxonium Ylides 
1.5 Donor-Acceptor Cyclopropanes 
As previously discussed, cyclopropanes are high-energy species with reactivity 
that is often analogous to that of olefins. However, as high in energy as cyclopropanes 
are, they are generally not quick to react to form new entities. In order to increase the 
kinetic reactivity of cyclopropanes, adding substituents on carbon atoms can induce a 
bond polarization, decreasing its activation energy.83-84 Attaching an electron donor and 
an electron acceptor vicinally across a C-C bond produces what are known as donor-
acceptor cyclopropanes (DACPs). This substitution pattern creates an electronic “push-
pull” effect along a cyclopropyl C-C bond, resulting in high bond polarization and ready 
heterolytic cleavage of the species, forming a zwitterionic 1,3-dipolar intermediate 
(Figure 1.3).  
 




































D = electron donor
       [OR, SR, NR2, CH2SiR3, vinyl, (hetero)aryl, alkyl]
A = electron acceptor





Although bond polarization has only been discussed qualitatively until this point, 
the effect of donors and acceptors in DACPs has been computationally studied to 
quantify said effects by Werz and coworkers.85 After testing over 70 combinations of 
electron donors and acceptors, it was concluded that when one of the two substituents 
becomes increasingly electron donating and the other substituent is increasingly electron 
withdrawing, transition state energies decrease. Continuing to add donors and acceptors 
vicinally across C-C bonds further increases bond polarization, therefore decreasing 
activation energy (Figure 1.4).84 
 
Figure 1.4 Effect of Increasing Bond Polarization on Activation Energy 
 To this end, a number of groups have sought out DACPs as tools for developing 
new synthetic methodologies (Figure 1.5) and toward the syntheses of natural products, 
such as bruguierol,86 goniomitine,87 and the formal synthesis of platensimycin88 (Figure 
1.6). In 2005, Pagenkopf and co-workers published a review of DACPs, covering their 
formation, Lewis acid-mediated reactions, and formal [3+2]-cycloaddition reactions.89 In 
2014, Werz and co-workers published an extensive review covering the use of DACPs in 
a number of intermolecular reactions, including ring-opening reactions and 
cycloadditions, with some time spent discussing rearrangements.83 Soon after, France and 
co-workers also published another review discussing the use of DACPs in intramolecular 
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ring-opening cyclization reactions, covering cycloisomerizations, formal cycloadditions, 
umpolung reactions, rearrangements, ring-opening lacton-/lactamizations, and their 
application in natural product syntheses.84 Another authority on cyclopropanes, Jérôme 
Waser, published a review covering cyclization reaction and annulations of 
aminocyclopropanes.90 Pagenkopf also recently reviewed the ability of DACPs to 
undergo cycloaddition reactions with nitriles.91 With all of this in mind, it should suffice 
to state that DACPs a great methodological tool to the synthetic organic community. 
 
Figure 1.5 Various Reactivities of DACPs 
 























































1.6 The Formal Homo-Nazarov Cyclization 
One other powerful methodology not discussed so far involving DACPs is the 
ring expansion methodology formal homo-Nazarov cyclizations. The term “homo-
Nazarov” was first used by Tsuge and co-workers in 1988 when they reported an acid-
catalyzed ring expansion of cyclopropyl vinyl ketones to form cyclohexenones (Scheme 
1.9A).92 While this was the first use of this terminology, the ring-opening/ring-closing 
reactivity of cyclopropyl ketones to form cyclohexenone products was first published in 
1980 by Murphy and co-workers (Scheme 1.9B). In this example, cyclopropyl aryl 
ketones were exposed SnCl4 to form aryl-fused cyclohexanones in up to 80% yield.93-94 
 
Scheme 1.9 Early Examples of the Homo-Nazarov Cyclization 
While unnamed at the time, the first investigation of the mechanism of the formal 
homo-Nazarov cyclization was published by Murphy and co-workers in 1982,95 with 
Waser and co-workers conducting another mechanistic study in 2009.96 Upon activation 
of the cyclopropyl vinyl ketone by a Brönsted or Lewis acid, the cyclopropane ring opens 
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vinyl group to form an oxyallyl cation. This oxyallyl cation is then quenched via 
elimination by removal of an adjacent proton, forming the cyclohexenone product. 
However, in the presence of water, the acyclic cation is trapped to form a γ-
hydroxyketone, confirming this polar mechanism; this is the origin of the “formal” 
preceding the homo-Nazarov cyclization name. 
 
Scheme 1.10 Mechanism of the Formal Homo-Nazarov Cyclization 
Since Tsuge and co-worker’s first use of the “homo-Nazarov” terminology, 
further exploration of this reactivity was not published until some 20 years later, when 
Yadav reported the synthesis of 2,3-heteroaromatic-fused cyclohexanones via the ring 
opening of DACPs.97 After this report, a plethora of publications began to appear in the 
literature on these ring-opening/ring-closing cyclizations of cyclopropyl vinyl (or aryl) 
ketones. In 2009, Waser and co-workers reported the first catalytic homo-Nazarov 
cyclization using 20 mol % TsOH with cyclopropyl vinyl ketones; however, substrates 
were limited to activated olefins and heteroarenes as interceptors of the acyclic cation.98 
Soon after, France and co-workers reported the first Lewis acid-catalyzed formal homo-
Nazarov cyclization utilizing donor-acceptor-acceptor cyclopropanes with 30 mol % 
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acyclic cation interceptors.99 In 2011, Waser further expanded the scope to include 
heteroatom-activated cyclopropanes with a number of heteroarenes as the representative 
olefin.100 Since this time, a number of other reports on formal homo-Nazarov 
methodology have been published, including a formal homo-Nazarov protocol of 
alkylidene cyclopropanes,101 an allylsilane-interrupted formal homo-Nazarov 
cyclization,102 a tandem, bicatalytic, cyclopropanation/formal homo-Nazarov cyclization 
in continuous flow,103 a formal homo-Nazarov protocol toward tetrahydroindolizines,104 
and an asymmetric formal homo-Nazarov protocol toward enantioenriched 
dihydronaphthalenes.105 France and co-workers also published a review highlighting the 
formal homo-Nazarov cyclization as an incredibly useful synthetic tool toward diversity-
oriented synthesis.106 With all of these recently developed methodologies, it is no wonder 
that the formal homo-Nazarov cyclization is a powerful synthetic tool; a majority of this 
thesis will continue to investigate the formal homo-Nazarov cyclization, focusing on 
further exploring the chemical space, investigating catalysis with DACPs, and expanding 
the scope of substrates to be used with this methodology. 
1.7 Structure of Dissertation 
The following dissertation explores novel methodologies using DACPs to access 
complex, polycyclic molecular scaffolds found in natural products and pharmaceutically 
relevant compounds. The thesis can be seen as focusing on two major areas; the first area 
that will be explored is the development of a novel homo-Nazarov cyclization 
methodology. The second area is the synthesis of two bioactive natural products, the 
anticancer molecule Propolisbenzofuran B, and the antimalarial Flinderole A. Two 
appendices to the thesis are also attached, which focus on the development of a 
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dehydrative Nazarov methodology, and a study on the effects of substituents on the 
formation of α-alkylidene-γ-butyrolactones (ABLs) from a dehydrative, ring-opening 
cyclization of cyclopropanes. 
Chapter 2 will focus on the development of the novel catalytic, interrupted formal 
homo-Nazarov cyclization using DACPs and allylsilanes. Included in this chapter will be 
a discussion of the importance of oxyallyl cations within methodological research and 
natural product synthesis over the last several years. Also included will be a discussion of 
the limitations and focus of prior literature on the subject. This chapter will demonstrate 
an attempt to achieve catalysis and chemodivergence from identical starting materials in 
the homo-Nazarov cyclization and the limitations of this approach. Two intermolecular 
oxyallyl cation trapping nucleophiles have been studied thus far: allylsilanes and 
(hetero)arenes. Ongoing efforts to effect an intramolecular variant toward highly complex 
polycyclic scaffolds will also be discussed. 
Chapter 3 will center on a new approach toward the anticancer natural product 
Propolisbenzofuran B. The bioactivity of the molecule will be discussed and the previous 
approach toward synthesizing the molecule and its limitations will be addressed. In our 
two attempts thus far, DACPs and homo-Nazarov cyclization methodology are used to 
achieve the synthesis of the cyclohexyl/benzofuran-fused core of the molecule. The 
limitations of our previous attempt to synthesize the molecule will be discussed, and a 
new linear sequence toward addressing those limitations will be revealed. 
In Chapter 4, a new approach toward the synthesis of the antimalarial natural 
product Flinderole A will be shown. In our approach, we attempt to utilize a Nazarov-
like, Friedel-Crafts methodology, using a novel unsaturated α-sulfonylamide as 
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precursor. Using this method, we attempted a route geared toward achieving molecular 
diversity and synthesized a library of analogs for structure-activity relationship studies. 
Within this chapter will be a discussion of the limitations of previous methodologies 
toward the molecule and how we sought to address them. 
Chapter 5 will summarized all of the previous chapters discussed. Also as part of 
this chapter, a number of novel strategies will be proposed as a follow-up to the 
methodology discussed. A number of further steps to achieve the syntheses of the natural 
products in the thesis will also be proposed. 
After the conclusion of the thesis, two appendices will be discussed. In the first 
appendix, a novel dehydrative Nazarov cyclization approach toward 
cyclopenta[b](hetero)aromatics will be discussed, specifically focusing on the synthesis 
of the Nazarov precursors, unsaturated β-hydroxy-(hetero)aromatic esters, and the effects 
of time on the selectivity of the reaction. The second appendix will discuss a novel 
dehydrative, ring-opening reaction of cyclopropanes to form ABLs. Within this 
discussion will be a particular focus on substituent effects on E/Z selectivity in the ABL 
products. 
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CHAPTER 2. CATALYTIC AND CHEMODIVERGENT 
INTERRUPTED HOMO-NAZAROV CYCLIZATION 
REACTIONS †,‡ 
2.1 Oxyallyl Cations: A Handle for Chemical Diversity 
Oxyallyl cations remain a valuable synthetic tool to the synthetic organic 
community due to their electrophilic nature and ease of accessibility. Researchers were 
originally interested in allyl cations as a means to generate 7-membered carbocycles, via 
[4+3]-cycloadditions, due to the cycloadditions pathways toward 5- and 6-membered 
rings through [3+2]-cycloadditions of allyl anions with dienophiles and [4+2]-
cycloadditions of dienes with dienophiles, respectively. Allyl cations were known to be 
much harder to access, reacting with solvent upon generation, and other more stable allyl 
cations polymerizing.1 Oxyallyl cations, on the other hand, provide greater stability and 
more controlled reactivity. Although oxyallyl cations may have originated in the late 19th 
century with the first Favorskii reaction,2 research into the reactivity of the intermediate 
itself did not take place until 1962, when Fort reported the methanolysis of α-chloro-
dibenzylketone.3 In this initial report, Fort proposed an elimination-addition mechanism 
promoted by 2,6-lutidine. It was not until later that Fort obtained more concrete evidence 
for the oxyallyl intermediate when he reported its capture with furan via a [4+3]-
cycloaddition.4 Since this report, a number of methods for the generation and utility of 
oxyallyl cations have been published. 
                                                
† Allylsilane trapping studies done in collaboration with Raynold Shenje and Katherine M. Francois. 
Published in Org. Lett. 2014, 16, 6468-6471. 
‡ (Hetero)aryl trapping studies done in collaboration with Raynold Shenje. Published in J. Org. Chem. 
2016, 81, 8253-8267. 
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2.1.1 Generation of Oxyallyl Cations 
There are many different methods to generate oxyallyl intermediates, while three 
tend to stand out above all others: (1) heterolytic cleavage of 2-alkoxyallyl halides, (2) 
enolization of α-haloketones, and (3) metal reduction of α,α’-dihaloketones. The first 
mentioned method, heterolytic cleavage of 2-alkoxyallyl halides, generally uses silver 
salts as a method of halogen abstraction to generate oxyallyl cations. The first example of 
this method came only ten years after Fort’s seminal report, published by Hoffman. In his 
report, Hoffman used silver trifluoroacetate to generate a methoxyallyl cation, which 
subsequently underwent a [4+3]-cycloaddition with furan to form the bicycle shown in 
Scheme 2.1.5 Since Hoffman’s report, this remains one of the most reliable methods to 
generate oxyallyl cations to date. 
 
Scheme 2.1 Hoffman’s Seminal Work with Oxyallyl Cations 
The second method, using acids or bases to generate oxyallyl cations from α-
haloketones, also remains a popular method. The first example of a [4+3]-cycloaddition 
with oxyallyl cations was Fort’s original report, in which he used 2,6-lutidine to generate 
the oxyallyl to be captured by furan.4 In a more recent example, Wu and co-workers 
reported a Na2CO3-promoted [3+2]-cycloaddition of electron-rich 3-substituted indoles 
with α-haloketones (Scheme 2.2).6 Base-promoted methods have also been useful in the 
transformations of azaoxyallyl cations.7-10 Alternatively, Lewis acids can also be used as 











with Fe2(CO)9 and TiCl4 to generate oxyallyl cations, which are subsequently reacted 
with alkynes to form cyclopentenones (Scheme 2.3).11 
 
Scheme 2.2 Wu’s Base-Mediated [3+2]-Cycloaddition 
 
Scheme 2.3 Harbinger’s Lewis Acid-Activated Bissulfonylketones as Oxyallyl Precursors  
The third method of generating oxyallyl cations relies on metals to reduce α,α’-
dihaloketones. In this method two one-electron reductions occur, typically using zinc 
dust, at one of the α-positions of the dihaloketone. The first reduction generates a radical 
cationic intermediate, which is subsequently reduced to form an enolate. The second 
halogen is abstracted by the metal salt to form oxyallyl cations (Scheme 2.4). Several 
chemists have relied on this method to generate oxyallyl cations, including Hoffman,12 
Noyori,13 and Mann.14  
 
Scheme 2.4 Zinc Reduction of Dibromoketones to Form Oxyallyl Cations 
While the three previously mentioned methods are some of the most reliably used 
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published over the last few decades. The anhydride-mediated activation of α-hydroxy 
alkyl vinyl ethers as used is another method developed by Hoffman15-16 (Scheme 2.5) that 
went on to be used in the total synthesis of aphanamol.17 In this method, an allyl 
trifluoroacetate is generated with TFAA from allyl alcohol 2-12. Upon heating with a 
diene, the oxyallyl cation is generated and undergoes a [4+3]-cycloaddition to form 
bicyclic scaffolds of the type 2-13. One other method for the generation of oxyallyl 
cations is the photolytic degradation of 3,3,5,5-tetraalkyl- or 3,5-dialkyl-3,5-diaryl-3,5-
dihydro-4H-pyrazol-4-ones via the release of nitrogen gas. This method has been used to 
generate oxyallyl cations en route to tetrasubstituted cyclopropanones or cis-/trans-1,3-
dialkyl-1-aryl-2-indanones (Scheme 2.6).18-20 This methodology, although still in its 
infancy, could potentially become a promising route to oxyallyl cations via a 
photochemical method rather than other chemical methods. 
 
Scheme 2.5 Hoffman’s TFAA-Mediated Generation of Oxyallyl Cations 
 
Scheme 2.6 Photochemical Generation of Oxyallyl Intermediates 
The final methods, and most relevant to the chapter at hand, to introduce oxyallyl 
cations in this chapter is their generation within the Nazarov and FHN reactions. Since 
their origin by these mechanisms was covered previously in Chapter 1.2 and 1.6, they 
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2.1.2 Synthetic Utility of Oxyallyl Cations 
The electrophilic nature of oxyallyl cations gives rise to a plethora of reactivity 
with a vast array of nucleophilic partners. As mentioned a number of times previously, 
oxyallyl cations readily undergo [4+3]-cycloadditions (Scheme 2.7). To this end, a 
number of reviews have been written focusing specifically on only this reactivity.10, 17, 21-
25 In this reaction pathway, oxyallyl cations undergo a [4π+2π]-electrocyclization with 
dienes and (hetero)cyclic dienes, giving rise to seven-membered and bicyclic 
carbocycles, such as 2-19. This reaction can proceed either via a concerted or stepwise 
mechanism, as exhibited in Hoffman’s,26 Noyori’s,27 and Montaña’s28-29 results. It does 
seem however that diastereoselectivity is dependent upon several factors, including 
electron deficiency of the oxyallyl cation, the counterion used, and reaction 
temperature.30 
 
Scheme 2.7 Generic Concerted [4+3]-Cycloaddition Mechanism with Oxyallyl Cations 
Another powerful use for oxyallyl cations, though much more uncommon, is in 
[3+2]-cycloadditions.31 Unlike the [4+3]-cycloaddition, the [3+2]-cycloaddition is not 
thermally allowed by Frontier molecular orbital theory, resulting in almost exclusively a 
stepwise mechanism. Also unlike the [4+3]-cycloaddition, oxygen atoms often participate 
in the reaction, resulting in two major product types: cyclopentenones and saturated 









Scheme 2.8 Generic Thermal [3+2]-Cycloaddition Mechanism with Oxyallyl Cations 
2.2 Previous Nazarov Methodologies 
The Nazarov cyclization is a particularly powerful methodology that has led to the 
formation of very densely functionalized cyclopentenones. As powerful as it may be, the 
Nazarov previously suffered from several major drawbacks, including (1) the use of 
stoichiometric to super-stoichiometric amounts of very strong Brönsted or Lewis acids 
for activation, leading to (2) functional group incompatibility, and (3) lack of regio- and 
stereoselectivity although a pericyclic 4π-electrocyclization process (Scheme 2.9). The 
shortcomings of this methodology has been a focal point of several research groups, such 
as (1) Denmark, who developed a silicon-directed Nazarov cyclization to alleviate 
regioselectivity issues32 and later induce enantioselectivity,33 (2) Tius, who employed 
electron-donating groups at the α-position of pentadienyl cation precursors toward 
inducing activation via catalysis,34 (3) Frontier, who used both electron-donating and 
electron-withdrawing groups to effect a polarized Nazarov cyclization, leading to 
catalysis,35-36 (4) Aggarwal, who published a catalytic, enantioselective process by 










Scheme 2.9 Drawbacks of Early Nazarov Methodology 
Perhaps one of the most influential inspirations for this thesis work came from 
that of West’s group and the exploration of the interrupted Nazarov cyclization. West 
employed a number of nucleophilic trapping agents to capture the oxyallyl cation of the 
Nazarov mechanism, including halogens, hydrides, allylsilanes, (hetero)arenes, dienes, 
olefin cascades, heteroatoms, and azides, leading to unsaturated cyclopentanones, rather 
than the cyclopentenones of the traditional Nazarov cyclization (Scheme 2.10).38 
 











1. Stoichiometric Brönsted or Lewis acid required 
2. Functional group incompatibility











































2.3 Previous Formal Homo-Nazarov Methodologies 
As one might glean from the previous section, the Nazarov reaction of divinyl 
ketones has been extensively explored, and the breadth of literature on the topic continues 
to grow. When one replaces one of the vinyl groups with a cyclopropane, a homologous 
reaction type occurs: the formal homo-Nazarov (FHN) reaction. As discussed extensively 
in Chapter 1, cyclopropanes have similar reactivity to olefins. From this, one can 
reasonably assume that cyclopropanes can undergo activation by Brönsted or Lewis acids 
toward ring-opening cyclization to form six-membered, rather than five-membered, 
carbocycles. Over the last ten years, dozens of publications have appeared in the 
literature on this topic covering Brönsted acid-39 and Lewis acid-catalyzed40 reactions, the 
formation of cyclohexanone-fused heteroaromatics,41 continuous flow FHN chemistry,42 
and several natural product syntheses utilizing the methodology. 
With the plethora of FHN chemistry that has been developed, an interrupted 
variant of the FHN reaction remains underexplored chemical space. In this variant, much 
like West’s interrupted Nazarov, a number of nucleophiles could be used to provide 
access to a plethora of densely functionalized cyclohexanones, rather than the 
cyclopentanones of the interrupted Nazarov.  Before this work, to our knowledge, only 
one other publication involving an interrupted FHN variant had been explored. In this 
publication, Yadav and co-workers revealed an allylsilane-interrupted FHN cyclization 
using DACPs, 1.2 equivalents of SnCl4, and 10 equivalents of allyltrimethylsilane 
(Scheme 2.11).43 Pioneering within its own right, Yadav’s methodology was limited in a 
number of ways: (1) two regioisomers of the bicyclo[3.2.1]octanone product were formed 
with little selectivity, (2) a stoichiometric amount of the highly corrosive and toxic SnCl4 
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promoter is required, and (3) very limited substrate scope (only eight substrates, six of 
which used -CH2TBDPS as a donor). Considering these limitations, there exists a need 
for a more robust methodology both to alleviate these issues with the interrupted FHN 
cyclization and to further expand its viability in other synthetic applications. 
 
Scheme 2.11 Yadav’s Pioneering Interrupted FHN Cyclization 
2.4 The Development of a Catalytic Interrupted FHN Cyclization 
Drawing inspiration from previous methodologies developed in the France lab 
(Scheme 2.12),40-42 it was hypothesized that adding a second acceptor geminally to the 
first acceptor group would further polarize the cyclopropane C-C bond, helping to 
achieve catalytic ring-opening. In doing this, one would then alleviate one of the major 
issues with previous interrupted FHN methodologies and achieve catalysis. Catalysis also 
provides a much milder reaction environment, which could lead to better functional 
group tolerance, and thus, broader substrate scope. It was also hypothesized that adding 
the second acceptor would polarize the oxyallyl cation, resulting in regioselective attack 
by nucleophiles. Essentially, by simply adding a second acceptor group, one might be 































Scheme 2.12 France’s Previous Work with Cyclopropyl Vinyl Ketones 
2.4.1 Reaction Design 
Moving forward with designing a catalytic interrupted FHN cyclization, a 
moderate electron donor needed to be chosen in order to effect ring opening. Methyl and 
phenyl substituents were chosen as the donor groups, providing dual stabilization of the 
ring-opening cation intermediate; the phenyl group provides benzylic stabilization of the 
cation, and the methyl group creates a tertiary center. 1,3-dicarbonyls were chosen as 
acceptors due to their ease of accessibility and their ability to form six-membered 
coordinate complexes with oxophilic Lewis acids. More specifically, esters were chosen 
because of their ease of removability by Krapcho conditions in these systems, and their 
ability to induce charge localization of the oxyallyl intermediates. 
2.4.2 Synthesis of the Model Substrate and Proof of Principle 
The model substrate, shown in Scheme 2.13, was synthesized according to the 
France lab’s previously reported protocol.40 Its synthesis began by treating methyl 
malonyl chloride with methoxy methylamine and triethylamine to form a Weinreb amide 
ester, which is then taken forward for diazo transfer using tosyl azide and trimethylamine. 
The diazo then undergoes a Rh-catalyzed cyclopropanation with α-methylstyrene (AMS), 





















Scheme 2.13 Synthesis of the Model Donor-Acceptor-Acceptor Cyclopropane 
After synthesizing the model substrate, the model cyclopropane substrate was 
exposed to 30 mol % SnCl4 and 5 equivalents of allyltrimethylsilane in DCM at room 
temperature. SnCl4 was chosen due to its oxophilic character and strong Lewis acidity. It 
has also been shown in some of West’s previous publications that SnCl4 is tolerant of 
allylsilanes in interrupted Nazarov reactions.44 In this initial reaction, the desired 
allylated, interrupted FHN product was obtained in 65% yield as a keto-enol mixture, but 
some of the general FHN cyclohexenone product was also obtained (Scheme 2.14). 
While this provided important proof of concept, the reaction could be improved in two 
major ways: (1) decreased catalyst loading and (2) increased yield/selectivity toward the 
desired allylated products. 
 
Scheme 2.14 Initial Allylative Interrupted FHN Cyclization 
2.4.3 Reaction Optimization 
Optimization began with screening a number of Lewis acids at 20 mol % of the 
Lewis acid, 10 equivalents of allyltrimethylsilane, with the cyclopropane at 0.1 M in 
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moderate yields of the desired allylated product, albeit in reduced yields. 2+ salts favored 
FHN products over interrupted products. SnCl4 performed the most efficiently, giving the 
desired allylated product at 75% yield with a chemoselectivity of 17:1 of the desired 
product to the FHN product. Sc(OTf)3 gave the second highest yield; however, selectivity 
toward the allylated product was significantly reduced. All other Lewis acids gave 
significantly lower yields, reduced selectivity, or much longer reaction times.  
Because SnCl4 performed best in the catalyst screen, the next screen analyzed 
catalyst loading (Table 2.2). A series of 30, 20, 15, 10, and 5 mol % were each tested. 
The screen was conducted with 5 equivalents of allyltrimethylsilane and the model 
substrate at 0.1 M in DCM. 30 mol % performed best, yielding the allylated product in 
51% in one hour. However, 20 mol % gave 42% yield in 24 hours, with slightly higher 
selectivity. All other loading gave either significantly decreased yields or much longer 
reaction times. Because 30 mol % loading is indicative of low catalyst turnover, and 20 
mol % gave comparable yield with slightly higher selectivity, 20 mol % was carried 







Table 2.1 Lewis Acid Screening 
 
 
Entry Lewis Acid Time (hr) Yield (%)
a  
2-45 2-45:2-46 
1 SnCl4 24 75 17:1 
2 TiCl4 96 34 1:1.1 
3 In(OTf)3 2 41 1.7:1 
4 Sc(OTf)3 6 43 4.2:1 
5 Al(OTf)3 72 42 6.8:1 
6 Yb(OTf)3 70 26 2.3:1 
7 Ga(OTf)3 70 12 1:1.3 
8 Sn(OTf)2 48 20 1.2.4 
9 Zn(OTf)2 48 13 1.2.3 
10 Cu(OTf)2 48 11 1:6.7 
11 Mg(OTf)2 48 9 1:4.2 
12 InCl3 48 28 1:1.5 
13 BF3•Et2O 70 34 1.1:1 
a Isolated yields after column chromatography. 
 
Table 2.2 Various SnCl4 Loading 
 
Entry SnCl4 (mol %) Time (hr) 
Yield (%)a 
2-45 2-45:2-46 
1 30 1 51 1.9:1 
2 20 24 42 2.2:1 
3 15 24 32 2.1:1 
4 10 48 24 2.3:1 
5 5 48 16 2.8:1 
a Isolated yields after column chromatography. 
Because of the inherent corrosive properties and toxicity of neat SnCl4, the 
viability of In(OTf)3 as a back-up catalyst (Table 2.3) was screened. In(OTf)3 performed 
well in the initial screen, giving 41% yield of desired product in 2 hours, although 
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could both increase selectivity and yield. Lowering the loading of In(OTf)3 to 5 mol % 
did increase reaction time by 17 hours, but increased yield to 63% and selectivity from 
1.7:1 to 5.6:1 of the desired product to FHN product. 
Table 2.3 Various In(OTf)3 Loading 
 





1 20 2 41 1.7:1 
2 15 3 49 4:1 
3 10 5 43 2.7:1 
4 5 19 63 5.6:1 
a Isolated yields after column chromatography. 
b Reactions performed at 0.1 M in DCM at room temperature 
After determining 20 mol % SnCl4 to be the optimal catalyst and loading, the final 
screen tested the viability of other solvents in toward this reactivity (Table 2.4). Both 
polar protic and polar aprotic solvents, THF, and EtOAc provided only decomposition 
and side products. THF and EtOAc likely coordinated to the catalyst, preventing FHN 
reactivity. Only chlorinated solvents, hexane, and toluene gave any desired product. All 
of these solvents provided decreased yields and selectivities compared to DCM, so DCM 
was chosen as the optimal solvent.  
After choosing the optimal solvent, cyclopropane concentration and allylsilane 
loading was screened (Table 2.5). In this screen, 20 mol % of SnCl4 was used; the 
indicated loading of allylsilane, and DCM was used as the solvent. Increasing 
concentration to 1 M drastically decreased reaction time while slightly decreasing yield 
and significantly reducing selectivity. At 5 equivalents of allyltrimethylsilane, both yield 
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equivalents of allyltrimethylsilane by increasing concentration was also conducted. 
Unfortunately, only decreased reaction times were observed. In conclusion, the optimized 
conditions were determined to be 20 mol % SnCl4, 10 equivalents of allyltrimethylsilane, 
and the cyclopropane at 0.1 M in DCM. 
Table 2.4 Solvent Screen 
 
Entry Solvent Time (hr.) Yield (%)
a 
2-45 2-45:2-46 
1 MeOH 36 -- -- 
2 DMF 36 -- -- 
3 MeCN 10 -- -- 
4 THF 72 -- -- 
5 EtOAc 2 -- -- 
6 1,2-DCE 6 63 6.5:1 
7 Hexane 36 20 1.7:1 
8 Toluene 36 36 2.3:1 
9 DCM 24 75 17:1 
a Isolated yields after column chromatography. 
 
Table 2.5 Concentration and Allylsilane Loading Optimization 
 
Entry Conc. (M) Silane (equiv.) Time (hr) 
Yield (%)a 
2-45 2-45:2-46 
1 0.1 10 24 78 16.7:1 
2 1 10 2.5 60 1.9:1 
3 0.1 5 24 59 2.9:1 
4 0.3 5 26 47 2.2:1 
5 0.5 5 5 42 1.1:1 
6 1 5 1 57 2.1:1 







SnCl4 (20 mol %)

















SnCl4 (20 mol %)













2.4.4 Reaction Scope 
After obtaining the optimized conditions, the scope of differing substrates was 
investigated. In the course of the examination of scope, some diastereoselectivity was 
expected. The observed diastereoselectivities could be attributed to product development 
control, in which the transition state for allylsilane attack is late on the reaction 
coordinate, and therefore, very product-like.45-46 In this model, the product with the least 
torsional strain is produced following allylsilane attack. However, further studies need to 
be conducted to truly elucidate the origin of the diastereoselectivities. 
The first position altered was the donor group on the cyclopropane. The results of 
this study are contained in Scheme 2.15. The best performing donor was PMP, giving 
92% yield and 4.2:1 dr. Because of its very strong electron donating ability, this 
presumably decreases activation energy, thus increasing yield. A simple phenyl donor did 
not proceed well with SnCl4 as a catalyst, so In(OTf)3 was used instead, yielding 38% of 
desired product at a 2.4:1 dr. Highly electron deficient donors, such as the 4-CF3-phenyl, 
did not give any desired product under either SnCl4 or In(OTf)3 conditions, likely due to 
high activation energy toward ring opening. Heteroaromatic donors were also tolerated, 
giving moderate yield (65%) and low diastereoselectivity. 
 45 
 
Scheme 2.15 Investigation of the Cyclopropane Donor Group 
Next, the effect of different substituents on the vinyl group was investigated 
(Scheme 2.16). Para-methoxyphenyl was chosen as the cyclopropane donor due to the 
high yield of allylated product. Installing a β-silyl substituent does not provide β-silyl 
stabilization of the oxyallyl intermediate; it instead yields only FHN product through 
Hosomi-Sakurai-type elimination. A heteroatom in the α-position, however, gives the 
desired allylation product, whether through a cyclic or acyclic ether. Yields for these 























38%, dr = 2.4:1
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Scheme 2.16 Investigation of Vinylic Substituent Effects 
Finally, substituents on the allylsilane were explored (Scheme 2.17). Introducing 
a methyl group at the β-position to the trimethylsilyl group was well tolerated, giving 
68% yield and total diastereoselectivity. Geminal dimethyl allyltrimethylsilane does not 
give any desired product, presumably due to the large amount of steric hindrance upon 
oxyallyl attack. Finally, cinnamyl trimethylsilane is tolerated, giving the desired allylated 
product in 35% yield and a dr of 5.4:1.3:1:0. The low yield, much like the germinal 
dimethyl allyltrimethylsilane, can be attributed to significant steric hindrance toward 
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Scheme 2.17 Investigation of Substituents on Allylsilanes 
2.5 Chemodivergence in the Interrupted, FHN Cyclization 
As part of the study, it was further hypothesized that when bulkier allylsilanes are 
used, the silyl group could be retained. To begin the study, the optimized conditions were 
used with the PMP cyclopropyl donor and allyl-TBDPS. In the initial reaction, the 
temperature was also decreased in an attempt to further slow desilylation. Gratifyingly, 
the silyl group was retained, although an unexpected hexahydrobenzofuran product was 
obtained in 20% yield. This O-alkylated product is in stark contrast to the formal [3+2] 
C-alkylated product observed by Yadav and coworkers.43 Neither Yadav’s C-alkylated 
nor allylated FHN product was observed in this study. The lack of C-alkylated product is 
likely due to the polarization of the oxyallyl intermediate, forcing O-attack upon the β-
silyl stabilized cation. This represented the first example of this reactivity in the F 
cyclization. Its discovery instigated a further investigation, including optimization of the 
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2.5.1 Reaction Optimization 
Due to the initial success of SnCl4 as a catalyst, the first optimization screen 
investigated its loading using allyl-TBDPS as the allylsilane (Table 2.6). PMP was, again, 
chosen as the cyclopropane donor due to its efficiency toward the initial allylative, 
interrupted FHN conditions. Decreasing the concentration five-fold increased yield to 
33% and decreased degradation products. Further decreasing the concentration to 0.01 M 
increased yield slightly more to 37%. Increasing catalyst loading to 50 mol % increases 
yield to 49% also decreasing the amount of degradation observed. Increasing catalyst 
loading to 120 mol % drastically increased yield to 69%. Attempts to improve the 
reaction with other Lewis acids led to decreased yields and significant degradation.  
Table 2.6 Optimization of Lewis Acid/Concentration Toward Formal [3+2]-Cycloaddition 
 
Entry Loading (mol %) Conc. (M) Time (hr) Yield (%)
a 
1 20 0.1 3 20 
2 20 0.05 1 33 
3 20 0.01 2 37 
4 50 0.01 1 49 
5 100 0.01 0.25 48 
6 120 0.01 1 69 
a Isolated yields after column chromatography.  
b FHN products were not isolated. 
2.5.2 Substrate Scope and Limitations 
With optimized conditions in hand, substrate scope was then examined (Scheme 
2.18). A number of cyclopropane donors proved viable toward this formal [3+2] 






















those observed earlier in the allylative FHN cyclization. An α-ethoxy vinyl substituent 
also drastically improved diastereoselectivity. Bulky allylsilanes, such as allyl-TBDPS, 
allyl-TBS, allyl-TIPS afforded the highest yields due to drastically encumbered 
desilylation. Employing a labile allylsilane, such as allyl-TMS, was not tolerated due to 
the rapid rate of desilylation, giving only a 38% yield of the hexahydrobenzofuran 
product. 
 
a Isolated yields. b Stereochemistry shown for the major diastereomer. 
Scheme 2.18 Scope of the Tandem, Interrupted, FHN Cyclization/Formal [3+2] Cycloaddition 
2.6 Mechanistic Rationale of Allylative and Formal [3+2] Interrupted FHN 
Products 
In the preceding investigations of the FHN cyclization, only donor-acceptor-
acceptor cyclopropanes were used. The mechanism (Scheme 2.19) is suspected to 















































































secondary acyclic cation. This acyclic intermediate then undergoes ring closing via attack 
by the vinyl substituent, forming a cyclic oxyallyl cation. Because of the second acceptor 
group, this oxyallyl cation has a localized charged in the tertiary α’-position, which 
undergoes olefin attack by the appropriate allylsilane. A acyclic, β-silyl stabilized cation 
is formed, which then undergoes one of two pathways: (a) in the catalytic Lewis acid 
conditions, a labile allylsilane is used, which is desilylated via Hosomi-Sakurai-type 
elimination to form the allylated cyclohexanone products, or (b) in the stoichiometric 
Lewis acid conditions, a sterically encumbered allylsilane is used (hindering 
desilylation), which undergoes O-alkylation to form the formal [3+2]-cycloaddition, 
hexahydrobenzofuran products. A third pathway (c) is also possible, which forms C-
alkylated [3+2]-cycloaddition products; these products were not observed an any of our 
studies, likely due to the decreased nucleophilicity at the α-position owed to the 
secondary acceptor. 
 
































































2.7 Potential Utility of Interrupted FHN Products 
The potential synthetic utility of the products formed through the interrupted FHN 
reaction was demonstrated through a number of derivatizations (Scheme 2.20). Firstly, 
allylated cyclohexenols are easily capped with TMSCl and triethylamine, forming TMS-
enol ethers that can be used in further derivatizations. This TMS capping reaction was 
important in elucidating diastereomeric ratios of cyclohexenol products in the allylative, 
interrupted, FHN cyclization. Secondly, the ester groups can be removed via Krapcho 
decarbalkoxylation conditions to give cyclohexanones. Finally, a second allylation 
followed by a Grubbs’ RCM sequence leads to bicyclo[3.2.1]nonane frameworks, a 
scaffold found in the caryolane-type natural products. These simple derivatizations show 
the synthetic potential of these interrupted FHN products. 
 




















































2.8 A Novel, (Hetero)Arylative, Interrupted FHN Cyclization 
With robust conditions for both an allylative and a formal [3+2] cycloaddition 
interrupted FHN cyclization, it was then hypothesized that a similar, unexplored, 
(hetero)arylative variant could be established by similar mechanism, generating a variety 
of interesting α-(hetero)aryl cyclohexanones/cyclohexenols. In this pathway, the desired 
(hetero)aryl nucleophile would undergo Friedel-Crafts attack on the cyclic oxyallyl 
intermediate within the FHN mechanism. Reactivity of this type is precedented by West 
and coworkers, who established a Nazarov variant of this reaction.38 In this work, donor-
acceptor-acceptor cyclopropanes would be used as a means to promote catalysis and 
regiospecific (hetero)arylations. Henceforth, this would represent a divergent synthetic 
pathway in the interrupted FHN cyclization in which a simple change in nucleophile 
would result in drastically different products (Scheme 2.21). 
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2.8.1 Project Justification 
Methodologies have been developed to access α-(hetero)aryl cyclohexanones and 
generally fall into two different categories (Scheme 2.21). In the first category, normal 
polarity approaches have been developed utilize the nucleophilic nature of the α-position 
of carbonyls. Generally, a ketone is exposed to a base, generating an enolate, which 
subsequently attacks the electrophilic position of a (hetero)arene. In many examples, 
palladium catalysts are used to mediate such processes, readily providing access to α-
(hetero)aryl ketones (Scheme 2.22A).47 In other examples, either base or Lewis acid is 
use to generate an enolate and hypervalent iodide reagents act as electrophilic centers for 
α-(hetero)arylation (Scheme 2.22B).48 In a more recent example, MacMillan and co-
workers showcased an umpolung approach toward α-(hetero)aryl ketones using a base-
mediated generation of oxyallyl cations from α-tosyloxyketones (Scheme 2.22C).49 A 
(hetero)arylative, interrupted FHN cyclization would represent another complementary 
umpolung approach toward α-(hetero)aryl cyclohexanones.  
 







































This methodology would also provide access to a number of biologically relevant 
natural products containing this α-(hetero)aryl cyclohexanone structural motif (Figure 
2.1). Some examples include walsucochinoid D,50 an 11β-hydroxysteroid dehydrogenase 
type 1 (11β-HSD1) inhibitor, which could play a role in regulating type 2 diabetes, and 
the antibacterial diterpenoid natural product, 1-oxofurruginol.51 Other intriguing α-
(hetero)aryl natural products have also been isolated, including the antiviral alkaloid 
tubingensin A52 and the anticancer natural product fevicordin A.53  
 
Figure 2.1 α-(Hetero)Aryl Cyclohexanone Natural Products 
2.8.2 Reaction Design and Proof of Concept 
Due to its effectiveness in the previous allylative and formal [3+2] interrupted 
FHN cyclization, the PMP cyclopropane donor was again chosen as a model substrate. 
Anisole was chosen as the nucleophile for two reasons: (1) anisole has been shown as an 
effective nucleophile in a number of previous Friedel-Crafts transformations, and (2) 
para regioselectivity has been demonstrated for previous Friedel-Crafts reactions with 
anisole. The study began utilizing the optimized conditions from the previous allylative 
study (20 mol % SnCl4, 0.1 M in DCM, and 10 equivalents of nucleophile) to effect the 
transformation (Scheme 2.23). Gratifyingly, the reaction proceeded smoothly, giving the 
desired α-PMP cyclohexanone in 67% yield as a keto-enol mixture. The reaction was also 



































FHN product. The represented the first literature example of an arylative, interrupted 
FHN cyclization. 
 
Scheme 2.23 Initial Arylative Interrupted FHN Cyclization Reaction 
2.8.3 Reaction Optimization 
After obtaining this pleasing initial result, a number of efforts were made to 
further optimize the reaction, focusing on increasing yield of and selectivity toward the 
arylated product, decreasing catalyst loading, and finding a suitable alternative catalyst to 
the highly toxic SnCl4. A number of 2+, 3+, and 4+ Lewis acids were screened (Table 
2.7). Unfortunately, no suitable alternative to SnCl4 was found, producing the highest 
yields and selectivity toward the desired product. However, InCl3 gave comparable yields 
to SnCl4 but approximately half of the selectivity.  
Considering the high yields of each catalyst, both were taken forward for further 
loading studies (Table 2.8). Reducing the loading of SnCl4 to 10 and 5 mol % decreased 
yield to 56% and 50% respectively. Similarly, decreasing the loading of InCl3 to 15, 10, 
and 5 mol % also reduced yield to 65%, 62%, and 38% respectively. With only a 
decrease of 7% in yield, 10 mol % InCl3 would be taken forward as a suitable, non-toxic 
back-up catalyst for substrates not compatible with SnCl4. All other attempts to optimize 

























led to no improvement. The optimal conditions moving forward were 20 mol % SnCl4 
(with 10 mol % InCl3 as a back-up), 10 equivalents of the (hetero)arene, and the 
cyclopropane at 0.1 M in DCM reacting at room temperature. 
Table 2.7 Lewis Acid Screen 
 





1 SnCl4 1 67 3 
2 Mg(OTf)3 27 63b 11 
3 Cu(OTf)3 1.5 0 25 
4 Al(OTf)3 1 0 26 
5 In(OTf)3 1 11 19 
6 Sc(OTf)3 1 10 15 
7 Ga(OTf)3 1 0 24 
8 Ni(OTf)2 21 40b 15 
9 La(OTf)3 21 40b 16 
10 Zn(OTf)2 1.5 0 26 
11 Yb(OTf)3 1 0 0 
12 In(OTf)3 + LiCl (1 eq.) 1 19 26 
13 BF3•Et2O 1 0 0 
14 InCl3 24 69 6 
15 TiCl4 24 0 0 
16 Ca(NTf)2•n-Bu4NPF6 0.5 0 36 
a Isolated yields after column chromatography.  
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Table 2.8 Optimization of Catalyst Loading 
 
Entry Lewis acid Loading (mol %) Time (hr) Yield (%)
a 
1 SnCl4 20 1 67 
2 SnCl4 10 1 56 
3 SnCl4 5 1 50 
4 InCl3 20 24 69 
5 InCl3 15 24 65 
6 InCl3 10 24 62 
7 InCl3 5 24 38 
a Isolated yields after column chromatography. 
 
2.8.4 Reaction Scope 
After obtaining the optimized conditions, substrate scope was examined. First, a 
number of different donor groups on the cyclopropane were tested using anisole as the 
nucleophilic trapping agent (Scheme 2.24). More electron deficient donors (Ph, 4-F-Ph) 
were well tolerated, providing products in moderate yields (44% and 56%, respectively). 
A β-silyl stabilized cation provided the aryl-trapped product in 57% yield with good 
diastereoselectivity, likely attributed to a steric effect of TBDPS. A tertiary cation (R1 = 
Me, R2 = Ph) was also a useful substrate, but provided low diastereoselectivity (2.0:1). 
Finally, a heteroaromatic donor was well suited for reactivity, giving the desired product 
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Scheme 2.24 Examination of Cyclopropane Donors 
Next, two vinylic substituents other than methyl were examined (Scheme 2.25). 
When methyl is replaced with an ether substituent, no desired product is obtained, likely 
due to the reduced electrophilicity of the oxyallyl cationic intermediate. This is in stark 
contrast to the result obtained in the allylative interrupted FHN study, which gave good 
yields and a single diastereomer. Adding a β-silyl substituent also resulted in no desired 
product; only FHN product was obtained. This is likely attributed to the quick Hosomi-






























67%, dr = 7.7:1
2-80b
44%, dr = 4.5:1
2-80c
56%, dr = 10.5:1
2-80d
62%, dr = 8.3:1
2-80e
57%, dr = 11.2:1
2-80f
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Scheme 2.25 Investigation of Vinylic Substituents 
Thirdly, a set of arene nucleophiles besides anisole was investigated (Scheme 
2.26). Blocking the 4-position of anisole with a methyl group (thus inducing attack at the 
2-position) drastically reduces yield, indicating a significant steric effect preventing aryl 
attack at the 2-position. Both 1,2- and 1,3-dimethoxybenzene served as effective 
nucleophiles giving the desired product in 72% and 88% yields respectively. 1-
methoxynaphthalene was also a competent nucleophile, giving the 4-substituted 1-
methoxynaphthalene product exclusively in 70% yield. A non-basic aniline derivative, 
triphenylamine, was effective as well; however a basic aniline derivative, such as N,N-
dimethylaniline, was not efficacious, likely due to catalyst poisoning by the basic amine. 
Several electron deficient arenes (2-83,f-m) were examined as well. However, no desired 
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Scheme 2.26 Investigation of Various Arene Nucleophiles 
Finally, a number of heteroarenes were investigated as effective trapping agents 
(Scheme 2.27). N-methyl and N-tosyl pyrroles gave no desired products; N-methyl 
pyrrole was too effective a nucleophile, and attacked the acyclic cation produced upon 
ring opening. N-tosyl pyrrole, on the other hand, is not as nucleophilic; only FHN product 
was obtained. Benzothiophene and N-tosyl indole were effective nucleophiles, giving the 
desired products in 73% and 69% yield respectively. 2,5-dimethylfuran and 2,5-dimethyl 
thiophene also worked well, showing that steric influence has little effect on smaller 
heteroarenes nucleophiles. Furan and thiophene were efficacious, giving only 2-
substituted products, due to the increased nucleophilicity at that position. However, N-
tosyl-3-methylindole was not a potent nucleophile for this transformation, likely due to 











88%, dr = 6.8:1
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71%, dr = 2.0:1
2-84b
72%, dr = 5.3:1
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2-methoxythiophene proceeded to give exclusively the 5-substituted product in 75% 
yield. 
 
Scheme 2.27 Investigation of Heteroarene Nucleophiles 
All products contained in the above substrate scope were obtained as highly 
complex keto-enol tautomers and diastereomeric mixtures. As such, two methods were 
examined to simplify NMR spectra to definitively obtain dr. The first method, O-
silylation with TMSCl, was not effective likely due to the significantly sterically 
encumbered enol. However, subjecting each substrate to Krapcho decarbalkoxylation 
conditions provided greatly simplified NMR spectra, allowed for definitive dr 
determinations via crude NMR of the Krapcho reaction, and provided effective separation 
of the diastereomers in column chromatography. NOE NMR of the minor diastereomers 
revealed a correlation between the benzylic proton and the α-methyl groups that was not 



















(R = Me) No desired product
(R = Ts) No desired product
2-86e-f
(X = O) 87%, dr = 3.8:1
(X = S) 74%, dr = 4.1:1
2-86c-d
(X =S) 73%, dr = 2.3:1
(X = NTs) 69%, dr = 2.6:1
2-86i-j
(X = O) 66%, dr = 1.8:1
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substituents have a trans- relationship across the cyclohexanone. This also gave evidence 
to nucleophiles favoring oxyallyl approach opposite the aryl donor in order to minimize 
unfavorable 1,3-diaxial interactions. 
2.8.5 Utility of α-(Hetero)Aryl Cyclohexanone Products 
The potential synthetic utility of the products generated from the arylative 
interrupted FHN cyclization was demonstrated through a simple derivatization sequence 
(Scheme 2.28). Inspired by Padwa’s work on alkenes tethered to furans,54 it seemed 
sensible to attempt to tether an allyl group to the α-furyl substituted cyclohexanones 
generated from the demonstrated arylative interrupted FHN cyclization. Cyclohexanone 
2-86i was allylated using sodium hydride and allyl bromide to form the now tethered 
alkene system 2-88 in 53% yield as an inseparable diastereomeric mixture of 
7.1:3.6:3.1:1 dr. This mixture was then heated to promote a Diels-Alder [4+2]-
cycloaddition to form the tricyclic core 2-89 in 46% yield (based on recovered starting 
material), a scaffold found in the Swietenia mahagoni limonoid natural products.55 
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Scheme 2.28 Synthetic Utility of Arylative Interrupted FHN Products 
2.9 Efforts Toward an Intramolecular Arylative Interrupted FHN Cyclization 
Considering each of the examples thus far of an interrupted FHN cyclization 
(allylative, alkylative, or arylative) has been an intermolecular transformation, one might 
acknowledge the need for an intramolecular variant. As shown previously in Figure 2.1, 
many α-(hetero)aryl cyclohexanone natural products have (hetero)aryl substituents linked 
directly to the cyclohexanone core directly at the α-position and at the β-position through 
an alkyl tether. As such, a simple alkyl tether to the (hetero)aryl nucleophile in the 
interrupted FHN cyclization would provide facile access to this polycyclic architecture 
found in these natural products (Scheme 2.29). Using cis-1-oxofurruginol as an example, 
one might envision arriving at the polycyclic framework using an intramolecular, 
arylative, interrupted FHN cyclization. The cis-framework in this strategy is essential, as 
it is expected that the tethered aryl nucleophile will attack from the same side from which 




































tether. This ethylene tether would be attached via a Horner-Wadsworth-Emmons reaction 
between the aldehyde 2-93 and the β-ketophosphonate ester 2-94. 2-94 could be accessed 
via a deprotonated phosphonate and the cyclopropyl diester 2-95. 
 
Scheme 2.29 Retrosynthetic Analysis Toward an Intramolecular, Arylative, Interrupted FHN Cyclization 
2.9.1 Previous Efforts 
Sometime before the above synthetic route was proposed, Raynold Shenje 
proposed and attempted a number of sequences toward the tethered arene substrate. His 
attempted routes are summarized in Scheme 2.30. His first synthetic attempt (Scheme 
2.30A) involved a Grubbs cross metathesis of a substrate from the previous interrupted 
FHN studies with a homoallylic 3-methoxybenzene, with no success. In this pathway, 
there was likely dimerization with the alkene 2-96. Secondly, Shenje attempted a 
Knoevenagel condensation of the β-ketoester cyclopropane 2-98 with aldehyde 2-93, 
again with no success (Scheme 2.30B). In this attempt, the high temperatures likely 
caused ring-opening degradation products originating from the cyclopropane. His final 
synthetic attempt involved tethering the arene to an unsaturated ester first, then building 
the donor-acceptor-acceptor cyclopropane, again, with no success (Scheme 2.30C). In 




































alkene center that can react and form a cyclopropyl dimer product. The route proposed in 
the above retrosynthetic analysis provides a number of advantages over previous 
attempts: (1) assembling the cyclopropane first prevents dimerization issues with 
cyclopropanations in the prescence of two alkenes, (2) all subsequent reactions after 
cyclopropanation are conducted at low temperature, slowing ring-opening degradation 
reactions of cyclopropanes at higher temperatures, and (3) attaching the tethered arene in 




Scheme 2.30 Raynold Shenje’s Previous Attempts at a Tethered Aryl Nucleophile 
2.9.2 Current Work and Proof of Concept 
This work began with deprotonation of the commercially available diethyl 
ethylphosphonate (2-103) and reacting with the cyclopropane 2-104, a common 
intermediate in the previous interrupted FHN studies, to produce the β-ketophosphonate 
cyclopropane 2-105. After several optimizations (Table 2.9), yields for this carbonyl 
addition were increased from 42% to 82% yield by using 1.2 equivalents of deprotonated 








































































Wadsworth-Emmons reaction with aldehyde 2-93 proved to be much more difficult than 
anticipated, giving an initial yield of 12%. After a host of optimizations (Table 2.10), 
including altering bases and equivalents of bases, yield was increased to only 39%. 
However, enough material was obtained to continue forward to probe the viability of the 
intramolecular, arylative, interrupted FHN cyclization. Gratifyingly, upon initial exposure 
to the optimized conditions of the allylative and arylative interrupted FHN studies 
(excluding the arene nucleophile), the desired product was obtained in 21% yield. 
Changing Lewis acid catalyst to In(OTf)3, however, increased yield to 41%. To our 
knowledge, this represented the first example and proof of concept toward an 
intramolecular, arylative, interrupted FHN cyclization (Scheme 2.31). This also provides 
an important stepping-stone toward using these interrupted FHN methodologies in the 
synthesis of polycyclic α-arylcyclohexanone natural products scaffolds. 





(equiv.) Base (equiv.) 
Yield (%) 
2-105 
1 3 n-BuLi (1.1) 42 
1.2 1 n-BuLi (1.3) 63 
1 1.2 n-BuLi (1.1) 53 
1.2 1 LiHMDS (1.3) 0 
1.2 1 n-BuLi 82b 





















(equiv.) Base (equiv.) 
Yield (%) 
2-97 
1.1 1 NaH (1.3) 12 
1.1 1 NaH (1.2) 26b 
1.1 1 n-BuLi (1.15) 6 
1.1 1 LiHMDS (1.2) 10 
1.1 1 NaH (5) 9c 
1.1 1 NaH (1.2) 18d 
1.1 1 NaHMDS (1.2) 9 
1.1 1 DBU (1.2) 10e 
1.1 1 NaH (1.2) 39d,f 
a Isolated yields. b Fresh NaH used. 
 c Stirred while warming to room temperature overnight. 
 d Slow addition of aldehyde over three hours. 
 e Stirred at room temperature overnight. 
 f Stirred with warming to room temperature overnight. 
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2.10 Summary: Allylative, Alkylative, and Arylative Methods in the Interrupted 
FHN Cyclization 
FHN methodologies are becoming more prevalent in the literature toward the 
constructive of highly complex cyclohexanone scaffolds; however, until the publication 
of this work, only one known publication of an interrupted variant was known. Included 
in this chapter are the first Lewis acid-catalyzed allylative and arylative interrupted FHN 
cyclizations, and a stoichiometric Lewis acid-mediated alkylative interrupted FHN 
cyclization. The interruption of the FHN reaction originates from the ability of competent 
nucleophiles to capture cyclic oxyallyl cationic intermediates within the FHN 
mechanism.  
The first catalytic allylative method was disclosed using 20 mol % SnCl4 and 
allylsilane nucleophiles as nucleophiles toward a FHN ring-opening/ring-
closing/Hosomi-Sakurai cascade. Reaction products were provided in moderate to high 
yields and moderate to excellent diastereoselectivities. Concurrently, an alkylative 
method was disclosed using stoichiometric SnCl4 and allylsilanes to initiate a 
FHN/formal [3+2]-cycloaddition cascade toward the formation of unique 
hexahydrobenzofuran scaffolds. In a follow-up study, it was also discovered that 
(hetero)arenes are effective nucleophiles toward interrupting the FHN cyclization through 
a Friedel-Crafts alkylation pathway to form α-(hetero)aryl cyclohexanones using SnCl4 as 
a Lewis acid catalyst. Follow-up studies toward intramolecular, arylative, interrupted 
FHN cyclizations have also began. These studies serve as some of the pioneering 




Scheme 2.32 Scope of the Interrupted FHN Reaction Thus Far 
2.11 Experimental Section 
2.11.1 Interrupted FHN Cyclizations with Allylsilanes 
For both experimentals and NMR spectra for work in the interrupted FHN 
cyclization using allylsilanes, see Shenje, R.; Williams, C. W.; Francois, K. M.; France, 
S. Catalysis and Chemodivergence in the Interrupted, Formal Homo-Nazarov Cyclization 
Using Allylsilanes. Org. Lett. 2014, 16 (24), 6468-6471.   
2.11.2 Intermolecular, (Hetero)Arylative, Interrupted FHN Cyclizations 
For both experimentals and NMR spectra for work in the intermolecular, 
(hetero)arylative interrupted FHN cyclization, see Williams, C. W.; Shenje, R.; France, S. 














(yield up to 69%)













(yield up to 92%)





























(yield up to 88%)
(dr up to 12:1)
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α-(Hetero)aryl Cyclohexanones. J. Org. Chem. 2016, 81, 8253-8267. 
2.11.3 Intramolecular, Arylative, Interrupted FHN Cyclizations 
Chromatographic purification was performed as flash chromatography with 
Silicycle silica gel (40-65µm) or preparative thin-layer chromatography (prep-TLC) 
using Silicycle silica gel F254 (1000 µm) plates and solvents indicated as eluent with 
nitrogen for pressure. For quantitative flash chromatography, technical grades solvents 
were utilized. Analytical thin-layer chromatography (TLC) was performed on Silicycle 
silica gel 60 F254 TLC glass plates. Visualization was accomplished with UV light. 
Infrared (IR) spectra were obtained using a Shimadzu IRAffinity-1S FTIR with a 
Specac Quest ATR attachment. The IR bands are characterized as weak (w), medium 
(m), and strong (s). Proton and carbon nuclear magnetic resonance spectra (1H NMR and 
13C NMR) were recorded on a Varian Mercury Vx 300 MHz spectrometer, or Bruker 400 
MHz and 500 MHz spectrometers with solvent resonances as the internal standard (1H 
NMR: CDCl3 at 7.26 ppm; 13C NMR: CDCl3 at 77.0 ppm). 19F NMR spectra were 
recorded on a Bruker 400 MHz spectrometer using PhCF3 as an external standard. 1H and 
19F NMR data are reported as follows: chemical shift (ppm), multiplicity (s = singlet, d = 
doublet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of 
doublets, t = triplet, m = multiplet, br = broad), coupling constants (Hz), and integration. 
Mass spectra were obtained using a MicroMass Autospec M.  The accurate mass analyses 
were run in EI mode at a mass resolution of 10,000 using PFK (perfluorokerosene) as an 
internal calibrant. Uncorrected melting points were measured with a digital melting point 
apparatus (DigiMelt MPA 160).  
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3-(3-methoxyphenyl)propan-1-ol: Lithium aluminum hydride (4.21 g, 111 
mmol) was added to a flask, suspended in THF (70 mL), and cooled to 0°C. 3-(3-
methoxyphenyl)propanoic acid (5.00 g, 27.7 mmol) in THF (70 mL) was added slowly 
and stirred at 0°C for 2 hours. The reaction was quenched at 0°C with sat. aq. NH4Cl 
until evolution of H2 ceased and EtOAc was added. 1 M HCl was then added until the 
resulting aluminum salts dissolved. The resulting mixture was extracted three times with 
EtOAc, washed with sat. aq. NaHCO3, washed with brine, dried over MgSO4, filtered 
through celite, and concentrated to give the resulting alcohol (4.6702 g, >99%) as a 
brown oil. The alcohol was carried forward without further purification. Characterization 
was consistent with that previously reported.56 
 
3-(3-methoxyphenyl)propanal: IBX (3.30 g, 11.7 mmol) was added to a flask 
and suspended in MeCN (36 mL). 3-(3-methoxyphenyl)propan-1-ol (1.52 g, 9.14 mmol) 
was then added neat and the mixture was heated to reflux overnight. The reaction mixture 
was cooled to room temperature and filtered through a pad of celite, which was rinsed 
with EtOAc, and concentrated to give a brown oil (1.51 g, 98% yield) which was used 










General procedure for phosphonate substitution on cyclopropyl diesters:  
Adapted from Lee’s published procedure.58 The appropriate phosphonate (1.2 eq.) 
was added to a flask and dissolved in THF (1.0 M in relation to phosphonate) and cooled 
to -78°C. n-Butyllithium (1.3 eq.) was added and stirred at -78°C for 3 hours. The 
cyclopropyl diester (1.0 eq.) was dissolved in THF (1.0 M in relation to the cyclopropyl 
diester) and added and stirred at -78°C until the cyclopropyl diester was fully consumed 
by TLC analysis. The reaction was quenched with sat. aq. NH4Cl (unless otherwise 
indicated), extracted three times with EtOAc, washed with brine, dried over Na2SO4, 




propane-1-carboxylate: Synthesized according to the general procedure using diethyl 
ethyl phosphonate (1.10 mL, 6.811 mmol), n-butyllithium (3.00 mL, 7.50 mmol), and 
dimethyl 2-(4-methoxyphenyl)cyclopropane-1,1-dicarboxylate59  (1.50 g, 5.68 mmol) for 
1 hour after addition of the cyclopropyl diester. After work-up and purification (Rf = 0.14, 
50% EtOAc/Hexane), the desired cyclopropyl phosphonate 2-105 (1.87 g, 82% yield) 
was given as a colorless oil. Diastereomeric ratio = 4.20:3.88:1:0. 1H NMR (500MHz, 
CDCl3) δ = 7.36 - 7.35 (m, 0.49 H), 7.25 - 7.21 (m, 0.47 H), 7.13 - 7.09 (m, 2.06 H), 6.89 
- 6.87 (m, 0.53 H), 6.82 - 6.77 (m, 2.52 H), 4.48 - 4.31 (m, 1.59 H), 4.23 - 3.98 (m, 6.85 
H), 3.80 (s, 0.81 H), 3.78 - 3.76 (m, 3.54 H), 3.71 (s, 0.73 H), 3.41 (t, J = 8.7 Hz, 1.07 H), 









2.37 (dd, J = 4.6, 8.2 Hz, 1.05 H), 2.21(dd, J = 4.6, 8.5 Hz, 0.21 H), 2.09 (m, J = 4.6, 9.5 
Hz, 0.21 H), 1.75 (dd, J = 4.6, 9.2 Hz, 1.19 H), 1.47 - 1.38 (m, 4.71 H), 1.36 - 1.28 (m, 
8.53 H), 1.26 - 1.18 (m, 1.90 H). 13C NMR (126MHz, CDCl3) δ = 200.3, 168.8, 158.9, 
130.3, 130.1, 127.4, 126.6, 113.8, 113.4, 113.3, 62.7, 62.6, 62.5, 62.5, 55.3, 55.2, 51.7, 
51.0, 44.8, 44.3, 43.3, 36.5, 23.8, 16.4, 16.4, 16.4, 16.3, 16.3, 10.9, 10.8. IR: 2984 (w), 
2945 (w), 1717 (m), 1697 (m), 1637 (m), 1612 (m), 1516 (s), 1246 (s), 1016 (s) cm-1. 
HRMS (EI) m/z: [M]+ Calcd. for C19H27O7P 398.1494; Found 398.1490.  
 
General procedure for the synthesis of cyclopropyl vinyl ketones:  
Sodium hydride (60% dispersion in mineral oil, 1.2 eq.) was suspended in THF 
(0.5 M in relation to NaH) and cooled to 0°C. The appropriate cyclopropyl phosphonate 
(1.1 eq.) in THF (0.33 M in relation to the cyclopropyl phosphonate) was added and 
stirred at 0°C for 30 minutes. The subsequent aldehyde (1.0 eq.) was dissolved in THF 
(10 mL) and added via syringe pump over 3 hours. The reaction solution was allowed to 
warm to room temperature overnight or until consumption of the cyclopropyl 
phosphonate. The reaction was then quenched with sat. aq. NH4Cl, extracted three times 
with EtOAc, washed with brine, dried over Na2SO4, filtered through celite, and 












using sodium hydride (111 mg, 2.78 mmol), cyclopropyl phosphonate 2-105 (975 mg, 
2.45 mmol) and 3-(3-methoxyphenyl)propanal (369 mg, 2.25 mmol) stirring at room 
temperature overnight. After work-up and purification (Rf = 0.46, 20% EtOAc/Hexane), 
the desired cyclopropyl vinyl ketone 2-97 (356 mg, 39% yield) was given as a colorless 
oil. E/Z ratio = 3.57:1. 1H NMR (500MHz, CDCl3) δ = 7.23 - 7.19 (m, 1.34 H), 7.17 - 
7.11 (m, 2.46 H), 6.82 - 6.77 (m, 3.36 H), 6.77 - 6.71 (m, 3.00 H), 6.65 - 6.62 (m, 1.00 
H), 5.60 - 5.55 (m, 0.28 H), 3.81 - 3.80 (m, 1.10 H), 3.80 (s, 2.69 H), 3.78 (s, 3.38 H), 
3.41 (t, J = 8.7 Hz, 0.30 H), 3.35 (s, 0.78 H), 3.33 - 3.27 (m, 3.81 H), 2.74 - 2.69 (m, 1.99 
H), 2.67 - 2.64 (m, 0.57 H), 2.61 - 2.46 (m, 2.61 H), 2.29 - 2.25 (m, 0.39 H), 2.22 (dd, J = 
4.9, 7.9 Hz, 0.95 H), 1.93 - 1.92 (m, 0.75 H), 1.82 (d, J = 1.2 Hz, 2.77 H), 1.70 - 1.65 (m, 
0.29 H), 1.44 (dd, J = 4.9, 9.2 Hz, 0.96 H). 13C NMR (126MHz, CDCl3) δ = 196.0, 
169.2, 159.7, 158.6, 142.5, 141.2, 137.2, 129.9, 129.4, 127.0, 120.7, 114.1, 113.4, 111.4, 
55.1, 52.0, 41.4, 34.6, 30.5, 29.7, 19.8, 12.1. IR: 2949 (w), 1732 (m), 1664 (m), 1610 




1,2,3,4,4a,9,10,10a-octahydrophenanthrene-3-carboxylate: Cyclopropane 2-97 (100 
mg, 0.245 mmol) was dissolved in DCM (4.9 mL) with 4Å molecular sieves and SnCl4 (6 
µL, 0.049 mmol) was added. The reaction was stirred for 3 hours and quenched with 









Na2SO4, filtered through celite, and concentrated. The crude residue was purified by flash 
chromatography (Rf = 0.33, 20% EtOAc/Hexane) to give 2-106 (25 mg, 25% yield) as a 
colorless oil. 1H NMR (500MHz, CDCl3) δ = 7.17 - 7.12 (m, 2 H), 6.89 - 6.85 (m, 2 H), 
6.78 - 6.75 (m, 2 H), 6.73 - 6.71 (m, 1 H), 3.82 - 3.79 (m, 6 H), 3.76 - 3.74 (m, 3 H), 3.68 
(dd, J = 5.2, 13.4 Hz, 1 H), 3.00 - 2.88 (m, 2 H), 2.68 (dd, J = 6.7, 18.0 Hz, 1 H), 2.31 - 
2.12 (m, 3 H), 1.91 - 1.82 (m, 1 H), 1.47 - 1.40 (m, 4 H). 13C NMR (126MHz, CDCl3) δ 
= 208.7, 170.5, 158.4, 158.3, 135.8, 135.2, 129.9, 128.2, 114.7, 114.1, 113.2, 55.2, 55.2, 
54.2, 53.5, 52.0, 48.3, 40.6, 37.7, 27.0, 24.2, 20.4. IR: 2949 (w), 2837 (w), 1742 (m), 
1705 (m), 1609 (m), 1512 (m), 1242 (s) cm-1. HRMS (EI) m/z: [M]+ Calcd. for C25H28O5 
408.1937; Found 408.1945. 
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CHAPTER 3. PROGRESS TOWARD THE SYNTHESIS OF 
PROPOLISBENZOFURAN B 
3.1 Propolis: From Alternative Medicine to Attractive Natural Product Source 
Not to be confused with beeswax, propolis is a strongly adhesive resin collected 
by bees from a number of botanical sources. It is collected by bees and mixed with 
various salivary enzymes, beeswax, and other digested material, and is used for the 
strengthening of the honeycomb and preventing the entrance of intruders into the hive 
(hence its alternative name, bee glue). Because propolis is formed from various botanical 
sources, the composition of propolis used in hives differs greatly depending on the plants 
from which it is sourced. For example, propolis obtained from temperate zones, such as 
Europe, contain mostly phenolic compounds and flavonoids (Figure 3.1A);1 however, 
propolis obtained from tropical zones contain vastly different molecular architectures, 
such as labdane diterpenoids (Figure 3.1B).2 Dating back as far as 300 B.C.,3 propolis has 
been reputed to have a number of potent biological properties, including antiseptic, 
antifungal, anti-inflammatory, antioxidant, and anesthetic properties.4 Propolis and its 
extracts are currently in use across the globe in many alternative medicine products, 
mostly for dermatological applications. Because of propolis’s reputation for biological 
activity, the natural products within propolis extracts have become an attractive target as 
new therapeutic compounds.  
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Figure 3.1 Different Molecular Architectures within Propolis from Different Areas 
Brazilian propolis in particular has become a plentiful source of bioactive 
molecules, with its phytochemical diversity most attributed to the number of types of 
propolis found within the country. Many different compounds have been isolated from 
Brazilian propolis, including the anti-inflammatory agents apigenin, artepillin C, and 
many others.5 In 2000, two novel benzofuran natural products, propolisbenzofurans A 
and B (Figure 3.2), were isolated from Brazilian propolis and were found to have modest 
cytotoxic effects toward liver-metastatic murine colon 26-L5 carcinoma (12.4 and 13.7 
µg/mL, respectively) and human HT-1080 fibrosarcoma (13.9 and 43.2 µg/mL, 
respectively).6 However, like many other natural products, propolisbenzofurans A and B 
do not exist in great abundance from the crude material from which they were extracted. 
From 1.8 kilograms of raw Brazilian propolis, only 7 milligrams of Propolisbenzofuran A 
and 18.2 milligrams of propolisbenzofuran B were obtained. As such, more extensive 
investigation into the bioactive properties of these two molecules is not feasible if only 






























Figure 3.2 Propolisbenzofurans A and B 
Propolisbenzofuran A possesses a central 3,4-dihydro-2H-pyran core scaffold, 
with one of the major substituents consisting of a 5-hydroxy-6-acetylbenzofuran (shown 
in red, Figure 3.2) attached at its 2-position, and the other two substituents appearing to 
derive from an acetylated ferulic alcohol in a trans configuration across the pyran ring 
(shown in blue, Figure 3.2). Propolisbenzofuran B, on the other hand, possesses a rather 
unique 5-hydroxy-6-acetylbenzofuran-fused cyclohexanone (shown in red) core scaffold, 
with the other two substituents again being derived from an acetylated ferulic alcohol in a 
trans configuration across the cyclohexanone ring (shown in blue). Because of its unique 
heteroaryl-fused cyclohexanone core, modest anticancer potency, and the need for further 
biological investigations, propolisbenzofuran B remains an attractive target to synthetic 
chemists. 
3.2 Previous Synthetic Efforts Toward Propolisbenzofuran B 
As an attractive target to synthetic chemists, two groups thus far have synthesized 
propolisbenzofuran B, each within the last five years. The first synthesis was published in 
2014 by Thomson and co-workers;7 this synthesis featured a CAN-mediated oxidative 
coupling between two silyl tethered enolates as a key step. The majority of the synthesis 
















Colon Carcinoma ED50 = 12.4 µg/mL
Fibrosarcoma ED50 = 13.9 µg/mL
3-6, Propolisbenzofuran B
Colon Carcinoma ED50 = 13.7 µg/mL
Fibrosarcoma ED50 = 43.2 µg/mL
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B was published in 2017 by Ramana and co-workers;8 this synthesis featured a rhodium-
catalyzed intramolecular hydroacylation as the key step to form the benzofuran fused 
cyclohexanone core. The majority of this synthesis will also be discussed in detail in 
Chapter 3.2.2. 
3.2.1 Thomson’s Synthesis of Propolisbenzofuran B7 
Although Thomson and co-workers were forced to retool their original synthesis 
to accompany a failed late-stage Fries acylation, a great majority of their synthetic 
sequence remained the same. To begin the synthesis (Scheme 3.1), Thomson and co-
workers began by first alkylating vanillin with isopropyl bromide, followed by a Horner-
Wadsworth-Emmons reaction with methyl diethylphosphonoacetate to form the methyl 
ferulic ester derivative 3-9. This ferulic ester was then heated with the Rawal-Kozmin 
diene 3-10 to undergo a Diels-Alder cycloaddition to form a cyclic enol ether, followed 
by reduction of the ester with LiAlH4 and removal of the TBS protecting 
group/elimination of diethylamine to form cyclohexenone 3-11. Protection of the primary 
alcohol followed by bromination formed the vinyl bromide 3-12 in 72% yield over 2 
steps. This vinyl bromide would serve as a major fragment of the molecule as part of a 
convergent synthetic sequence. 
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Scheme 3.1 Thomson’s Vinyl Bromide Fragment 
Thomson’s retooling came from the failure of a late stage Fries acylation of the 
benzofuran, originating from cyclohexenone 3-13. However, from simply adding an ethyl 
group to form 3-14, oxidation of the benzylic methylene unit to a ketone would later 
provide the desired natural product. Compound 3-14 is readily accessible from a three-
step sequence from the commercially available cyclic vinyligous ester 3-16, giving 79% 
yield over three steps. From 3-14, formation of the silyl enol ether, followed by reaction 
of the enolate of 3-12 gives the asymmetric silyloxy compound 3-17 in 98% yield. In the 
next step, Thomson demonstrated an oxidative coupling using ceric ammonium nitrate 
(CAN) between two enolates tethered by a silyl group to form the stereoisomeric mixture 
of 1,4-diketone 3-18. This isomeric mixture, however, was no unpleasant consequence, as 
the only important stereocenters were previously set in the Diels-Alder step. Gratifyingly 
for Thomson’s group, this oxidative coupling step represented a key methodological 
showcase for some of their previous work.9-11  
After removal of the TES protecting group, oxidation with PCC on silica gel 
formed a dihydroquinone which, when exposed to TMSOTf, undergoes a benzannulation 




































this second key step, masking of the benzofuran alcohol with an isopropyl group allowed 
for a clean chromium-mediated oxidation of the benzylic methylene to the desired 
ketone, 3-20, in 32% isolated yield. Despite all attempts to increase yield, including 
higher oxidant loading, increasing temperature, and prolonging reaction times, no 
increase in yield was observed. However, the benzylic oxidation was a clean reaction that 
gave a 93% yield based on recovered starting material. The final three steps involved 
simply removing protecting groups and adding other simple functionality. The TBDPS 
ether was removed using 20% hydrofluoric acid, and addition of an acetyl group to the 
corresponding alcohol with acetic anhydride followed. Finally, removal of the aryl 
isopropyl ethers with AlCl3 provided the desired natural product 3-6 in 77% yield over 
the final three steps. This represented the first documented synthesis of 
propolisbenzofuran B, occurring over 17 steps in the longest linear sequence at 2.2% 
overall yield (Scheme 3.2). 
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Scheme 3.2 Thomson’s Final Synthetic Sequence Toward Propolisbenzofuran B 
While Thomson’s synthesis was the first reported in the literature for 
propolisbenzofuran B, several disadvantages were evident. Despite being a rather 
simplistic structure (only two stereocenters), this synthesis suffered from a rather long 
synthetic sequence plagued by the necessity of a number of protection/deprotection 
sequences, and two low-yielding steps were observed in the latter stages of the synthesis 
(steps 9 and 14). With these things in mind a shorter, higher yielding, and more modular 
synthetic route would be a great step forward for the synthesis of this natural product. 
3.2.2 Ramana’s Synthesis of Propolisbenzofuran B8 
Much like Thomson’s pioneering synthesis of propolisbenzofuran B, the second 
synthesis of the natural product by Ramana and co-workers required much revision 

















































































propargyl alcohol 3-21 would undergo a base-mediated allene ether formation to 3-22, 
which would be taken forward for a [1,3]-O→C rearrangement and subsequent steps to 
form 3-23. However, with methyl substitution at the 2-position of the benzofuran, the 
propargyl ether isomerization failed under all condition examined. As such, the 
subsequent desired carbonyl would have to be installed at a later stage. Conditions to 
promote the desired isomerization would be examined on benzofuran 3-24, with a 
hydrogen atom at the 2-position. 
 
Scheme 3.3 Ramana’s Required Synthetic Revisions Toward Propolisbenzofuran B 
Ramana’s synthesis begins (Scheme 3.4) with the condensation of ethyl 
benzoquinone 3-25 with the trans-morpholine enamine of propionaldehyde, 3-27, to form 
the hydroxybenzofurans 3-28 and 3-29 in 38% and 36% yields respectively over two 
steps. However, the only relevant isomer to the synthesis was 3-29, which was taken 
forward for hydroxyl protection by isopropyl bromide to form 3-30. After a SeO2-
mediated oxidation to aldehyde 3-31, attack by the lithiated arene 3-32 provided the 
desired alcohol in relatively high yield over two steps. Alcohol 3-33 was then subjected 
to propargylation to 3-24 in 87% yield, followed by an allene isomerization and a key 








































The enal was then reduced with DIBAL-H and protected with TBDPSCl to form 3-35 in 
87% yield over two steps. Deprotonation of the benzofuran with n-BuLi and attack on 
DMF proceeded relatively smoothly, giving key intermediate 3-23 in 68% yield. 
However, alcohol 3-36 was obtained as an inseparable mixture with amide 3-37. This 
was of little consequence because after subjection to IBX, the desired aldehyde 3-23 was 
separately recovered. 
 
Scheme 3.4 Generation of Key Annulation Intermediate 3-23 
Following the formation of intermediate 3-23, it was subjected to the next key 
step, an intramolecular, rhodium-catalyzed olefin hydroacylation with Wilkinson’s 


































































































(7%, relative to 3-35)
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benzofuran-fused cyclohexanone 3-38 in a moderate 61% yield a 6:1 trans:cis 
diastereomeric mixture. After separation by preparative HPLC, the trans isomer was then 
subjected to essentially the same 4-step reaction sequence as in Thomson’s report to 
complete the synthesis (Scheme 3.5). This represented only the second and most recent 
synthesis of propolisbenzofuran B, with Ramana and co-workers completing the 
molecule in 16 steps in the longest linear sequence and 1.0% overall yield (based on 
isolated yields). 
 
Scheme 3.5 Ramana's Final Steps to Propolisbenzofuran B 
Ramana’s synthesis demonstrated the first example of the construction of a 4,5-
disubstituted cyclohexanone scaffold using a rhodium-catalyzed intramolecular olefin 
hydroacylation. This method provided a unique and complementary approach to 
Thomson’s oxidative coupling/benzannulation sequence. However, Ramana’s synthesis 
suffered from many of the same disadvantages as Thomson’s synthesis, such as low-
yielding steps (especially late in the sequence) and a series of protection/deprotection 
steps. It also suffered from low diastereoselectivity and a number of difficult separations, 
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drawbacks in mind, a more diastereoselective, functionality-tolerant, and higher yielding 
route could be designed to alleviate such issues. 
3.3 Homo-Nazarov Cyclizations: Access to Heteroaryl-Fused Cyclohexanones 
As mentioned previously in Chapter 1.6, homo-Nazarov reactions have been used 
previously as a method to access (hetero)aryl-fused cyclohexanones by several groups.12-
15 In Yadav’s original 2008 report with substrates of this kind,12 approximately 10 
substrates are shown with high yield and broad substrate scope; unfortunately, four 
equivalents of the toxic Lewis acid SnCl4 are required, even at high temperatures. In 
Waser’s methodological report,13 20 mol % tosic acid is used to activate DACPs toward 
homo-Nazarov cyclization reactions. However, of the only two examples utilizing 
heteroaryl cyclopropyl ketones, only N-methylindoles are efficacious. In France’s 
report,15 15 examples of heteroaryl cyclopropyl ketones are effective, with 
(benzo)thiophenes, (benzo)furans, and N-methylindoles shown as competent substrates. 
With these publications in mind, we believed that a homo-Nazarov cyclization approach 
would represent a faster and more modular route to propolisbenzofuran B that would 
alleviate many of the issues found in the previous two syntheses.  
 

























3.4 A Homo-Nazarov Approach Toward Propolisbenzofuran B 
3.4.1 Raynold Shenje’s Previous Undertaking of a Homo-Nazarov Route 
In the France group’s first attempt at synthesizing propolisbenzofuran B, Raynold 
Shenje devised a retrosynthetic analysis that utilized the donor-acceptor-acceptor 
cyclopropanes that are a hallmark of France’s homo-Nazarov chemistry (Scheme 3.6). In 
this synthetic route, Shenje envisioned gaining proof-of-concept through the truncated 
model 3-43. The heteroaromatic-fused cyclohexanone would be assembled via a 
hydrolysis/ decarboxylation sequence from the tetracyclic lactone 3-44. Tetracyclic 
lactone would be assembled via the key step of the synthesis, a homo-Nazarov 
cyclization of lactone-fused cyclopropane 3-45. Compound 3-45 is synthesized from an 
intramolecular cyclopropanation of diazo 3-46, which is quite readily accessed from 
commercially available 2-benzofuran carboxylic acid and trans-cinnamyl alcohol. 
 
Scheme 3.6 Shenje's Retrosynthetic Analysis of Propolisbenzofuran B 
Armed with a logical synthetic route, Shenje set out first to synthesize 














































oxalyl chloride and triethylamine. Acetylated cinnamyl alcohol was deprotonated with 
LiHMDS, and then reacted with the acid chloride of 3-47 to form β-ketoester 3-50 in 
44% yield over two steps. This β-ketoester was then subjected to diazo transfer condition 
with tosyl azide and triethylamine to give the α-diazo-β-ketoester 3-46 in 80% yield, 
which was taken forward for a rhodium-catalyzed intramolecular cyclopropanation with 
Rh2(esp)2 to obtain the desired lactone-fused cyclopropane 3-45 in 80% yield. 
 
Scheme 3.7 Shenje's Synthesis of Lactone-Fused Cyclopropane 3-45 
Next, Shenje set out to evaluate the feasibility of the key-step of his synthetic 
sequence, the homo-Nazarov reaction to generate the benzofuran-fused cyclohexanone 3-
44. After an extensive Lewis acid, concentration, and concentration screen, Shenje 
discovered the optimized conditions for reactivity were 10 mol % Ca(NTf2)2, 10 mol % 
n-Bu4NPF6 in DCM at 0.2 M producing the desired cyclohexanone in 63% yield.16 
However, a rather unexpected result was also obtained – inversion of stereochemistry at 
the benzylic position to give cyclohexanone epi-3-44 (Scheme 3.8). This stereochemical 
outcome can be attributed to the polar mechanism of the ring-opening/ring-closing 




























This planar carbocationic species can be attacked from either face, resulting in loss of the 
desired stereochemical outcome. 
 
Scheme 3.8 Shenje’s Homo-Nazarov Cyclization Outcome 
While this result was not ideal, it did not deter Shenje from designing a new 
strategy toward propolisbenzofuran B in subsequent steps. The synthesis of epi-
propolisbenzofuran B could be achieved through this route, and upon synthesis of the 
benzofuran-fused cyclohexanone epi-3-44, a sequence of steps could be employed to 
afford the desired stereochemical outcome (Scheme 3.9): (1) a 
hydrolysis/decarboxylation sequence to afford the alcohol 3-51, (2) compound 3-51 
would be oxidized to an aldehyde, (3) a base-mediated epimerization would afford the 
trans diastereomer epi-3-51, and finally (4) a reduction/acetylation sequence would then 
give compound 3-43. All steps would be expected to translate to the non-truncated 
substrate, as no steps in the epimerization sequence would interfere with the added 
functionality. While this sequence would alleviate the stereochemical issue at hand, it 
adds three extra linear steps to the route, which would negatively affect overall yield. As 
such, a major revision to the retrosynthetic analysis of the natural product to avoid 
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Scheme 3.9 Revisions Toward the Desired Stereochemical Outcome 
3.4.2 Revising the Route to Propolisbenzofuran B: A Trans-Selective Outcome 
As Shenje’s route gave the undesired stereochemical outcome of the homo-
Nazarov reaction and steps began to add up, we began to revise our synthetic route 
toward propolisbenzofuran B. One hypothesis was that fused lactone greatly influenced 
the stereochemical outcome of the key homo-Nazarov cyclization step. As such, we first 
revised our synthesis to exclude the use of a lactone-fused cyclopropane in the homo-
Nazarov step (Scheme 3.10A) and include a vicinally disubstituted cyclopropane. We 
envisioned that this would remove any torsional influence forcing attack from a single 
face to afford undesired cis diastereomers, as precedented in Nishii’s dehydrative homo-





























Scheme 3.10 Shenje's Previous Work vs. Nishii's Stereoselective Cyclization 
We began designing a synthetic route of propolisbenzofuran via the retrosynthetic 
analysis shown in Scheme 3.11. The ketone as the 6-position of the benzofuran would be 
installed by oxidation of a benzyl alcohol, while the ester group would be removed via a 
Krapcho decarbalkoxylation from 3-54. Cyclohexanone 3-54 would be obtained from the 
key step of the synthesis, a homo-Nazarov cyclization of cyclopropane 3-55. The key 
cyclopropane intermediate is accessed from lithiated benzofuran 3-56 and the lactone-
fused cyclopropane 3-57. The lactone-fused cyclopropane would be synthesized from a 
rhodium-catalyzed intramolecular cyclopropanation from diazo 3-58, much like that in 
Shenje’s previous route. The diazo would be prepared from a diazo transfer of the diester 
formed from ferulic alcohol 3-59 and methyl malonyl chloride. This route, we believed, 
would alleviate many of the issues in Shenje’s previous undertaking, avoiding the 
oxidation/epimerization/reduction/ acetylation sequence altogether. This revised route 
also would provide a more convergent strategy, dividing the molecule into two major 
fragments: the cyclopropane and benzofuran fragments. This convergent strategy would 
provide potential for the rapid synthesis of unnatural analogs as well. Armed with this 
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Scheme 3.11 Revised Synthetic Route Toward Propolisbenzofuran B 
In order to gain insight into the diastereoselectivity of our key homo-Nazarov 
step, we began preparing two truncated model systems using phenyl and PMP as 
cyclopropyl donors, although PMP would better represent the electronics of the actual 
system (Scheme 3.12). 4-Methoxy cinnamyl alcohol was prepared from 4-methoxy 
cinnamic acid 3-61 through an esterification with methanol/reduction with DIBAL-H 
sequence in 69% yield over 2 steps. The two methyl cinnamyl malonate esters 3-64 and 
3-65 were prepared from methyl malonyl chloride in the presence of triethylamine. From 
this point, the appropriate diazo compounds were prepared using tosyl azide, and 
subsequent cyclopropanations occurred in 59% and 70% yield for the PMP (3-68) and Ph 
(3-69) substrates, respectively. From Nishii’s previous work, it had been shown that 
lithiated arenes attack the lactone portion of similar cyclopropanes, so we proceeded with 










































































acetylations were then performed on the resulting alcohols to give the desired 
cyclopropanes 3-70 and 3-71.  
 
Scheme 3.12 Preparation of Truncated Cyclopropyl Substrates 
Following this, we proceeded to test the viability of these cyclopropyl substrates 
toward the desired homo-Nazarov reactivity. Upon exposing the phenyl cyclopropane 3-
71 to Shenje’s optimized conditions, an undesired dihydrofuran (DHF) isomer was 
isolated with no desired benzofuran-fused cyclohexanone detected (Scheme 3.13A). At 
this point, we believed that this result was a function of the calcium catalyst system rather 
than the substrate. However, all studies from this point forward were conducted on the 
PMP-substituted cyclopropane substrate, as it should provide a better representation of 
the electronics on the elaborated substrate. From our previous studies in Chapter 2, and 
previous literature precedence that SnCl4 could transform DHF substrates into the desired 
cyclohexanones,19 we believed that SnCl4 would provide a better environment for the 
desired reactivity. Gratifyingly, upon subjecting cyclopropane 3-70 to 30 mol % SnCl4, 
the desired benzofuran-fused cyclohexanone 3-73 was obtained in 90% yield, with no 
DHF isomer detected. Following this, a Krapcho decarbalkoxylation was performed to 
determine diastereoselectivity, and the trans-isomer of 3-74 was found to be the major 













   














3-64, R = PMP (88%)
3-65, R = Ph (77%)
R
3-66, R = PMP (85%)
3-67, R = Ph (99%)
3-68, R = PMP (59%)
3-69, R = Ph (70%)
3-70, R = PMP (53%, 2 steps)





diastereomer at a ratio of ~6:1 (Scheme 3.13B). This provided the proof-of-concept that 
our revised homo-Nazarov strategy was a viable route to the trans substitution observed 
in propolisbenzofuran B, avoiding the oxidation/epimerization/reduction/acetylation steps 
required in Shenje’s previous strategy altogether. 
 
Scheme 3.13 Ring-Opening Cyclizations of Two Catalyst Systems 
3.4.3 Progress Toward Propolisbenzofuran B Thus Far 
Armed with the knowledge that the revised route gave the desired trans-
substitution within the natural product, we then set out to synthesize propolisbenzofuran 
B itself (Scheme 3.14). We began with the synthesis of the cyclopropane fragment 3-57. 
We began with vanillin and proceeded with the same alkylation/Horner-Wadsworth-
Emmons sequence as Thomson and co-workers to obtain the unsaturated ester 3-9. 
Reduction of 3-9 was carried out with DIBAL-H in quantitative yield to give alcohol 3-
75, which was then converted to the methyl ferulic malonyl ester 3-76 with methyl 
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transfer conditions to afford the α-diazo-methyl ferulic malonyl ester 3-58 in 78% yield. 
Intramolecular cyclopropanation with Rh2(esp)2 then gave the cyclopropane fragment 3-
57 in 59% yield. While many of the steps remain unoptimized, the cyclopropane 
fragment was obtained in only 6 steps with an overall yield of 36%. 
 
Scheme 3.14 Synthesis of the Cyclopropane Fragment 3-57 
With the cyclopropane fragment in hand, we then proceeded with the synthesis of 
the benzofuran fragment. Although the needed benzofuran precursor 3-80 had been 
synthesized several times previously, we had issue replicating the results to obtain 3-80 
from any preparations obtained from past literature; only 3-81 was obtained instead 
(Scheme 3.15).20-22 Undeterred by this result, we pressed on to find a new route to 3-80 
(Scheme 3.16). We began with the alkylation of 4-methoxyphenol with 
bromoacetaldehyde diester acetal 3-78 to give 3-83. Following this, annulation to form 5-
methoxybenzofuran proceeded smoothly and subsequent demethylation gave 5-
hydroxybenzofuran in 80% yield. Two different routes to synthesize 3-80 then 
















































reaction with AlCl3 under thermal or photochemical conditions were unsuccessful. 
Another route involving the synthesis of carbamate 3-87 was also attempted,23 although 
also unsuccessful. Further work to synthesize 3-80 is currently underway by Doris Chen, 
another graduate student in the France lab. 
 
Scheme 3.15 Attempts to Replicate the Synthesis of 3-80 from Previous Literature 
 
Scheme 3.16 Other Attempts to Synthesize 3-80 
3.5 Summary of Efforts Toward the Synthesis of Propolisbenzofuran B 
A novel route utilizing a homo-Nazarov cyclization to access the benzofuran-
fused cyclohexanone core of propolisbenzofuran B has been developed. A mildly 
diastereoselective protocol requiring 30 mol % SnCl4 for the key trans stereochemical 
outcome was investigated, although further optimization in this key step and throughout 
the synthesis is ongoing. A synthetic sequence to access the key cyclopropane precursor 






























































ongoing. With proof-of-concept of all key steps demonstrated, the total synthesis of the 
natural product could be envisioned. This convergent approach would allow access to a 
variety of unnatural analogs of propolisbenzofuran B in the search of key structure-
activity relationships. This protocol also demonstrates the potential of homo-Nazarov 
cyclizations in the total synthesis of natural products containing a cyclohexane core 
scaffold. 
 
Scheme 3.17 Summary of Efforts Toward Propopolisbenzofuran B Via a Revised Homo-Nazarov Strategy 
3.6 Experimental Section 
3.6.1 Synthetic Methods 
Chromatographic purification was performed as flash chromatography with 
Silicycle silica gel (40-65µm) or preparative thin-layer chromatography (prep-TLC) 
using Silicycle silica gel F254 (1000 µm) plates and solvents indicated as eluent with 1-5 
bar pressure. For quantitative flash chromatography, technical grades solvents were 
utilized. Analytical thin-layer chromatography (TLC) was performed on Silicycle silica 













































Infrared (IR) spectra were obtained using a Shimadzu IRAffinity-1S FTIR with a 
Specac Quest ATR attachment. The IR bands are characterized as weak (w), medium 
(m), and strong (s). Proton and carbon nuclear magnetic resonance spectra (1H NMR and 
13C NMR) were recorded on a Varian Mercury Vx 300 MHz spectrometer, or Bruker 400 
MHz, 500 MHz, and 800 MHz spectrometers with solvent resonances as the internal 
standard (1H NMR: CDCl3 at 7.26 ppm; 13C NMR: CDCl3 at 77.0 ppm). 19F NMR spectra 
were recorded on a Bruker 400 MHz spectrometer using PhCF3 as an external standard. 
1H and 19F NMR data are reported as follows: chemical shift (ppm), multiplicity (s = 
singlet, d = doublet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of 
doublet of doublets, t = triplet, m = multiplet, br = broad), coupling constants (Hz), and 
integration. Mass spectra were obtained MicroMass Autospec M.  The accurate mass 
analyses were run in EI mode at a mass resolution of 10,000 using PFK 
(perfluorokerosene) as an internal calibrant. Uncorrected melting points were measured 
with a digital melting point apparatus (DigiMelt MPA 160).  
 
Cinnamyl methyl malonate: Cinnamyl alcohol (0.94 mL, 7.32 mmol) was added to a 
flask and dissolved in DCM (7.3 mL). Triethylamine (0.61 mL, 4.39 mmol) was added, 
stirred for 10 minutes, and cooled to 0°C. Methyl malonyl chloride (0.39 mL, 3.66 mmol) 
was added slowly, and the mixture was warmed to room temperature to stir overnight. 
The reaction was quenched with sat. aq. NaHCO3, extracted three times with DCM, dried 
over MgSO4, filtered through celite, and concentrated. The crude mixture was purified by 









1-cinnamyl 3-methyl 2-diazomalonate: Cinnamyl methyl malonate (635 mg, 2.71 
mmol) was added to a flask and dissolved in MeCN (14 mL). Triethylamine (0.58 mL, 
4.15 mmol) was added and the mixture was stirred for 10 minutes. Tosyl azide (0.51 mL, 
3.32 mmol) was added and the mixture was stirred at room temperature overnight. The 
mixture was then concentrated and purified by flash chromatography (Rf = 0.14, 10% 
EtOAc/Hexane) to give the diazo (703 mg, 99% yield) as a yellow oil. Characterization 
was consistent with that reported.25 
 
Methyl (1R,5S,6R)-2-oxo-6-phenyl-3-oxabicyclo[3.1.0]hexane-1-carboxylate: 
Rh2(esp)2 (9 mg, 0.01 mmol) was added to a flask and dissolved in DCM (100 mL) and 
cooled to 0°C. 1-cinnamyl 3-methyl 2-diazomalonate (680 mg, 2.61 mmol) was dissolved 
in DCM (20 mL) and added in one portion at 0°C and warmed to room temperature for 3 
hours. The reaction was quenched with sat. aq. thiourea, extracted three times with DCM, 
washed with brine, dried over Na2SO4, filtered through celite, and concentrated. The 
crude mixture was purified by flash chromatography (Rf = 0.16, 20% EtOAc/Hexane) to 
give the cyclopropyl lactone 3-69 (426 mg, 70% yield) as a waxy white solid. 












phenylcyclopropane-1-carboxylate: Adapted from a previously published procedure.18 
Benzofuran (168 mg, 1.42 mmol) was added to a flask, dissolved in THF (0.37 mL), and 
cooled to 0°C. n-Butyllithium (0.54 mL, 1.36 mmol) was added dropwise to the solution, 
stirred for 30 minutes at 0°C, and warmed to room temperature for 1 hour. In a separate 
flask, cyclopropyl lactone 3-69 (300 mg, 1.29 mmol) was dissolved in THF (4.5 mL) and 
cooled to 0°C. The benzofuran solution was then cannulated dropwise into the 
cyclopropyl lactone solution to be stirred at 0°C for 2 hours. An aliquot was removed to 
be quenched with Ac2O. The rest of the solution was quenched with sat. aq. NH4Cl, 
extracted three times with EtOAc, washed with brine, dried over Na2SO4, filtered through 
celite, and concentrated. The crude mixture was purified by prep-TLC (Rf = 0.62, 50% 
EtOAc/Hexane) to give a mixture of compounds SI-3-1 and an indiscernable byproduct 
as a 3.8:1 mixture (202 mg, <41% yield) as a colorless oil. 1H NMR (500MHz, CDCl3) δ 
= 7.73 (td, J = 1.1, 7.9 Hz, 1.02 H), 7.65 - 7.61 (m, 1.27 H), 7.60 - 7.57 (m, 1.03 H), 7.55 
(dd, J = 0.9, 8.2 Hz, 0.29 H), 7.50 (ddd, J = 1.2, 7.1, 8.5 Hz, 1.11 H), 7.38 - 7.30 (m, 5.64 
H), 7.30 - 7.20 (m, 3.40 H), 7.05 (d, J = 0.9 Hz, 0.26 H), 4.47 - 4.43 (m, 0.29 H), 4.20 (d, 
J = 8.5 Hz, 0.28 H), 3.96 (td, J = 5.6, 11.9 Hz, 1.08 H), 3.51 (ddd, J = 4.6, 8.2, 12.2 Hz, 
1.16 H), 3.46 (d, J = 7.9 Hz, 1.01 H), 3.38 (s, 3.00 H), 3.35 (s, 0.80 H), 3.14 (dt, J = 5.6, 
8.3 Hz, 1.32 H), 2.96 - 2.93 (m, 0.27 H), 1.87 (t, J = 5.6 Hz, 0.99 H). 13C NMR 











129.0, 128.6, 128.6, 128.2, 128.1, 127.7, 127.4, 127.1, 126.9, 124.8, 124.1, 123.5, 123.0, 
121.6, 113.9, 112.4, 111.6, 105.0, 101.0, 68.1, 60.8, 52.5, 51.7, 46.7, 46.0, 34.3, 33.8, 
32.9, 28.1 IR: 2976 (w), 1774 (s), 1728 (m), 1514 (m) cm-1. HRMS (EI) [M+Na]+ m/z: 
Calcd. for C21H18O5Na, 373.1046; found 373.1043. 
 
Methyl (1S,2S,3R)-2-(acetoxymethyl)-1-(benzofuran-2-carbonyl)-3-
phenylcyclopropane-1-carboxylate: Cyclopropyl alcohol mixture SI-3-1 (170 mg, 
<0.485 mmol) was dissolved in DCM (4.9 mL) and cooled to 0°C. Acetic anhydride 
(0.055 mL, 0.58 mmol), N,N-di(iso-propyl)ethylamine (0.10 mL, 0.58 mmol), and 4-
(N,N-dimethylamino)pyridine (14 mg, 0.10 mmol) was added to the solution and stirred 
at 0°C for 1 hour. The reaction was quenched with 1% HCl, extracted three times with 
DCM, washed with water, dried over Na2SO4, filtered though celite, and concentrated. 
The crude mixture was purified by flash chromatography (Rf = 0.53, 30% 
EtOAc/Hexane) to give cyclopropyl acetate 3-71 (143 mg, <75% yield). 1H NMR 
(500MHz, CDCl3) δ = 7.74 - 7.71 (m, 1 H), 7.60 - 7.56 (m, 2 H), 7.51 - 7.47 (m, 1 H), 
7.35 - 7.24 (m, 6 H), 4.41 (dd, J = 6.1, 12.2 Hz, 1 H), 3.85 (dd, J = 8.9, 12.2 Hz, 1 H), 
3.59 (d, J = 7.6 Hz, 1 H), 3.37 (s, 3 H), 3.23 (ddd, J = 6.4, 7.8, 9.0 Hz, 1 H), 1.69 (s, 3 H). 
13C NMR (126MHz, CDCl3) δ = 182.4, 170.4, 167.5, 155.6, 152.7, 133.7, 128.9, 128.5, 
128.3, 127.5, 126.8, 124.1, 123.4, 113.4, 112.3, 61.7, 52.6, 46.2, 33.5, 30.4, 20.4. IR: 
2951 (w), 1737 (s), 1670 (s), 1554 (s) cm-1. HRMS (ESI) [M+Na]+ m/z: Calcd. for 










carboxylate: Ca(NTf2)2 (8 mg, 0.013 mmol) and n-Bu4NPF6 (5 mg, 0.013 mmol) was 
added to a flask. Compound 3-71 was dissolved in DCM (0.63 mL) and added to the 
catalyst mixture. The reaction was stirred for 3 hours and quenched with water. The 
aqueous layer was extracted three times with DCM, dried over Na2SO4, filtered through 
celite, and concentrated. The crude residue was purified by flash chromatography (Rf = 
0.39, 20% EtOAc/Hexane) to give the title compound (21.5 mg, 43% yield). 1H NMR 
(500MHz, CDCl3) δ = 8.32 (d, J = 0.9 Hz, 1 H), 7.72 - 7.67 (m, 1 H), 7.61 - 7.55 (m, 1 
H), 7.44 - 7.37 (m, 4 H), 7.37 - 7.32 (m, 1 H), 7.32 - 7.27 (m, 1 H), 5.68 (d, J = 4.6 Hz, 1 
H), 4.52 (dd, J = 3.7, 11.0 Hz, 1 H), 4.34 (dd, J = 7.9, 11.0 Hz, 1 H), 3.79 (s, 3 H), 3.73 - 
3.67 (m, 1 H), 2.11 (s, 3 H). 13C NMR (126MHz, CDCl3) δ = 170.9, 164.3, 156.4, 154.8, 
144.8, 140.5, 128.8, 128.4, 127.8, 126.9, 125.1, 123.5, 122.5, 114.9, 111.8, 102.4, 85.8, 
65.0, 52.0, 51.4, 20.9. IR: 1740 (s), 1701 (s), 1605 (s) cm-1. HRMS (EI) [M]+ m/z: 
Calcd. for C23H20O6, 392.1260; found 392.1250. 
 
(E)-3-(4-methoxyphenyl)prop-2-en-1-ol: Methyl (E)-3-(4-methoxyphenyl)acrylate 
(5.00 g, 26.0 mmol) was dissolved in DCM (50 mL) and cooled to -78°C. DIBAL-H (1M 
in DCM, 78 mL, 78 mmol) was added slowly and the reaction was stirred at -78°C for 2 
hours. The reaction was quenched with sat. aq. Na2SO4 and aluminum salts filtered off. 










filtered through celite, and concentrated. The crude mixture was purified by flash 
chromatography (Rf = 0.15, 20% EtOAc/Hexane) to give the title compound (3.81 g, 90% 
yield) as a white powder. All characterization was consistent with that previously 
reported.26 
 
(E)-3-(4-methoxyphenyl)allyl methyl malonate: (E)-3-(4-methoxyphenyl)prop-2-en-1-
ol (3.80 g, 23.1 mmol) was dissolved in DCM (23 mL) and triethylamine (3.90 mL, 27.7 
mmol) was added. The solution was cooled to 0°C and methyl malonyl chloride (2.75 
mL, 25.5 mmol) was added slowly and warmed to room temperature overnight. The 
reaction was quenched with sat. aq. NaHCO3, extracted three times with DCM, dried 
over MgSO4, filtered through celite, and concentrated. The crude mixture was purified by 
flash chromatography (Rf = 0.26, 20% EtOAc/Hexane) to give the title compound (5.38 
g, 88% yield) as a colorless oil. Characterization was consistent with that reported.27 
 
(E)-1-(3-(4-methoxyphenyl)allyl) 3-methyl 2-diazomalonate: (E)-3-(4-
methoxyphenyl)allyl methyl malonate (3.45 g, 13.1 mmol) was dissolved in MeCN (26 
mL) and triethylamine (2.20 mL, 15.8 mmol) was added and stirred for 10 minutes. Tosyl 
azide (2.40 mL, 15.7 mmol) was added and stirred at room temperature overnight. The 
reaction mixture was then concentrated. Tosyl amine byproduct was recrystallized with 
DCM and filtered. The filtrate was concentrated and purified by flash chromatography (Rf 
= 0.20, 20% EtOAc/Hexane) to give 3-66 (3.22 g, 85% yield) as a yellow oil. 1H NMR 










H), 6.17 (td, J = 6.8, 15.8 Hz, 1 H), 4.87 (dd, J = 1.2, 6.7 Hz, 2 H), 3.84 (s, 3 H), 3.81 - 
3.80 (m, 3 H). 13C NMR (126MHz, CDCl3) δ = 161.6, 160.8, 159.7, 135.0, 128.7, 128.0, 
127.1, 120.0, 114.0, 66.4, 55.3, 52.5. IR: 2955 (w), 2837 (w), 2135 (s), 1755 (s), 1732 
(s), 1690 (m), 1607 (m), 1512 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. for C14H14O5N2, 




carboxylate: Rh2(esp)2 (42 mg, 0.05 mmol) was dissolved in DCM (200 mL) and cooled 
to 0°C. Diazo 3-66 (3.20 g, 11.0 mmol) was dissolved in DCM (20 mL) and added all at 
once at 0°C. The reaction was warmed to room temperature overnight and quenched with 
sat. aq. thiourea, extracted three times with DCM, washed with brine, dried over Na2SO4, 
filtered through celite, and concentrated. The crude mixture was purified by flash 
chromatography (Rf = 0.14, 30% EtOAc/Hexane) to give the title compound (1.71 g, 59% 
yield) as a white solid. 1H NMR (500MHz, CDCl3) δ = 7.19 - 7.14 (m, 2 H), 6.86 - 6.82 
(m, 1 H), 4.48 (dd, J = 4.9, 9.2 Hz, 1 H), 4.35 (d, J = 9.5 Hz, 1 H), 3.79 (s, 3 H), 3.54 (s, 
3 H), 3.26 (t, J = 4.9 Hz, 1 H), 2.89 (d, J = 5.5 Hz, 1 H). 13C NMR (126MHz, CDCl3) δ = 
170.1, 164.1, 159.4, 129.8, 123.4, 113.8, 67.2, 55.2, 52.7, 37.8, 37.5, 27.8. IR: 2955 (w), 
1770 (s), 1726 (m), 1610 (m), 1516 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. for C14H14O5, 










methoxyphenyl)cyclopropane-1-carboxylate: Benzofuran (744 mg, 6.30 mmol) was 
dissolved in THF (2.8 mL) and cooled to 0°C. n-Butyllithium (1.7 M in hexane, 3.70 mL, 
6.29 mmol) was added dropwise at 0°C and stirred for 30 minutes. The benzofuran 
solution was then warmed to room temperature and stirred 1 hour. The cyclopropyl 
lactone 3-68 (1.50 g, 5.72 mmol) was dissolved (with heating) in THF (45 mL) and 
cooled to 0°C. The benzofuran solution was then cannulated into the cyclopropyl lactone 
solution at 0°C and stirred for 2 hours. The reaction was quenched with sat. aq. NH4Cl, 
extracted three times with EtOAc, washed with brine, dried over Na2SO4, filtered through 
celite, and concentrated. The crude mixture was purified by flash chromatography (Rf = 
0.21, 30% EtOAc/Hexane) and the title compound was given as a mixture with other 
compounds (1.56 g, ratio: 16.7:4.0:1) as an orange oil. The mixture was carried forward 
for acetylation. 1H NMR (500MHz, CDCl3) δ = 8.13 - 8.12 (m, 0.10 H), 7.75 - 7.71 (m, 
1.00 H), 7.69 - 7.66 (m, 0.14 H), 7.64 - 7.60 (m, 1.20 H), 7.60 - 7.57 (m, 0.98 H), 7.57 - 
7.53 (m, 0.39 H), 7.52 - 7.47 (m, 1.02 H), 7.41 - 7.37 (m, 0.17 H), 7.36 - 7.30 (m, 1.52 
H), 7.30 - 7.24 (m, 3.04 H), 7.15 (dd, J = 0.6, 8.9 Hz, 0.51 H), 7.03 (d, J = 0.9 Hz, 0.22 
H), 6.90 (d, J = 8.9 Hz, 0.28 H), 6.88 - 6.83 (m, 2.00 H), 6.81 (d, J = 8.9 Hz, 0.50 H), 
5.66 - 5.63 (m, 0.12 H), 4.45 - 4.41 (m, 0.26 H), 4.18 (d, J = 8.5 Hz, 0.25 H), 3.99 - 3.93 
(m, 1.38 H), 3.82 - 3.79 (m, 3.69 H), 3.78 (s, 0.73 H), 3.49 (dd, J = 8.9, 11.9 Hz, 1.03 H), 







16.7 : 4.0  : 1
inseparable mixture
of 2 unknown compounds
MeO SI-3-2
 117 
0.95 H). 13C NMR (126MHz, CDCl3) δ = 183.6, 168.3, 167.9, 158.9, 158.6, 155.7, 
154.9, 154.6, 152.6, 145.2, 132.7, 130.0, 129.7, 128.6, 127.7, 127.0, 126.9, 126.8, 126.3, 
125.9, 124.7, 124.1, 123.5, 123.4, 123.0, 122.4, 121.6, 114.3, 114.1, 113.9, 113.6, 113.6, 
112.4, 111.8, 111.6, 104.9, 100.9, 85.9, 68.1, 64.3, 60.8, 55.3, 55.2, 54.9, 52.6, 51.8, 51.4, 
46.6, 45.9, 34.6, 33.4, 32.5, 28.3. IR: 3464 (w), 2951 (w), 2837 (w), 1730 (m), 1667 (m), 
1612 (m), 1552 (m), 1516 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. for C22H20O6, 




methoxyphenyl)cyclopropane-1-carboxylate: The previous alcohol mixture SI-3-7 
(1.24 g) was dissolved in DCM (33 mL) and cooled to 0°C. Acetic anhydride (0.37 mL, 
3.91 mmol), di(iso-propyl)ethylamine (0.68 mL, 3.91 mmol), and 4-(N,N-
dimethylamino)pyridine (80 mg, 0.65 mmol) were added at 0°C and stirred for 1 hour. 
The reaction was quenched with 1% HCl, extracted three times with DCM, dried over 
Na2SO4, filtered through celite, and concentrated. The crude mixture was purified by 
flash chromatography (Rf = 0.36, 30% EtOAc/Hexane) to give the title compound (1.29 
g, 53% over 2 steps). 1H NMR (500MHz, CDCl3) δ = 7.72 (td, J = 1.1, 7.9 Hz, 1 H), 7.59 
- 7.56 (m, 2 H), 7.51 - 7.46 (m, 1 H), 7.32 (ddd, J = 0.9, 7.1, 7.9 Hz, 1 H), 7.24 - 7.19 (m, 
2 H), 6.86 - 6.81 (m, 2 H), 4.41 (dd, J = 6.1, 12.2 Hz, 1 H), 3.82 (dd, J = 8.9, 12.2 Hz, 1 
H), 3.79 (s, 3 H), 3.54 (d, J = 7.9 Hz, 1 H), 3.39 (s, 3 H), 3.18 (ddd, J = 6.0, 7.9, 9.1 Hz, 1 









152.7, 129.9, 128.5, 126.8, 125.6, 124.1, 123.4, 113.7, 113.3, 112.3, 61.7, 55.2, 52.6, 
46.2, 33.1, 30.7, 20.3. IR: 2953 (w), 1738 (s), 1670 (s), 1555 (s), 1516 (s) cm-1. HRMS 




tetrahydrodibenzo[b,d]furan-3-carboxylate: Cyclopropane 3-70 (306 mg, 0.724 mmol) 
was dissolved in DCM (7.1 mL). SnCl4 (25 µL, 0.21 mmol) was added and the mixture 
was stirred for 1 hour. The reaction was quenched with water, extracted three times with 
DCM, dried over Na2SO4, filtered through celite, and concentrated. The crude mixture 
was purified by flash chromatography (Rf = 0.28, 30% EtOAc/Hexane) to give 3-73 (275 
mg, 90% yield). (Diastereomeric Ratio = 4.0:1:0) 1H NMR (500MHz, CDCl3) δ = 8.08 - 
8.04 (m, 0.28 H), 7.61 - 7.53 (m, 1.38 H), 7.42 (ddd, J = 1.2, 7.1, 8.5 Hz, 1.36 H), 7.40 - 
7.29 (m, 1.25 H), 7.19 - 7.15 (m, 2.27 H), 7.13 (d, J = 8.9 Hz, 0.76 H), 7.04 (ddd, J = 0.8, 
7.1, 8.0 Hz, 1.44 H), 6.95 - 6.88 (m, 3.14 H), 6.64 - 6.61 (m, 0.26 H), 6.59 - 6.56 (m, 1.00 
H), 4.70 - 4.66 (m, 0.27 H), 4.38 (d, J = 10.7 Hz, 1.34 H), 4.26 - 4.20 (m, 0.34 H), 4.09 - 
4.01 (m, 1.66 H), 3.99 - 3.92 (m, 2.66 H), 3.88 (d, J = 12.2 Hz, 0.35 H), 3.85 - 3.82 (m, 
8.32 H), 3.74 - 3.73 (m, 0.99 H), 3.16 - 3.08 (m, 1.31 H), 3.04 - 2.95 (m, 0.40 H), 2.13 - 
2.10 (m, 3.63 H), 2.02 - 2.00 (m, 0.87 H). 13C NMR (126MHz, CDCl3) δ = 188.3, 182.3, 










145.9, 137.8, 136.4, 130.9, 130.5, 129.9, 129.4, 129.4, 128.3, 128.1, 125.8, 125.7, 124.9, 
123.7, 123.4, 123.2, 121.9, 114.6, 114.5, 112.8, 112.8, 111.5, 63.0, 62.5, 62.3, 56.9, 56.8, 
55.3, 55.3, 55.3, 52.7, 52.6, 46.9, 46.3, 45.5, 42.5, 41.1, 40.0, 20.7, 20.6. IR: 1738 (s), 





yl)methyl acetate: Sodium chloride (64 mg, 1.13 mmol) was added to a flask with water 
(3 drops). The ß-ketoester 3-73 (160 mg, 0.379 mmol) was dissolved in DMSO (1.5 mL) 
and added. The mixture was heated to 150°C overnight and cooled to room temperature. 
The reaction was extracted three times with EtOAc, washed three times with brine, dried 
over MgSO4, filtered through celite, and concentrated. The crude mixture was purified by 
flash chromatography (Rf = 0.33, 30% EtOAc/Hexane) to give 3-74 (64 mg, 46% yield) 
as an orange oil. 1H NMR (800MHz, CDCl3) δ = 7.54 - 7.52 (m, 1 H), 7.39 (ddd, J = 1.5, 
7.2, 8.4 Hz, 1 H), 7.16 - 7.12 (m, 2 H), 7.03 (ddd, J = 1.0, 7.1, 8.1 Hz, 1 H), 6.91 - 6.87 
(m, 2 H), 6.64 - 6.61 (m, 1 H), 4.27 - 4.23 (m, 1 H), 4.07 - 4.03 (m, 1 H), 4.03 - 3.99 (m, 
1 H), 3.84 - 3.80 (m, 3 H), 2.90 - 2.85 (m, 1 H), 2.81 - 2.73 (m, 2 H), 2.06 (s, 3 H). 13C 
NMR (126MHz, CDCl3) δ = 186.9, 170.7, 159.2, 156.3, 147.2, 135.9, 131.2, 129.6, 







1736 (s), 1676 (s), 1512 (s) cm-1. HRMS (ESI) [M+H]+ m/z: Calcd. for C22H21O5, 
365.1384; found 365.1380. 
 
 ((1S,2R)-1-(4-methoxyphenyl)-4-oxo-1,2,3,4-tetrahydrodibenzo[b,d]furan-2-
yl)methyl acetate: Sodium chloride (64 mg, 1.13 mmol) was added to a flask with water 
(3 drops). The ß-ketoester 3-73 (160 mg, 0.379 mmol) was dissolved in DMSO (1.5 mL) 
and added. The mixture was heated to 150°C overnight and cooled to room temperature. 
The reaction was extracted three times with EtOAc, washed three times with brine, dried 
over MgSO4, filtered through celite, and concentrated. The crude mixture was purified by 
flash chromatography (Rf = 0.37, 30% EtOAc/Hexane) to give epi-3-74 (10 mg, 7% 
yield) as a yellow oil. 1H NMR (800MHz, CDCl3) δ = 8.13 (td, J = 0.7, 7.7 Hz, 1 H), 
7.42 (td, J = 0.8, 8.1 Hz, 1 H), 7.37 (dt, J = 1.0, 7.5 Hz, 1 H), 7.35 - 7.32 (m, 1 H), 7.14 - 
7.10 (m, 2 H), 6.96 - 6.91 (m, 2 H), 4.31 (d, J = 8.8 Hz, 1 H), 4.14 - 4.11 (m, 1 H), 4.09 - 
4.05 (m, 1 H), 3.84 (s, 3 H), 2.85 (dd, J = 4.0, 16.3 Hz, 1 H), 2.82 - 2.76 (m, 1 H), 2.74 - 
2.69 (m, 1 H), 2.09 (s, 3 H). 13C NMR (126MHz, CDCl3) δ = 192.9, 170.7, 170.1, 159.3, 
155.1, 129.5, 129.3, 125.4, 124.6, 121.9, 117.0, 114.5, 114.5, 111.4, 64.8, 55.3, 43.3, 
43.2, 40.6, 20.8. IR: 1736 (s), 1672 (s), 1611 (m), 1584 (m), 1512 (s) cm-1. HRMS (ESI) 











methoxyphenyl) acrylate7 (3.00 g, 12.0 mmol) was dissolved in DCM (30 mL) and 
cooled to -78°C. DIBAL-H (1 M in DCM, 36 mL, 36 mmol) was added dropwise and the 
reaction was stirred at -78°C for 1 hour. The reaction was quenched with sat. aq. Na2SO4 
and the aluminum salts filtered off. The filtrate was extracted three times with DCM, 
dried over MgSO4, filtered through celite, and concentrated to give the title compound 
(2.71 g, >99% yield) as a cloudy oil. 1H NMR (500MHz, CDCl3) δ = 6.94 (d, J = 2.1 Hz, 
1 H), 6.89 (dd, J = 2.1, 8.2 Hz, 1 H), 6.84 (d, J = 8.2 Hz, 1 H), 6.54 (td, J = 1.4, 15.9 Hz, 
1 H), 6.24 (td, J = 6.0, 15.9 Hz, 1 H), 4.52 (spt, J = 6.1 Hz, 1 H), 4.30 (dt, J = 1.4, 5.9 Hz, 
2 H), 3.86 (s, 3 H), 1.50 (br. s., 1 H), 1.38 - 1.34 (m, 6 H). 13C NMR (126MHz, CDCl3) δ 
= 150.3, 147.2, 131.2, 130.0, 126.5, 119.5, 115.5, 109.6, 71.4, 63.8, 55.9, 22.0. IR: 3381 
(br., w), 2976 (w), 2934 (w), 1508 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. for C13H18O3, 
222.1256; found 222.1255. 
 
(E)-3-(4-isopropoxy-3-methoxyphenyl)allyl methyl malonate: Alcohol 3-75 (2.01 g, 
9.00 mmol) was dissolved in DCM (9 mL), triethylamine (1.50 mL, 10.8 mmol) was 
added, and the solution was cooled to 0°C. Methyl malonyl chloride (1.1 mL, 10.2 mmol) 
was added slowly and warmed to room temperature overnight. The reaction was 
quenched with sat. aq. NaHCO3, extracted three times with DCM, dried over MgSO4, 













a pale yellow oil. 1H NMR (500MHz, CDCl3) δ = 6.93 (d, J = 2.1 Hz, 1 H), 6.91 - 6.88 
(m, 1 H), 6.85 - 6.81 (m, 1 H), 6.60 (d, J = 15.9 Hz, 1 H), 6.14 (td, J = 6.7, 15.9 Hz, 1 H), 
4.78 (dd, J = 1.2, 6.7 Hz, 2 H), 4.53 (spt, J = 6.1 Hz, 1 H), 3.86 (s, 3 H), 3.75 (s, 3 H), 
3.42 (s, 2 H), 1.36 (d, J = 6.1 Hz, 6 H).  13C NMR (126MHz, CDCl3) δ = 166.9, 166.3, 
150.3, 147.6, 135.0, 129.2, 120.2, 119.9, 115.2, 109.6, 71.3, 66.3, 55.9, 52.5, 41.3, 22.0.  
IR: 2976 (w), 1732 (s), 1508 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. for C17H22O6, 
322.1416; found 322.1402. 
 
 
(E)-1-(3-(4-isopropoxy-3-methoxyphenyl)allyl) 3-methyl 2-diazomalonate: 
Compound 3-76 (2.00 g, 6.20 mmol) was dissolved in MeCN (31 mL) and triethylamine 
(1.05 mL, 7.45 mmol) was added and stirred for 10 minutes. Tosyl azide (1.15 mL, 7.45 
mmol) was added and the reaction was stirred at room temperature overnight. The 
reaction was then concentrated. The tosyl amine byproduct was recrystallized with DCM 
and filtered. The filtrate was concentrated and purified by flash chromatography (Rf = 
0.54, 50% EtOAc/Hexane) to give the title compound (1.52 g, 70% yield) as a yellow oil. 
1H NMR (500MHz, CDCl3) δ = 6.94 (d, J = 1.8 Hz, 1 H), 6.90 (dd, J = 1.8, 8.2 Hz, 1 H), 
6.84 (d, J = 8.2 Hz, 1 H), 6.63 (d, J = 15.6 Hz, 1 H), 6.18 (td, J = 6.7, 15.9 Hz, 1 H), 4.87 
(dd, J = 1.2, 6.7 Hz, 2 H), 4.54 (spt, J = 6.1 Hz, 1 H), 3.87 (s, 2 H), 3.85 (s, 3 H), 1.37 (d, 
J = 6.1 Hz, 6 H). 13C NMR (126MHz, CDCl3) δ = 161.5, 160.8, 150.3, 147.7, 135.4, 










1757 (s), 1735 (s), 1691 (m), 1510 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. for 




oxabicyclo[3.1.0]hexane-1-carboxylate: Rh2(esp)2 (16 mg, 0.02 mmol) was added to a 
flask and dissolved in DCM (150 mL) and cooled to 0°C. Diazo 3-58 (1.50 g, 4.30 mmol) 
was dissolved in DCM (50 mL) and added in one portion at 0°C and warmed to room 
temperature overnight. The reaction was quenched with sat. aq. thiourea, extracted three 
times with DCM, washed with brine, dried over Na2SO4, filtered through celite, and 
concentrated. The crude mixture was purified by flash chromatography (Rf = 0.31, 50% 
EtOAc/Hexane) to give the cyclopropyl lactone 3-57 (811 mg, 59% yield) as a pale 
yellow solid. 1H NMR (500MHz, CDCl3) δ = 6.81 (d, J = 8.2 Hz, 1 H), 6.76 (d, J = 1.8 
Hz, 1 H), 6.74 (ddd, J = 0.6, 2.1, 7.9 Hz, 1 H), 4.55 - 4.45 (m, 2 H), 4.37 - 4.32 (m, 1 H), 
3.82 (s, 3 H), 3.54 (s, 3 H), 3.26 - 3.23 (m, 1 H), 2.87 (d, J = 5.5 Hz, 1 H), 1.34 (dd, J = 
1.2, 6.1 Hz, 6 H). 13C NMR (126MHz, CDCl3) δ = 170.1, 164.0, 150.0, 147.2, 124.2, 
120.7, 114.9, 112.4, 71.2, 67.3, 56.0, 52.6, 37.9, 37.7, 27.7, 22.0, 21.9. IR: 2984 (w), 
2913 (w), 1770 (s), 1730 (s), 1516 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. for C17H20O6, 










1-(5-(2,2-diethoxyethoxy)-2-hydroxyphenyl)ethan-1-one: Prepared according to 
previously published conditions.21 Potassium carbonate (454 mg, 3.29 mmol) and 2’, 5’-
dihydroxyacetophenone (500 mg, 3.29 mmol) were combined and suspended in DMF (4 
mL). The suspension was heated to reflux and bromoacetaldehyde diethyl acetal (0.50 
mL, 3.29 mmol) in DMF (4 mL) was added via syringe pump over 1 hour. The reaction 
stirred for 4 hours at reflux and then cooled to room temperature. The reaction was 
quenched with water, extracted three times with EtOAc, washed three times with brine, 
dried over MgSO4, filtered through celite, and concentrated. The crude mixture was 
purified by flash chromatography (Rf = 0.52, 20% EtOAc/Hexane) to give the acetal 3-79 
(200 mg, 23% yield) as a yellow oil. 1H NMR (500MHz, CDCl3) δ = 11.86 (s, 1 H), 7.23 
(d, J = 3.1 Hz, 1 H), 7.14 (dd, J = 3.1, 9.2 Hz, 1 H), 6.91 (d, J = 9.2 Hz, 1 H), 4.82 (t, J = 
5.2 Hz, 1 H), 3.98 (d, J = 5.2 Hz, 2 H), 3.77 (qd, J = 7.0, 9.4 Hz, 2 H), 3.64 (qd, J = 7.1, 
9.3 Hz, 2 H), 2.60 (s, 3 H), 1.25 (t, J = 7.0 Hz, 6 H). 13C NMR (126MHz, CDCl3) δ = 
204.0, 157.0, 150.7, 124.9, 119.2, 119.2, 114.8, 100.5, 69.5, 62.7, 26.8, 15.3. IR: 2976 
(w), 2932 (w), 2882 (w), 1645 (m), 1618 (m), 1483 (s) cm-1. HRMS (EI) [M]+ m/z: 
Calcd. for C14H20O5, 268.1311; found 268.1314. 
 
1-(5-hydroxybenzofuran-4-yl)ethan-1-one: Acetal 3-79 (502 mg, 1.87 mmol) was 
dissolved in toluene (9.3 mL) and added to Amberlyst 15 (~50 mg) and heated to reflux 














was filtered through celite and concentrated. The crude mixture was purified by flash 
chromatography (Rf = 0.64, 30% EtOAc/Hex) to give 3-81 (67 mg, 20% yield) as a 
yellow oil. 1H NMR (500MHz, CDCl3) δ = 13.00 (s, 1 H), 7.74 - 7.73 (m, 1 H), 7.61 (dd, 
J = 1.1, 9.0 Hz, 1 H), 6.95 (dd, J = 0.9, 2.1 Hz, 1 H), 6.93 - 6.89 (m, 1 H), 2.76 (s, 3 H). 
13C NMR (126MHz, CDCl3) δ = 203.3, 161.2, 148.7, 147.0, 126.3, 119.9, 115.3, 111.8, 
107.5, 31.1. IR: 3130 (w), 2965 (w), 1608 (s), 1481 (s), 1421 (s) cm-1. HRMS (EI) [M]+ 
m/z: Calcd. for C10H8O3, 176.0473; found 176.0474. 
 
 
1-(2,2-diethoxyethoxy)-4-methoxybenzene: 4-hydroxyanisole (5.05 g, 40.7 mmol) and 
K2CO3 (5.55g, 40.7 mmol) were dissolved in DMF (100 mL) and bromoacetaldehyde 
diethyl acetal (6.05 mL, 40.7 mmol) was added. The mixture was heated to reflux 
overnight, cooled to room temperature, quenched with water, extracted three times with 
DCM, washed three times with brine, dried over MgSO4, filtered through celite, and 
concentrated. The crude mixture was purified by flash chromatography (Rf = 0.82, 30% 
EtOAc/Hexane) to give the acetal 3-83 (6.24 g, 57% yield) as a pale yellow oil. 
Characterization was consistent with that reported.28 
 
5-methoxybenzofuran: Acetal 3-83 (199 mg, 0.75 mmol) was dissolved in toluene (2 
mL) and added to Amberlyst 15 (~20 mg) and heated to reflux overnight using a Dean-










and concentrated. The crude mixture was purified by flash chromatography (Rf = 0.57, 
10% EtOAc/Hex) to give 3-84 (85 mg, 77% yield) as a pale brown solid. 
Characterization was consistent with that reported.28 
 
 
Benzofuran-5-ol: Prepared according to a previously published procedure.29 5-
methoxybenzofuran (203 mg, 1.37 mmol) was dissolved in DCM (2 mL) and cooled to -
78°C. Boron tribromide (1 M solution in DCM, 1.75 mL, 1.75 mmol) was added slowly 
and stirred for 2 hours at -78°C, warmed and stirred at room temperature for 1 hour, and 
quenched with 1 M HCl. The mixture was extracted three times with Et2O, washed with 
brine, dried over MgSO4, and concentrated. The crude mixture was purified by flash 
chromatography (Rf = 0.29, 20% EtOAc/Hexane) to give the title compound (137 mg, 
74% yield) as a white solid. Characterization was consistent with that reported. 
 
Benzofuran-5-yl acetate: Benzofuran-5-ol (112 mg, 0.835 mmol) was dissolved in 
DCM and cooled to 0°C. Acetic anhydride (0.09 mL, 1.00 mmol), diisopropylethyl amine 
(0.17 mL, 1.00 mmol), and 4-(N,N-dimethylamino)pyridine (20 mg, 0.17 mmol) was 
added and stirred for 30 minutes at 0°C. The reaction was quenched with 1% HCl, 
extracted three times with DCM, washed with brine, dried over MgSO4, filtered through 
celite, and concentrated. The crude mixture was purified by flash chromatography (Rf = 
0.50, 20% EtOAc/Hexane) to give the title compound (121 mg, 82% yield) as a white 








H), 7.33 - 7.30 (m, 1 H), 7.03 - 6.98 (m, 1 H), 6.76 (dd, J = 0.9, 2.1 Hz, 1 H), 2.33 (s, 3 
H). 13C NMR (126MHz, CDCl3) d = 170.0, 152.5, 146.3, 128.1, 118.1, 113.7, 111.8, 
106.8, 21.1. IR: 3157 (w), 3132 (w), 3067 (w), 2920 (w), 1753 (m), 1622 (s), 1485 (s), 
1423 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. for C10H8O3, 176.0473; found 176.0471. 
 
Benzofuran-5-yl diethylcarbamate: Synthesized according to a Chein’s protocol.23 
Benzofuran-5-ol (485 mg, 3.62 mmol) was dissolved in MeCN (7.2 mL) and K2CO3 (750 
mg, 5.42 mmol) and diethyl carbamoyl chloride (0.69 mL, 5.42 mmol) were added. The 
mixture was heated to reflux for 18 hours, cooled, and quenched with water. The aqueous 
layer was extracted three times with EtOAc, dried over Na2SO4, filtered through celite, 
and concentrated. The crude residue was purified by flash chromatography (Rf = 0.20, 
10% EtOAc/Hexane) to give the title compound (857 mg, >99% yield). 1H NMR 
(500MHz, CDCl3) δ = 7.62 (d, J = 2.1 Hz, 1 H), 7.48 - 7.43 (m, 1 H), 7.34 (d, J = 2.4 Hz, 
1 H), 7.04 (dd, J = 2.3, 8.7 Hz, 1 H), 6.73 (dd, J = 1.1, 2.3 Hz, 1 H), 3.52 - 3.35 (m, 4 H), 
1.32 - 1.17 (m, 6 H). 13C NMR (126MHz, CDCl3) δ = 154.7, 152.2, 147.1, 146.0, 127.9, 
118.5, 113.9, 111.5, 106.8, 42.2, 41.8, 14.2, 13.4. IR: 1708 (s) cm-1. HRMS (ESI) 
[M+Na]+ m/z: Calcd. for C13H15NO3Na, 256.0944; found 256.0945. 
 


























































































































16.7 : 4.0  : 1 inseparable m
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16.7 : 4.0  : 1 inseparable m
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CHAPTER 4. AN AZA-NAZAROV-LIKE PROTOCOL TOWARD 
THE SYNTHESIS OF THE ANTIMALARIAL FLINDEROLE 
ALKALOIDS 
4.1 Malaria: A Devastating Disease with Need for Innovative Therapeutics 
As drug-resistant bacteria and viruses continue to crop up, and infectious diseases 
that seemed long gone reemerge, the need for new therapeutics to combat such illnesses 
grows more necessary. One such infectious disease that remains a threat to humanity is 
malaria, a disease caused by a number of Plasmodia parasites (most often P. falciparum) 
that are transferred through the bites of the female Anopholes mosquito. It mostly found 
in tropical and sub-tropical regions where ~3.4 billion people reside, with an estimated 
216 million cases and 445,000 dead from the disease in 2016, making it one of the most 
devastating infectious diseases in the world.1 Groups most affected are young children, 
pregnant women, and travelers without malaria resistance. Symptoms are flu-like in 
nature, with high temperature fevers and shaking chills as some of the most common.2 
Some of the most common drugs for treating malaria are shown in Figure 4.1. 
Two of the most commonly used antimalarials, chloroquine and artemisinin, are thought 
to have activity by two different mechanisms. Chloroquine acts by inhibiting the 
biocrystallization of hematin - a toxic metabolite produced when Plasmodia digest 
hemoglobin – into a non-toxic form encased in food vacuoles.3 Artemisinin’s activity, on 
the other hand, was first suspected to originate from breakdown of the endoperoxide, 
forming reactive oxygen species that resulted in alkylation of proteins that lead to the 
death of the malaria parasites.4-5 It was later suggested, however, that its activity lies 
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either in (1) inhibition of the metabolism of hemoglobin, (2) the interaction of the 
endoperoxide with heme, preventing its polymerization/biocrystallization, or (3) 
interaction with hemozoin, causing its breakdown and eventual toxicity.6 However, 
malaria parasites are quickly developing resistance to many current antimalarials, 
including some of the most potent artemisinin combination therapies. There thus remains 
a need to develop other therapeutics to counteract this increasing resistance throughout 
the globe. 
 
Figure 4.1 Commonly Used Antimalarial Drugs 
4.1.1 Flindersial Alkaloids: Natural Products with Antimalarial Therapeutic Potential 
The flindersial alkaloids isolated in 2009 from Flindersia acuminata and 
Flindersia amboinensis represent a valuable class of novel natural products with potent 
antimalarial activity. In their isolation report, three new structures were revealed, 
flinderoles A-C, which contained similar bistryptamine-isoprene scaffolds to the 
borreverine class of compounds previously isolated from Flindersia fournieri in 1979 
(Figure 4.2).7-8 Flinderoles A-C were effective against P. falciparum and against multiple 


























































commonly used antimalarials, the flinderole alkaloids are not suspected to directly 
interfere with the hematin biocrystallization process. Instead, in vitro assays have 
suggested these alkaloids target hemoglobin metabolism much like artemisinin; in fact, 
the flinderole alkaloids inhibit the bioactivity of artemisinin when used in combination.11 
With these potent bioactivities and unique bistryptamine-isoprene scaffolds, these 
alkaloids have become attractive synthetic targets for organic chemists. 
 
Figure 4.2 Recently Isolated Flindersial Alkaloids 
4.2 Previous Synthetic Efforts Toward Flinderoles A-C 
Since the isolation of the flinderoles in 2009, a number of groups have sought out 
their syntheses, with the groups of Dethe and May being the most prominent. Because of 
the sheer number of syntheses of the flinderoles at this point, only key steps of their 























4-7, R = H, Flinderole A








4-10, Borreverine 4-11, R = H, Isoborreverine
4-12, R = Me, Dimethylisoborreverine
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4.2.1 Dethe and Co-Workers, 2011, 2013, 2014 
The first synthesis of flinderoles B and C was reported in 2011 – just two years 
after their isolation – by Dethe and co-workers.12 In this synthesis, Dethe proposed a 
biomimetic route based upon a symmetrical retrosynthetic dissection of the molecule. 
Using this analysis, a Lewis acid-mediated intermolecular [3+2]-cycloaddition was 
designed to assemble the pyrrolo[1,2-a]indole scaffold (Scheme 4.1). After designing a 
model system to optimize conditions for the cycloaddition, six total aryl and heteroaryl 
substrates were also investigated, with yield ranging from 74 to 86% using 20 mol % 
Cu(OTf)2 with the substrate at 0.05 M in DCM and diastereoselectivities up to ≥19:1. 
After this brief methodological study, Dethe and co-workers embarked on the synthesis 
of the natural products from known phenyl sulfonyl tryptophol13 4-13. The two [3+2]-
cycloaddition precursors were obtained in seven synthetic steps. However, BF3•OEt2 was 
employed in the key [3+2]-cycloaddition step to induce low diastereoselectivity (due to 
lack of coordination between the sulfonyl oxygens and indole nitrogen) to target both 
compounds 4-16 and epi-4-16. After only 3 more steps, flinderoles B and C were 
acquired in 11 total steps and 17.2% overall yield.  
This pioneering synthesis utilizing a [3+2]-cycloaddition to assemble the major 
framework of the molecule would provide inspiration for a number of other biomimetic 
syntheses of these natural products to be discussed below. This synthesis was amenable 
to a number of aryl and heteroaryl substrates, which would allow for rapid assembly of 
other synthetic analogs of these natural products. However, this synthesis suffered from 
the need for protecting group installation/removal chemistry, increasing overall step 
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count and decreasing overall yields. As such, further work could be done to eliminate the 
need for protecting groups and increase yield. 
 
Scheme 4.1 Dethe's Lewis Acid-Mediated [3+2]-Cycloaddition Toward Flinderoles B & C 
Just two years after this pioneering synthesis, Dethe and co-workers utilized the 
same strategy they previously used toward flinderoles B and C to synthesize flinderoles 
A-C and the borreverine natural products isoborreverine and dimethylisoborreverine 
(Scheme 4.2).14 However, this approach had one key difference – in 2013, a protecting 
group-free route was developed. This new route eliminated the use of 
protection/deprotection sequences, reducing the total step count for each of the natural 
products down to only six steps. However, the production of four isomers in a single step 
(4-18, epi-4-18, 4-19, and epi-4-19) reduces overall yield of a single natural product 



















































Scheme 4.2 Dethe's Protecting Group-Free Approach 
In 2014, Dethe and co-workers also tackled the flinderoles one last time in their 
pursuit of borreverine and other bisindole alkaloids, the caulindoles, using only slightly 
different starting materials (Scheme 4.3).15 In this final synthesis, Dethe developed a 
slightly more chemoselective approach to flinderole A; when free indole is used, 
cyclization occurs to form pyrrolo[1,2-a]indole frameworks. However, when sulfonylated 
indoles are used, the borreverine scaffold is formed. This final route alleviates one of the 
major issues in the previous synthesis – the chemoselectivity issue.  
Dethe’s pioneering research in the synthesis of the flinderoles has inspired many 
other chemists to pursue these natural products as well, whether by similar or brand new 
methodologies to access their pyrrolo[1,2-a]indole core framework. While 
chemoselectivity and protecting group strategies have been mostly resolved through their 
work, one issue still remains. When diastereoselectivity is needed, chemoselectivity is an 
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This leaves room for others to step in and attempt to develop a chemoselective and 
diastereoselective route to the flinderole and borreverine natural products. 
 
Scheme 4.3 Dethe's Final Synthesis of Flinderole A and Borreverine 
4.2.2 Toste and Co-Workers, 2011 
In June 2011, only four months after Dethe and co-workers’ seminal report, Toste 
and co-workers published a second synthesis of flinderoles B and C.16 In their synthesis, 
Toste devised a gold-catalyzed allene hydroarylation17-19 to construct the pyrrolo[1,2-
a]indole core (Scheme 4.4). Toste and co-workers embarked on their synthetic journey 
with the known compound tryptophol.20 After five synthetic transformations, the key 
precursor 4-27 was acquired in 29% yield over the five steps. In the key allene 
hydroarylation step, triphenylphosphinegold(I) was initially used with no positive results. 
After exchanging the catalyst with the electropositive NHC catalyst IPrAuCl, the reaction 
proceeded smoothly. Compound 4-27 was cyclized using 5 mol% IPrAuCl and 5 mol % 









































LiAlH4 α-Me, Flinderole A, 4-7













α-Η = 3’-epi-borreverine, 4-24
β-Η = Borreverine, 4-25
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Although 2 mol % of the catalyst system could also be used, yields dropped to 81% yield 
and significant amount of diene side products were observed. With the core pyrrolo[1,2-
a]indole scaffold in hand, the rest of the synthesis proceeded rather smoothly. The final 
key step was a Horner-Wadsworth-Emmons alkenylation of the 2-
(methylindole)phosphonate 4-30; fortunately this transformation was known through the 
work of Srinivasan and co-workers, giving Toste and co-workers a set of conditions with 
which to complete this step in 36% and 33% yield for trans- and cis-4-31, respectively. 
All in all, Toste and co-workers completed the synthesis of flinderoles B and C in 14 total 
steps in the longest linear sequence at an overall 4% yield. 
 
Scheme 4.4 Toste's Allene Hydroarylation Toward Flinderoles B & C 
Toste and co-workers in their synthesis provided a beautiful display of the 
application of gold-catalyzed hydroarylation of allenes in order to synthesize flinderoles 
B and C. This method provides yet another alternative route toward pyrrolo[1,2-a]indole 
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drastically low overall yield, mostly due to low yielding steps late in the synthesis. This 
route also includes a number of protection/deprotection sequences, increasing the step 
count. While this was an excellent showcase of Toste’s methodology, other 
methodologies could be developed to access the pyrrolo[1,2-a]indole core scaffold, 
allowing for more modular syntheses of flinderoles B and C and their analogs. 
4.2.3 May and Co-Workers, 2012 
In 2012, May and co-workers reported another biomimetic total synthesis of the 
flindersial alkaloids.21 Vallakati and May hypothesized that the flinderole scaffolds 
emerged from the dimerization of another natural product, borrerine, via a ring-opening 
isomerization and either a formal [3+2]-cycloaddition (to form the flinderoles) or a Diels-
Alder cycloaddition (to form the borreverines). Using this route, flinderoles A-C, 
desmethylflinderole C, isoborreverine, and dimethylisoborreverine were obtained in only 
three total steps from commercially available tryptamine (Scheme 4.5). Tryptamine was 
reacted with 2-methyl-2-butenal and then methyl carbonochloridate to form 4-33. 
Reduction with LiAlH4 gave the key intermediate, borrerine, which, depending on the 
reaction conditions, gave each of the flindersial alkaloids (without borreverine). 
Since this publication, May and co-workers have been seeking an enantioselective 
route toward the flindersial alkaloids.22 While it seems they are produced racemically in 
biological systems, it is prudent to understanding the bioactivity in context of the correct 
enantiomer of the natural product. To accomplish this, they devised a strategy to set the 
stereochemistry of the benzylic (2-methyl)propenyl group before the synthesis of the 
pyrrolo[1,2-a]indole scaffold. Thus far, a stereoselective synthesis of the key 
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intermediate toward the core framework has been completed (Scheme 4.6), though no 
other work toward an enantioselective synthesis has been reported. 
 
Scheme 4.5 May's Synthesis of the Flindersial Alkaloids 
 
Scheme 4.6 May's Synthetic Efforts Toward an Enantioselective Synthesis of the Flinderoles 
May’s synthetic efforts represent some of the most powerful methods to access 
the flindersial alkaloids to date. However, May’s strategy suffers from significant 
chemoselectivity issues. A number of products are isolated from a single reaction, leading 
to the need for careful separations. However, his strategy is very efficient, with little to no 
byproducts or degradation observed under optimized conditions. May and co-workers are 
the first and only group so far to attempt an enantioselective synthesis of the flindersial 
alkaloids. There still remains a need for a more chemoselective method, and further 
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3 days Isoborreverine, 4-11 (40%)
TFA Flinderole A, 4-7 (28%)























(10 mol %) Mg(Ot-Bu)2




4.2.4 Pandey and Co-Workers, 2016 
In 2016, Pandey and co-workers published the most recent synthesis of the 
flinderole alkaloids (Scheme 4.7).23 In this report, Pandey utilized a similar intermediate 
to that use by Dethe and co-workers in 2011, only replacing a protected tryptophol with a 
phthalimide-protected tryptamine 4-41. InCl3 was used to induce a formal [3+2]-
cycloaddition as the key step, with each of the flinderoles being obtained in only six 
steps. This represents yet another biomimetic route to the flinderoles; however, this route 
is plagued by the use of the phthalimide protecting group, adding to step count with 
protection and removal. Pandey’s route is also not diastereoselective, leading to both 
flinderole precursors that must be carefully separated. There again remains a need for a 
diastereoselective route to effectively acquire only a single one of the flinderoles. 
 
Scheme 4.7 Pandey's Synthesis of the Flinderoles 
4.3 Methods Toward the Flinderole Framework: Pyrrolo[1,2-a]indoles 
The key framework of the flinderoles is the central pyrrolo[1,2-a]indole core, a 
privileged scaffold in the realm of indole alkaloids. A current Reaxys search revealed 
approximately 36 known alkaloids containing this framework, each having it own unique 
structure and set of bioactivities. Many methods have been devised to access this core 

























synthesis of the flinderoles. To my knowledge, only one review has been published 
detailing methodologies (prior to 2016) to access the pyrrolo[1,2-a]indoles,24 and many 
other communication/articles have been published since.25-35 With a plethora of methods 
reported to access this scaffold and the potent bioactivity of many of these natural 
products, it is no surprise that the flinderoles have remained a popular target for synthetic 
chemists. 
4.3.1 An Aza-Nazarov-Like Protocol Toward the Pyrrolo[1,2-a]indole Core 
The Nazarov reaction represents a power method to synthesize densely 
functionalized cyclopentenones (Scheme 4.8A; for greater detail, see Chapter 1.2.2). Aza 
variants of the Nazarov reaction also represent a facile method to obtain densely 
functionalized lactams (Scheme 4.8B). In 2011, France and co-workers reported an aza-
Nazarov-like protocol toward the synthesis of densely functionalized pyrrolo[1,2-
a]indoles from β-amidoesters.36 Using In(OTf)3, these β-amidoesters were activated to 
induce an intramolecular Friedel-Crafts alkylation of the indole amide in a Michael-like 
fashion, forming the desired pyrrolo[1,2-a]indole framework (Scheme 4.9). Considering 
the catalytic nature of this protocol, breadth of scope, and high diastereoselectivity, we 
believed that this aza-Nazarov-like protocol represented a novel, highly modular, 
diastereoselective method toward the flinderole natural products. 
The aza-Nazarov-like, Friedel-Crafts-type (henceforth referred to as ANFC) 
cyclization reaction of α-sulfonylamides is completely unexplored. In fact, the Nazarov 
reaction of α-sulfonylketones is also very underexplored; to our knowledge, the only 
known report of Nazarov cyclizations on α-sulfonylketones was published by Frontier in 
2008, with only a single α-sulfonylketone substrate (Scheme 4.10).37 As such, the 
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synthesis of the flinderole natural products utilizing this architecture will have a four-fold 
impact: (1) the addition of a second electron-withdrawing group in the Nazarov 
cyclization should lower activation energy, increasing the likelihood of achieving 
catalysis, (2) this will further expand the chemical space of Nazarov-like reactions to α-
sulfonylcarbonyl substrates, (3) sulfones are useful synthetic handles, providing a 
pathway toward Julia olefinations, reductive desulfonylations, and the acidic nature of 
sulfone α-protons allow for effective α-functionalizations, and (4) with the use of 
sulfonyl protecting groups throughout the rest of the flinderole synthesis, all sulfonyl 
groups can be removed in a single, global deprotection step. 
 
Scheme 4.8 Nazarov vs. an Aza-Nazarov Cyclization Variant 
 
Scheme 4.9 France's Previous Aza-Nazarov-Like, Friedel-Crafts Cyclization Methodology 
 
Scheme 4.10 Frontier's Previous Methodology 
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up to 98% yield


























4.4 Current Progress Toward the Flinderole Alkaloids Utilizing an Aza-Nazarov-
Like Approach 
While many short synthetic routes to the flinderoles have been established, we 
hoped to develop a synthesis focusing on alleviating one of the major issues of previous 
syntheses – diastereoselectivity. We also hoped to improve on the modularity of previous 
syntheses, allowing for the synthesis of many unnatural analogs with the intention of 
improving bioactivity utilizing this novel α-sulfonylamide architecture. We first devised a 
synthetic route through using the retrosynthetic analysis shown in Scheme 4.11. 
Flinderole A was chosen due to the trans relationship of the two olefins across the 
pyrrole ring. In order to initially simplify the synthesis, a model system was designed 
using 3-methylindole as a major template. We envisioned 4-51 being synthesized via a 
Michael addition of the organometallic 4-52 on the unsaturated sulfone 4-53. The desired 
trans stereochemistry is expected to be favored due to steric effects; however, both cis 
and trans diastereomers should be obtained. The key intermediate 4-53 would be derived 
from a carbonyl methylenation using a Wittig-type reaction and alkene isomerization of 
the ketone 4-54. Compound 4-54 is derived from the ANFC cyclization of the α-
sulfonylamide 4-55 obtained from a Knoevenagel condensation. The sulfonyl group 
would be installed via a simple substitution reaction on the α-chloroamide 4-56. 
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Scheme 4.11 Retrosynthetic Analysis of Flinderole A 
To begin the synthesis of the model substrate 4-51, acylation of 3-methylindole 
with α-chloroacetic acid chloride afforded the desired intermediate 4-56 in 92% yield. 
Using a protocol developed by Venkateswarlu,38 sodium benzenesulfinate displaced 
chloride in the presence of PEG-400 to afford the α-sulfonylamide 4-57. Upon obtaining 
4-57, all attempts at a protic acid-promoted Knoevenagel condensation conditions to 
obtain 4-53 resulted only in the recover of starting material. Thus, a TiCl4-promoted 
Knoevenagel condensation was used; however, this reaction was incredibly inefficient 
and resulted in a 1:3.1 E:Z diastereomeric mixture. The material was enough the carry 





















































Scheme 4.12 Synthesis of Aza-Nazarov Substrate 4-55 
Next, several Lewis acids were screened for their viability as an ANFC 
cyclization catalyst. At this stage, only 3+ salts were screened, partly due to their success 
in France’s previous protocol. In entries 1-3 of Table 4.1, no reaction was observed with 
any of the 3+ salts at room temperature in DCM. At this stage, it was evident that this 
reaction was not a favorable reaction at room temperature; a solvent switch to 1,2-DCE 
was made and each subsequent reaction was conducted at reflux. Gratifyingly, the 
formation of the desired product was observed at these higher temperatures. However, 
reaction times were much longer than desirable, with the shortest time until full 
conversion (by TLC analysis) was 3 days. The highly oxophilic 3+ salts Al(OTf)3 and 
Ga(OTf)3 provide the best yields of 57% and 54% respectively after 3 days. Interestingly, 
the indole-fused azepinone byproduct 4-60 was also observed under these reaction 
conditions that, to our knowledge, is the first reactivity of this type to be observed on 
these diene systems. The highest yielding catalyst, Al(OTf)3, was also retested at 0.3 M in 
1,2-DCE to increase the effective concentration of the catalyst. As a result, the yield 
increased from 57% to 67%. This reaction represents the first ANFC cyclization on α-








































observed by the byproduct 4-60. Unfortunately, the reproducibility of this reaction is not 
consistent. More optimizations for this step remain to be completed, with more Lewis 
acids to be screened, and full solvent, temperature, and concentration screens. 
Table 4.1 ANFC Cyclization Lewis Acid Screen 
 
Entry Lewis Acid Temp (°C) Solvent Yield (%) 4-54 
Yield (%) 
4-60 Time (days) 
1 In(OTf)3 23 DCM 0 0  --a 
2 Sc(OTf)3 23 DCM 0 0  -- a 
3 Al(OTf)3 23 DCM 0 0  -- a 
4 In(OTf)3 84 1,2-DCE 48 0  3 
5 Sc(OTf)3 84 1,2-DCE 30 0  3 
6 Al(OTf)3 84 1,2-DCE 57 (67)b 14 (12)b 3 
7 Ga(OTf)3 84 1,2-DCE 54 16 3 
8 Yb(OTf)3 84 1,2-DCE 21 0 2 
9 La(OTf)3 84 1,2-DCE 0 0 -- a 
a No conversion observed after >24 hours. b Reaction performed at 0.3 M. 
Upon obtaining a reasonable amount of 4-54, a number of different pathways 
toward methylation were explored (Scheme 4.13). In pathway a, the formation of an alkyl 
enol ether was explored, with the expectation of using an organometallic reagent for 
conjugate addition to the vinyl sulfone39-41 4-61. However, all attempts at formation of 
the alkyl enol ether resulted in methylation of the α-carbon using methyl triflate or 
dimethyl sulfate. In pathway b, the formation of an enol triflate was expected to provide a 
handle for cross coupling, leading to the desired vinyl sulfone 4-53. However, after an 
attempt to form the enol triflate using triflyl chloride, crude 1H NMR gave inconclusive 























be used to generate the tertiary alcohol 4-63 which would be carried forward for 
condensation to for 4-53. The results of all attempts to synthesize the tertiary alcohol are 
summarized in Table 4.2, with no positive results. Finally, in pathway d, olefination of 
the ketone was expected to give the β,γ-unsaturated ketone. Wittig olefinations have been 
generally problematic with amides for the formation of enamines; olefinations with 
Tebbe’s reagent or the Petasis reagent, on the other hand, have been a powerful method 
for forming enamines from amides. It was also expected that an olefin isomerization 
would need to be investigated. However, upon reacting 4-54 with Tebbe’s reagent, it was 
discovered that no only had the olefination occurred, but isomerization of the alkene had 
also taken place in the same pot in 23% yield (Scheme 4.14). Further optimization also 
needs to be conducted for this step with other reagents such as the Petasis reagent. As 
such, the key pyrrolo[1,2-a]indole intermediate 4-53 had been synthesized.  
 



























































Table 4.2 Summary of Attempted Methyl Additions to Carbonyl 
 
 
Entry MeLi  (equiv.) 
Additive  
(equiv.) Temp. (°C) Yield (%) 
1 1.2 CeCl3•7H2O (1.3) -78  --a 
2 1.2 CeCl3 (2.0) -78  --a 
3 3.1 --  -78 to rt  --b 
a No conversion observed by TLC or NMR. b An intractable mixture was obtained. 
 
Scheme 4.14 Olefination/Olefin Isomerization with Tebbe's Reagent 
4.5 Summary of Progress Toward the Flinderoles Utilizing an ANFC Approach 
In conclusion, a highly modular, diastereoselective approach toward the flinderole 
natural products has been proposed. Using 3-methylindole, the synthesis of a key 
intermediate of the model substrate, the pyrrolo[1,2-a]indole containing an unsaturated 
cyclic sulfone, has been completed. An ANFC cyclization protocol was used to generate 
the pyrrolo[1,2-a]indole core scaffold using Al(OTf)3 as the Lewis acid catalyst. Using 
Tebbe’s reagent, an olefination/isomerization cascade protocol was serendipitously 
discovered, leading to the key intermediate needed for the final organometallic conjugate 
addition step to synthesize the bisindole framework of the flinderoles.  
Moving forward, a number of optimizations still need to be completed, along with 
completion of the model substrate. Because of the number of low yielding, irreproducible 
steps thus far, scalability remains an issue that also needs to be addressed. Once these 

































substrate can begin and should rapidly translate from the steps shown in the progress 
toward the synthesis of this model system. 
4.6 Experimental Section 
4.6.1 Synthetic Methods 
Chromatographic purification was performed as flash chromatography with 
Silicycle silica gel (40-65µm) or preparative thin-layer chromatography (prep-TLC) 
using Silicycle silica gel F254 (1000 µm) plates and solvents indicated as eluent with 1-5 
bar pressure. For quantitative flash chromatography, technical grades solvents were 
utilized. Analytical thin-layer chromatography (TLC) was performed on Silicycle silica 
gel 60 F254 TLC glass plates. Visualization was accomplished with UV light. 
Infrared (IR) spectra were obtained using a Shimadzu IRAffinity-1S FTIR with a 
Specac Quest ATR attachment. The IR bands are characterized as weak (w), medium 
(m), and strong (s). Proton and carbon nuclear magnetic resonance spectra (1H NMR and 
13C NMR) were recorded on a Varian Mercury Vx 300 MHz spectrometer, or Bruker 400 
MHz, 500 MHz, and 800 MHz spectrometers with solvent resonances as the internal 
standard (1H NMR: CDCl3 at 7.26 ppm; 13C NMR: CDCl3 at 77.0 ppm). 19F NMR spectra 
were recorded on a Bruker 400 MHz spectrometer using PhCF3 as an external standard. 
1H and 19F NMR data are reported as follows: chemical shift (ppm), multiplicity (s = 
singlet, d = doublet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of 
doublet of doublets, t = triplet, m = multiplet, br = broad), coupling constants (Hz), and 
integration. Mass spectra were obtained MicroMass Autospec M.  The accurate mass 
analyses were run in EI mode at a mass resolution of 10,000 using PFK 
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(perfluorokerosene) as an internal calibrant. Uncorrected melting points were measured 
with a digital melting point apparatus (DigiMelt MPA 160).  
General Procedure for Lewis Acid Screen:  
To a dry, nitrogen-purged round bottom flask was added the appropriate Lewis acid (20 
mol %). The unsaturated α-sulfonylamide (1.0 equiv.) was dissolved in the appropriate 
solvent (0.1 M). The reaction was heated to the appropriate temperature until the starting 
material was consumed (monitored by TLC). Water was then added to the reaction 
mixture and diluted with DCM. The mixture was extracted three times with DCM, 
washed with brine, dried over Na2SO4, filtered, and concentrated. The crude residue was 
then purified via flash chromatography and concentrated. 
 
 
2-chloro-1-(3-methyl-1H-indol-1-yl)ethan-1-one: Indole (15.0 g,  0.114 mol) was 
dissolved in toluene (114 mL) and chloroacetyl chloride (22.7 mL, 0.286 mol) was 
added. The mixture was heated to reflux overnight and concentrated. The mixture was 
purified by flash chromatography (Rf = 0.58, 25% EtOAc/Hexane) to give the title 
compound (21.8, 92% yield) as a brown solid. 1H NMR (300MHz, CDCl3) δ = 8.41 (d, J 
= 7.9 Hz, 1 H), 7.54 - 7.47 (m, 1 H), 7.43 - 7.29 (m, 2 H), 7.16 (s, 1 H), 4.52 (s, 2 H), 
2.29 (d, J = 1.3 Hz, 3 H). 13C NMR (75MHz, CDCl3) δ = 163.6, 135.9, 131.3, 125.6, 






2922 (w), 1708 (s), 1391 (s), 1207 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. for 
C11H10ClNO, 207.0451; found 207.0450. 
 
 
1-(3-methyl-1H-indol-1-yl)-2-(phenylsulfonyl)ethan-1-one: Prepared according to a 
previously reported method.38 Chloroacetyl indole (393 mg, 1.89 mmol) and sodium 
benzenesulfinate (476 mg, 2.90 mmol) was suspended in PEG-400 (7.5 mL). The mixture 
was heated to 50°C and stirred overnight. The reaction was quenched with water, 
extracted three times with EtOAc, washed with water, dried over Na2SO4, filtered 
through celite, and concentrated. The crude solid was purified by flash chromatography 
(Rf = 0.25, 25% EtOAc/Hexane) to give the title compound (462 mg, 78% yield) as a 
white solid. 1H NMR (500MHz, CDCl3) δ = 8.31 (d, J = 5.2 Hz, 1 H), 7.96 - 7.91 (m, 2 
H), 7.69 (tt, J = 1.2, 7.5 Hz, 1 H), 7.58 - 7.53 (m, 2 H), 7.52 - 7.47 (m, 1 H), 7.36 - 7.31 
(m, 2 H), 7.23 (s, 1 H), 4.63 (s, 2 H), 2.27 (d, J = 1.2 Hz, 3 H). 13C NMR (126MHz, 
CDCl3) δ = 158.9, 138.2, 135.9, 134.5, 131.8, 129.3, 128.6, 125.6, 124.5, 122.0, 120.2, 
119.0, 116.8, 62.3, 9.7. IR: 3132 (w), 2995 (w), 2941 (w), 1686 (s), 1307 (s) cm-1. 















Amidosulfone 4-59 (500 mg, 1.60 mmol) was dissolved in THF (35 mL) and cooled to 
0°C. TiCl4•2THF (1.07 g, 3.20 mmol) and carbon tetrachloride (0.31 mL, 3.20 mmol) 
were added and stirred for 1 hour at 0°C. 3-methyl-2-butenal (0.15 mL, 1.60 mmol) was 
added slowly and stirred for 1 hour at 0°C. Pyridine (0.51 mL, 6.38 mmol) was then 
added at 0°C, warmed to room temperature, and stirred 3 days. The reaction was 
quenched with water, extracted three times with Et2O, washed with sat. aq. NaHCO3, 
washed with brine, dried over MgSO4, filtered through celite, and concentrated. The 
crude mixture was purified by flash chromatography (Rf = 0.42, 25% EtOAc/Hexane) to 
give the title compound (198 mg, 33% yield) as a yellow solid. (Diastereomeric ratio = 
3.1:1) 1H NMR (500MHz, CDCl3) δ = 8.44 - 8.34 (m, 1.29 H), 8.12 - 8.07 (m, 0.65 H), 
7.94 - 7.89 (m, 1.94 H), 7.81 (d, J = 12.2 Hz, 0.99 H), 7.66 - 7.60 (m, 1.34 H), 7.59 - 7.49 
(m, 3.97 H), 7.39 - 7.31 (m, 2.68 H), 7.24 (d, J = 1.5 Hz, 0.31 H), 7.18 - 7.14 (m, 0.35 H), 
7.13 - 7.10 (m, 0.32 H), 7.03 (s, 0.93 H), 5.75 (quind, J = 1.3, 12.3 Hz, 0.99 H), 2.27 (d, J 
= 1.5 Hz, 0.97 H), 2.23 (d, J = 1.5 Hz, 3.00 H), 2.06 - 2.01 (m, 3.97 H), 1.85 - 1.80 (m, 
3.96 H). 13C NMR (126MHz, CDCl3) δ = 162.7, 161.0, 155.6, 154.9, 141.5, 140.2, 
139.9, 138.2, 136.0, 135.5, 133.6, 133.6, 133.3, 132.4, 132.3, 132.0, 129.1, 129.1, 128.2, 
128.0, 125.2, 124.4, 124.2, 123.7, 123.5, 119.5, 119.1, 119.0, 119.0, 118.9, 118.8, 116.8, 
116.6, 27.7, 27.1, 19.5, 19.0, 9.7.  IR: 3067 (w), 2972 (w), 2918 (w), 2855 (w), 1674 (m), 
1624 (m), 1578 (m), 1447 (s), 1144 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. for 





pyrrolo[1,2-a]indol-3-one: Al(OTf)3 (125 mg, 0.26 mmol) was added to a flask and 
unsaturated sulfone 4-55 (498 mg, 1.31 mmol) was dissolved in 1,2-DCE (4.4 mL) and 
added to the catalyst. The mixture was heated to reflux for 3 days and concentrated. The 
crude residue was purified by flash chromatography (Rf = 0.39, 20% EtOAc/Hexane) to 
give the title compound (335 mg, 67% yield) as a yellow solid. (Diastereomeric ratio = 
5.4:1) 1H NMR (500MHz, CDCl3) δ = 8.17 - 8.14 (m, 0.11 H), 8.03 - 7.98 (m, 1.97 H), 
7.96 - 7.91 (m, 1.50 H), 7.72 - 7.63 (m, 1.32 H), 7.62 - 7.52 (m, 2.67 H), 7.43 - 7.40 (m, 
1.13 H), 7.33 - 7.27 (m, 2.35 H), 5.12 (tdd, J = 1.4, 2.8, 10.0 Hz, 1.00 H), 4.98 - 4.92 (m, 
1.16 H), 4.38 (d, J = 2.4 Hz, 0.16 H), 4.83 (d, J = 0.6 Hz, 0.18 H), 4.27 (d, J = 3.7 Hz, 
1.02 H), 2.24 - 2.21 (m, 0.56 H), 2.10 (d, J = 1.2 Hz, 3.00 H), 1.93 (d, J = 1.2 Hz, 3.02 
H), 1.83 - 1.77 (m, 3.71 H). 13C NMR (126MHz, CDCl3) δ = 161.2, 137.4, 136.9, 136.5, 
134.5, 130.3, 129.4, 129.2, 129.1, 129.1, 124.7, 124.0, 120.8, 118.9, 114.0, 111.0, 76.2, 
34.0, 25.7, 18.3, 7.8. IR: 3061 (w), 2972 (w), 2918 (w), 2864 (w), 1732 (s) cm-1. HRMS 

















Al(OTf)3 (125 mg, 0.26 mmol) was added to a flask and unsaturated sulfone 4-55 (498 
mg, 1.31 mmol) was dissolved in 1,2-DCE (4.4 mL) and added to the catalyst. The 
mixture was heated to reflux for 3 days and concentrated. The crude residue was purified 
by flash chromatography (Rf = 0.19, 20% EtOAc/Hexane) to give the title compound (58 
mg, 11% yield) as a yellow solid. 1H NMR (500MHz, CDCl3) δ = 8.20 - 8.16 (m, 1 H), 
8.04 - 8.00 (m, 2 H), 7.90 (t, J = 6.9 Hz, 1 H), 7.61 - 7.57 (m, 1 H), 7.54 - 7.50 (m, 2 H), 
7.41 - 7.38 (m, 1 H), 7.27 - 7.23 (m, 2 H), 2.76 (d, J = 7.0 Hz, 2 H), 2.37 (s, 3 H), 1.54 (s, 
6 H). 13C NMR (126MHz, CDCl3) δ = 161.2, 147.6, 141.2, 140.6, 138.7, 136.9, 133.3, 
131.7, 128.7, 128.6, 125.3, 124.0, 117.8, 117.1, 116.8, 41.6, 39.4, 29.0, 11.4. IR: 3067 
(w), 2957 (w), 2866 (w), 1678 (s), 1306 (s), 1285 (s) cm-1. HRMS (EI) [M]+ m/z: Calcd. 




a]indole: β-Amidosulfone 4-54 (99 mg, 0.26 mmol) was dissolved in THF (1.0 mL) and 
cooled to 0°C. Tebbe’s reagent (0.63 mL, 0.5 M in toluene, 0.32 mmol) was added and 
stirred at 0°C for 4 hours. The mixture was diluted with EtOAc, quenched with 0.1 M 
NaOH, extracted three times with EtOAc, washed with brine, filtered through celite, and 
concentrated. The crude residue was purified by flash chromatography (Rf = 0.81, 30% 
EtOAc/Hexane) to give the title compound (23 mg, 23% yield) as a yellow solid. 1H 









H), 7.50 - 7.46 (m, 3 H), 7.23 - 7.15 (m, 2 H), 4.83 - 4.77 (m, 1 H), 4.38 - 4.33 (m, 1 H), 
3.01 (d, J = 1.8 Hz, 3 H), 2.11 (d, J = 2.1 Hz, 3 H), 1.88 (d, J = 1.2 Hz, 3 H), 1.58 (d, J = 
1.5 Hz, 3 H). 13C NMR (126MHz, CDCl3) δ = 148.5, 143.4, 139.6, 135.8, 134.2, 132.5, 
130.8, 128.6, 127.1, 122.3, 121.2, 120.7, 119.4, 119.2, 110.9, 107.7, 41.3, 25.6, 18.2, 
12.9, 7.9. IR: 3063 (w), 2970 (w), 2928 (w), 2870 (w), 1717 (w), 1695 (w), 1614 (w), 
1138 (s) cm-1. HRMS (ESI) [M+H]+ m/z: Calcd. for C23H24NO2S, 378.1522; found 
378.1520. 
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CHAPTER 5.  CONCLUSIONS AND FUTURE OUTLOOK 
5.1 Novel Homo-Nazarov Cyclization Methodologies 
Firstly, a number of novel variants of the homo-Nazarov cyclization were 
explored. Using DACPs, catalytic ring-opening reactions of cyclopropanes can be readily 
achieved under mild conditions. Moreover, the synthesis of cyclopropyl vinyl ketones is 
carried out in a modular route, allowing access to a variety of different starting materials. 
Because of the modular synthetic route and mild ring-opening conditions, a very broad 
substrate scope can be achieved and a breadth of chemical space is accessed.  The first 
catalytic and chemodivergent interrupted homo-Nazarov cyclization using allylsilanes 
nucleophiles was developed, giving rapid access to densely functionalized α-allyl 
cyclohexenol and hexahydrobenzofuran products. The first catalytic, arylative, 
interrupted homo-Nazarov cyclization protocol was also investigated, providing a 
modular route to α-(hetero)aryl cyclohexenols. The first example of an intramolecular 
formal homo-Nazarov cyclization/Friedel-Crafts-type arylation was also demonstrated. 
Finally, the synthesis of the anticancer natural product propolisbenzofuran B was pursued 
utilizing a homo-Nazarov cyclization synthetic route. 
The work contained within this dissertation revolving around the methodologies 
and application of DACPs will further inform the synthetic chemistry community of the 
utility of DACPs in the synthesis of densely functionalized carbocycles. Within the 
proposed route to propolisbenzofuran B, further evidence of the utility of DACPs toward 
synthesis of natural products will be provided. 
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Figure 5.1 Utility of DACPs Investigated Within This Dissertation 
5.2 Further Exploration of Interrupted Formal Homo-Nazarov Methodologies 
Chapter 2 explored the using of DACPs in Lewis acid-catalyzed interrupted 
formal homo-Nazarov cyclizations using allylsilanes and (hetero)arenes toward the 
interception of cyclic oxyallyl cations. This methodological investigation resulted in the 
synthesis of densely functionalized α-allyl cyclohexenols, hexahydrobenzofurans, and α-
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of the interrupted formal homo-Nazarov was also demonstrated. This proof-of-concept 
should provide a springboard for the development of an intramolecular, arylative, 
interrupted formal homo-Nazarov cyclizations of the same type. It should also provide 
inspiration toward other intramolecular variants of this methodology, including that with 
a tethered allylsilane nucleophile (Scheme 5.1). In this case, if a labile tethered allylsilane 
is used, one might envision the synthesis of vinyl-substituted hexahydroindanes of type 
5-2. In the case that a non-labile silyl nucleophile is used, the synthesis of oxatricylic 
compounds of type 5-3 could be readily achieved. 
 
Scheme 5.1 Intramolecular Allylsilane-Interrupted Formal Homo-Nazarov Methodology 
Beyond this potential methodological advance, a number of other interrupted 
formal homo-Nazarov methodologies with other nucleophiles could also be envisioned 
for the achievement of molecular complexity (Scheme 5.2). Using silane reducing agents, 
a reductive formal homo-Nazarov methodology might be achieved. Heteroatom 
nucleophiles could also be envisioned toward molecules of the type 5-8. Finally, in an 
attempt to synthesize azepine core scaffolds of the type 5-10, an azide nucleophile could 
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further show the synthetic utility of interrupted formal homo-Nazarov cyclization 
reactions and provide access to broader chemical space. 
 
Scheme 5.2 Further Expansions of the Interrupted Formal Homo-Nazarov Methodology 
5.3 Synthesis of Propolisbenzofuran B Analogs Via Formal Homo-Nazarov 
Cyclization Methodology 
In Chapter 4, appreciable progress was made toward the synthesis of 
propolisbenzofuran B utilizing a formal homo-Nazarov cyclization (FHN) to form the 
benzofuran-fused cyclohexanone core (Scheme 5.3). This protocol has already been 
shown to have broad substrate scope. Because of this, we believe that this cyclization 
methodology will provide access to a number of unnatural (and more drug-like) analogs 
of propolisbenzofuran B. After completion of the synthesis of the target, we hope to 
synthesize a number of synthetic analogs of propolisbenzofuran B and launch an 
investigative study into the structure-activity relationships of other fused heteroaromatics, 


































propolisbenzofuran B, we hope the synthetic community will realize the potential of 
cyclopropane ring-opening/ring-closing cyclizations. 
 
Scheme 5.3 Synthesis of Benzofuran-Fused Cyclohexanone Core by FHN Cyclization 
 
Figure 5.2 Unnatural Propolisbenzofuran B Synthetic Analogs 
5.4 Development of a Vinyligous Aza-Nazarov-Like Friedel-Crafts-Type 
Cyclization Toward Indole-Fused Azepines 
In Chapter 4, as part of the progress toward the synthesis of the flinderoles, a 
novel unsaturated α-sulfonylamide was used as the key precursor toward the pyrrolo[1,2-
a]indole framework. To our knowledge, this is a novel precursor in Nazarov cyclizations. 
The sulfonyl groups allow for a whole range of reactivity after a Nazarov cyclization 
step, such as reductive desulfonylations and Julia olefinations. As such, access to 
synthetic analogs of the flinderoles could be rapidly achieved (Scheme 5.4). In the case of 
the Julia olefination to synthesize intermediates of type 5-19, subsequent Michael-type 













































Scheme 5.4 Examples of Desulfonylation Reactions for Flinderole Derivatization 
 In the process of the aza-Nazarov-like Friedel-Crafts-type (ANFC) cyclization, 
an interesting side product was formed as part of the ANFC reaction step. In addition to 
the suspected (and desired) pyrrole 5-15, the 7-membered azepine 5-16 was also isolated 
(Scheme 5.5). To our knowledge, this represents the first reactivity of this type. We 
hypothesize that this reactivity stems from the likelihood that this reaction does not 
proceed via a concerted mechanism, mimicking a more Friedel-Crafts-type process 
(hence the nomenclature, ANFC). In addition to the more Friedel-Crafts-type mechanism, 
it is also suspected that the increased electron-withdrawing nature of the sulfonyl group 
further added to the cationic character of the second vinyl group, leading to addition at 
the distal carbon (Scheme 5.6). While much optimization is needed, this proof-of-concept 
reaction should give other chemists inspiration to pursue this type of reactivity further. If 
this methodology is viable, it will provide yet another method to access azepinoindole 
scaffolds found in many natural products. 
 




















































Scheme 5.6 Suspected Mechanism for Formation of the Pyrrole and Azepine Products 
5.5 Conclusion 
Within this dissertation, a few novel methodological advances were pioneered in 
the realm of ANFC reactions and interrupted FHN cyclizations. As such, the synthetic 
community will have found new methods to access α-allylcyclohexenols, 
hexahydrobenzofurans, and α-(hetero)arylcyclohexenols. A FHN methodology was 
pursued to access the benzofuran-fused cyclohexanone core of the anticancer natural 
product propolisbenzofuran B. An ANFC cyclization methodology was investigated 
toward the synthesis of the antimalarial flindersial alkaloids. Additionally, as part of the 
ANFC protocol, a new method to access azepino[1,2-a]indoles was uncovered, though 
much optimization is still needed. In each of the developed methodologies and syntheses, 
modular synthetic routes toward synthetic precursors were targeted in order to further 
investigate and expand the substrate scope, pushing the boundaries of what these 
methodologies will tolerate. As such, these methodologies can now be applied in the 
synthesis of many bioactive natural products and other pharmaceutically relevant 
























APPENDIX I. DEHYDRATIVE NAZAROV-TYPE ELECTRO-
CYCLIZATIONS OF ALKENYL (HETERO)ARYL 
CARBINOLS VIA CALCIUM CATALYSIS† 
I.1 Cyclopenta[b]thiophenes: Relevance 
Cyclopenta[b]thiophenes represent a unique isostere of indene that often exists as 
an equilibrium mixture of 3 forms: a 4H- and 6H- isomers, and a 5H-isoindene isostere 
(Figure I.1).1-3 The utility of cyclopenta[b]thiophenes is generally in the synthesis of 
metal complexes;4-12 however, their dihydro- derivatives are often used in the materials 
science community13-18 and in the realm of medicinal chemistry.19-22 While only a few 
syntheses of these unique structures have been reported, most involve the elaboration of 
thiophene-fused cyclopentanones. However, most have limited substrate scope and low 
functional group tolerance. Therefore, there exists a need for a highly general method for 
the synthesis of these cores.  
 
Figure I.1 Isomers of Cyclopenta[b]thiophenes 
 
                                                
† This work was conducted in collaboration with M. Cynthia Martin, Matthew J. Sandridge, and Zola A. 
Francis. My contribution included the synthesis and extensive purification of many of the β-ketoester and 
(hetero)aryl allylic alcohol starting materials, the attempted Diels-Alder derivatizations and editing to the 








I.2 Nazarov-like Cyclizations Toward Cyclopenta[b]thiophenes 
A recent re-emergence of interest in the Nazarov and Nazarov-like cyclizations 
has led to the development of many elegant methods toward the synthesis of highly 
functionalized cyclopentanes. In several such examples, ionization of the C-O bond of 
divinyl or heteroaryl-substituted allylic alcohols23-34 leads to the formation of 
cyclopentadienes and (hetero)aryl-fused cyclopentadienes via a 4π-electrocyclization 
approach, often coined as a “dehydrative Nazarov” or “cyclodehydration” (Scheme 
I.1).35-37 Recently, the France group recently reported a calcium-catalyzed, dehydrative 
ring-opening cyclization of (hetero)aryl cyclopropyl carbinols for the formation of 
(hetero)aryl-fused cyclohexa-1,3-dienes (Scheme I.2A).38 Inspired by these results, we 
sought to develop a similar catalytic, generalizable approach toward the synthesis of 
cyclopenta[b]thiophenes, which have been particularly synthetically challenging 
substrates when utilizing a dehydrative Nazarov-like approach (Scheme I.2B).39-40 
 
Scheme I.1 Mechanism of the Dehydrative Nazarov Cyclization 
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Scheme I.2 Calcium-Catalyzed, Dehydrative Cyclization Strategies 
I.2.1 Synthesis of (Hetero)aryl Allyl Carbinols 
Guided by Batey’s previous investigation of substituent effects in the dehydrative 
Nazarov cyclization toward functionalized indenes,41 we laid out a rather simple 2-step 
approach toward the desired (hetero)aryl allyl carbinol starting materials from known ß-
ketoesters (Scheme I.3). In the first step, a Knoevenagel condensation of ß-ketoesters I-7 
with chosen aldehydes yielded the desired unsaturated ß-ketoesters I-8 in up to 
quantitative yield. Following this, Luche reductions to form the subsequent carbinols I-9 
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Scheme I.3 Synthesis of (Hetero)Aryl Allyl Carbinols 
I.2.2 Reaction Optimization and Substrate Scope 
Upon synthesis of substrate I-9a, an extensive set of reaction optimization screens 
were carried out, including those examining Lewis/Brönsted acid catalysts, catalyst 
loadings, temperatures, solvents, concentration, and reaction time, which will not be 
discussed in detail here. It was determined that the optimized conditions were 10 mol % 
Ca(NTf2)2, 10 mol % n-Bu4NPF6 in benzene (0.05 M) at 40°C for 1.75 hours. With this 
set of conditions in hand, the substrate scope of the reaction was examined (Scheme I.4). 
O
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I-9a, R = H
I-9b, R = 4-OMe
I-9c, R = 4-Me
I-9d, R = 4-Br
I-9e, R = 4-CF3
I-9f, R = 2-OMe
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I-9i, R = ß-styryl
I-9j, R = 2-Np

















I-9l I-9m I-9n I-9o, R = H
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Scheme I.4 Examination of Substrate Scope 
In order to examine the electronic effects of differing substituents about the 
phenyl ring, carbinols I-9a-e were subjected to the optimized conditions. When a strong 
electron-donating group such as 4-methoxy is added to the ring, yield increases to 82%. 
However, when an electron-withdrawing group such as 4-trifluoromethyl is added, yield 
slightly decreases to 67%. This suggests only a small inductive effect on the outcome of 
the reaction, where yields are increased with electron-donating nature and slightly 
decreased with electron-withdrawing nature of the substituents.  
When a 2-methoxy group is added (I-9f), the reaction favors the 6H-
cyclopenta[b]thiophene, likely due to a steric effect slowing the rate of alkene 
isomerization to the more thermodynamically preferred 4H-cyclopenta[b]thiophene. 
However, when a 3-methoxy substituent (I-9g) is employed, the reaction is completely 
selective for the indene product due to the increased nucleophilicity of the position para 
S
I-10a, R = H (70%, 1:0)
I-10b, R = 4-OMe (82%, 1:0)
I-10c, R = 4-Me (66%, 1:6.5)
I-10d, R = 4-Br (69%, 1:0)
I-10e, R = 4-CF3 (67%, 1:0)
I-10f, R = 2-OMe (75%, 1:8)
I-10k, R = i-Pr (0%)
S
I-10h, R = 2-thienyl (66%)





I-10l (53%) I-10m (0%) I-10n (75%) I-10o, R = H (77%)







































to the methoxy group over the 2-position of the thiophene. In the case of the 2-thienyl 
moiety I-9h, no attack is observed at the 3-position of the thiophene, suggesting the 2-
position of the thiophene is more nucleophilic than the 2-position. In an extended π-
system (I-9i), only 22% yield is observed. This is likely due the generation of competing 
cationic intermediates, leading to multiple side products. 
When a 2-naphthyl substituent is used, four different products are observed as an 
only slightly determinable mixture of isomers. Only the ratio of the combined 
tetrasubstituted and trisubstituted alkene isomers was determinable. In the case that a 
purely alkyl substituent is used (I-9k), only an indeterminable mixture of products is 
observed, although a mixture of I-9k and its fully reduced alkyl alcohol was used. Other 
(hetero)arenes in place of the 3-thienyl moiety were also examined (I-9l-p), with good 
tolerance for most substrates. However, when the 3-thienyl is replaced with a 2-
benzofuran, only decomposition of the starting material is observed. 
I.2.3 Probing Interconversion of the 4H- and 6H-Cyclopenta[b]thiophenes 
During the course of the study, it was observed that the 4H- and 6H-
cyclopenta[b]thiophene products obtained from this methodology often interconverted 
over the course of the reaction when ran in dichloromethane as solvent. In order to gain a 
deeper understanding of this phenomenon, a 1.7:1 mixture of the tetra- and trisubstituted 
alkene products I-10a were subjected to the optimized catalyst and concentration reaction 
conditions and monitored over time. A significant increase in the amount of the 
tetrasubstituted product was observed after only 30 minutes in refluxing dichloromethane 
(15:1); however, if left stirring at reflux for 1 hour, the selectivity eroded significantly to 
3:5:1 (Scheme I.5). 
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Scheme I.5 Probing Isomerization of Products over Time 
Two plausible mechanisms exist for the isomerization of the two products: one 
involves a 1,5-hydride shift, while the other is simple a protonation/deprotonation 
pathway (Scheme I.6). There also exists the possibility of some continuum between the 
two. A series of reactions were conducted to probe the viability of each of these 
mechanisms. When the products I-10a are exposed to a Brönsted acid (HNTf2) in 
benzene at 40°C, only little erosion of selectivity toward the tetrasubstituted alkene is 
observed, suggesting the observed isomerization is likely only very slightly driven by a 
protonation/deprotonation mechanism. However, when exposed to the Lewis acid, 
significant, oscillating isomerization occurs over time. This leads to speculation that a 
complex involving the calcium catalyst and the products may promote interconversion. 
 
Scheme I.6 Plausible Mechanisms for Interconversion 
In order to determine the likelihood of the 1,5-hydride shift mechanism, a simple 
deuterium labeling study to probe any kinetic isotope effects was conducted by placing a 
deuterium atom at the α-position to the phenyl ring (Scheme I.7). Interestingly, when this 
deuterated I-9a starting material was subjected to the optimized reaction conditions for 





























trisubstituted alkene products were obtained in all three circumstances, suggesting a large 
kinetic isotope effect on the 1,5-hydride shift.  
 
Scheme I.7 Deuterium Labeling Studies to Probe Kinetic Isotope Effects 
Throughout these investigations, we were lead to several conclusions regarding 
the isomerization mechanism. Firstly, the trisubstituted product is formed first in the 
reaction mixture, and any tetrasubstituted alkene isomer is the result of an isomerization. 
Secondly, there exists a large kinetic isotope effect for isomerization. Thirdly, the 
calcium catalyst is not required for isomerization, although it does promote significant 
isomerization quickly. Although not discussed here, a solvent effect is also observed on 
the rate of isomerization of the tetra- and trisubstituted alkene products. Finally, some 
product degradation was observed over the course of the study, although it can be ruled 
as irrelevant in context of the observed erosion of isomer selectivity over reaction time. 
I.2.4 Attempted Derivatization of Cyclopenta[b]thiophene Products 
While Skramstad reported that 5H-cyclopenta[b]thiophenes were able to undergo 
Diels-Alder-type cyclizations, we set out to probe the viability of these reactions on the 
observed 4H-cyclopenta[b]thiophenes (Scheme I.8). However, when exposed to maleic 
anhydride (as a probe for normal electron demand cycloaddition), n-butyl vinyl ether (to 
probe for inverse electron demand cycloaddition), or 2,5-dimethylfuran (to probe the 
cyclopenta[b]thiophene as a dienophile), no desired reactivity was observed under any 





















Scheme I.8 Attempted Derivatizations 
I.3 Conclusion 
In summary, a calcium-catalyzed method for the synthesis of 
cyclopenta[b]thiophenes via a dehydrative Nazarov-like cyclization of (hetero)aryl 
alkenyl alcohols was disclosed. As such, it is one of the only known catalytic dehydrative 
Nazarov cyclization protocols in which thiophene rings are tolerated. Starting materials 
are accessed via a simple two-step route from known β-ketoesters, and products are 
obtained in up to 82% yield. A number of substituents were tolerated in this protocol, 
including aryl and heteroarenes substituents on the alkene. Cyclization generally occurs 
on the most nucleophilic ring, although mixtures are observed when nucleophilicities are 
similar. The arene series generally favors the trisubstituted alkene isomer, whereas the 2-
thienyl series favors the tetrasubstituted isomer. In the future, we hope to further improve 
the synthesis of the starting materials (particularly the Luche reduction), expand the 
scope of the reaction, and potentially utilize these molecules in the development of 
organometallic catalysts. 
I.4 Experimental Section 
For all experimental data, including detailed experimental procedures, 
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APPENDIX II. α-ALKYLIDENE-γ-BUTYROLACTONE 
FORMATION VIA BI(OTF)3-CATALYZED, 
DEHYDRATIVE, RING-OPENING CYCLIZATIONS OF 
CYCLOPROPYL CARBINOLS§ 
II.1 α-Alkylidene-γ-butyrolactone (ABL) Framework: Relevance 
The α-alkylidene-γ-butyrolactone (ABL) framework is found in a number of 
bioactive natural products, making it a relevant core both to the medicinal and synthetic 
organic chemistry community (Figure II.1).1-4 By 2009, it was estimated that over 5000 
ABL natural products and over 9000 synthetic analogs had been identified.5 Historically, 
ABLs have also been rather simple to derivatize, with hydrogenations,6 epoxidations,7 
conjugate additions,8 and amine additions9 being reported. ABLs are generally 
synthesized in a variety of ways: installation of alkylidenes on γ-butyrolactones,10-13 
lactonization,14-19 one-pot C-H insertion/olefination,20-22 cross metathesis,23-24 Dreiding-
Schmidt organometallic approach,25 Pd-catalyzed cross-coupling,26 enyne metathesis,27 
(retro-)Diels-Alder approaches,28-29 radical cyclizations,30-31 and Baeyer-Villiger 
approaches.32 Considering the synthetic importance of these ABL molecules, and despite 
the wealth of methodologies to currently access them, the continuation of methodological 
development to access these scaffolds is a meaningful endeavor. 
                                                
§ This work was conducted in collaboration with Matthew J. Sandridge and Brett D. McLarney. My 
contribution to this project involved the synthesis of several cyclopropyl carbinol starting materials, 
purifications, cyclizations, and editing to the report. Published in J. Org. Chem. 2017, 82, 10883-10897. 
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Figure II.1 ABL Scaffolds in Bioactive Molecules 
II.2 Ring-opening Cyclizations: A New Approach to ABLs 
In 2017, the France group published a calcium-catalyzed, ring-opening 
cyclization approach to (hetero)aryl-fused cyclohexa-1,3-dienes utilizing (hetero)aryl 
cyclopropyl carbinols (Scheme II.1). Over the course of that study, it was discovered that 
when the model substrate was subjected to the optimized reaction conditions, a unique 
ABL product (II-3a) was also isolated in 14% yield.33 In all other similar 
transformations, there was no mention of this unique product being formed.34-35 While 
vinyl cyclopropanes have been used to form ABLs in the past with substituted 
benzaldehydes in the presence of DABCO,36 there were no reports utilizing cyclopropyl 
carbinols. Fascinated by this result, we began an investigation to determine necessary 
conditions for selective ABL formation, with the goal of probing the factors that control 
chemoselectivity (ABL vs. dihydronaphthalene products) including the role of substituent 
effects. 
 






























































II.2.1 Synthesis of Cyclopropyl Carbinols 
Most cyclopropyl carbinols were synthesized via the same three-step route 
previously used by France and co-workers (Scheme II.2).33 From the known β-ketoesters 
II-4 the cyclopropanes were synthesized via diazo transfer followed by a Rh-catalyzed 
cyclopropanation. To generate secondary cyclopropyl carbinols (II-1a-v), LiEt3BH was 
used to reduce the corresponding ketone. Tertiary alcohols (II-1x-y), however, were 
generated via organolithium attack on the cyclopropyl ketones. In one unique case (II-
1w), Nishii’s Reformatsky approach was used (Scheme II.3).37 
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Scheme II.2 Synthesis of Cyclopropyl Carbinols 
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II.2.2 Optimization and Investigation of Substrate Scope 
Upon obtaining substrate II-1a, an extensive set of optimization screens was 
carried out, including Lewis/Brönsted acid catalysts, catalyst loading, solvent, 
temperature, and concentration screens. Although they will not be discussed further here, 
the optimized conditions for ABL formation from II-1a were determined to be 5 mol % 
Bi(OTf)3 in DCM (0.1 M) with 4Å molecular sieves at room temperature, giving the 
desired ABL in 62% yield. Over the course of the optimization, it was hypothesized that 
Bi(OTf)3 was serving as a surrogate to the in situ generation of TfOH. After a series of 
control reactions including those with protic acids (including 15 mol % TfOH, which 
performed similarly to Bi(OTf)3 with 61% yield), the addition of base, and probing other 
Bi(III) salts, it was determined that Bi(OTf)3 indeed serves as an easy-to-handle precursor 
to TfOH. It is also worth noting that an equivalent of water is required for ABL 
formation; higher equivalencies of water are detrimental to the cleanliness of the reaction, 
which the molecular sieves help to control.  
Upon obtaining optimized conditions, substrate scope for the reaction was 
examined. Firstly, the effects of the cyclopropane substituent were investigated (Table 
II.1). It was quickly recognizable that electron-rich donors on the cyclopropane group 
greatly favored the formation of the dihydronaphthalene products (for instance, II-1c), 
while less electron-rich donors typically favored ABL formation (II-1a, b, d-h). Yield 
generally increases with greater electron deficiency, and most are isolated as a single 
diastereomer. A 2-naphthyl donor is tolerated, giving II-3i in 24% yield as a single 
diastereomer. However, a 2-furyl donor (II-1j) gives only an intractable mixture. For the 
α-methyl phenyl cyclopropyl carbinol II-1k, the desired ABL is obtained in 38% yield as 
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a single diastereomer. In the disubstituted cyclopropyl carbinols II-1l-n, an elimination 
product was also observed (Figure II.2). However, indanyl and spirocyclopentyl ABLs 
II-3m and II-3n were obtained in 34% and 43% yields and 5:1 and 1:1 E:Z ratios, 
respectively. 
When the effects of the (hetero)aryl substituent were examined, it also became 
quite clear that the electronics of the system have a drastic effect on both the yield and 
E/Z ratio of products obtained (Table II.2). For instance, when the 3,4-dimethoxyphenyl 
group is replaced by a simple 4-methoxyphenyl group, yield increases to 73%; however, 
E/Z selectivity erodes to 7:1 (Table II.2, Entry 1). A simple phenyl, on the other hand, 
further decreases E/Z selectivity to 1:1 (Table II.2, Entry 2). When an electron-deficient 
arene is used (II-1q-r), yield decreases significantly, giving on 26% yield of the desired 
ABL II-3q as a 1:1 E:Z mixture or an intractable mixture, respectively. A benzofuran 
was tolerated, giving 48% of the desired ABL as a single diastereomer. Dialkyl carbinols 
(II-1u-v) were not effective substrates unless a tertiary alcohol (II-1w) was used. Tertiary 
benzylic carbinols were effective substrates, giving II-3x in 54% yield as a single 
diastereomer and II-3y in 41% yield as a 3:1 mixture of unassigned diastereomers. 
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Table II.1 Examination of Cyclopropane Donors 
 
aReactions performed with 1 equiv. of cyclopropyl carbinol and 10 mol % 
Bi(OTf)3 in DCM (0.1 M) at room temperature with 4Å molecular sieves. bIsolated 
yield after column chromatography. cE/Z ratios determined by crude NMR on 
crude mixtures. d5 mol % Bi(OTf)3 used. eE/Z ratios determined by isolated yield 
of (E)-II-3b and 1H NMR yield of (Z)-II-3b with dimethyl terephthalate as an 
internal standard. fOnly the dihydronaphthalene product observed. g20 mol % 
Bi(OTf)3 used. hIntractable mixture obtained. iNo ABL products observed. j5:1 
mixture of unassigned diastereomers. k12:1 mixture of dihydronaphthalene product 
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Table II.2 Examination of (Hetero)aryl Carbinol Substituents 
 
aReactions performed with 1 equiv. of cyclopropyl carbinol and 10 mol % Bi(OTf)3 
in DCM (0.1 M) at room temperature with 4Å molecular sieves. bIsolated yield 
after column chromatography. cE/Z ratios determined by crude NMR on crude 
mixtures. dE/Z ratios determined by isolated yield of (E)-II-3o and (Z)-II-3o. e1H 
NMR yield using dimethyl terephthalate as an internal standard. fIntractable 
mixture obtained. gNo reaction; only starting material recovered. h5 mol % of 
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Figure II.2 Elimination Products 
II.2.3 Rationalizing E/Z Selectivities Observed in ABL Products 
With the substrate scope fully examined at this stage, it seemed prudent to 
investigate the origins of the observed E/Z selectivities. To summarize a series of 
computational calculations of the reaction coordinates of substrates II-1a and II-1p, as 
the electron-donating ability of the (hetero)aryl substituent of the carbinol decreases (e.g., 
3,4-dimethoxyphenyl to phenyl), the molecule compensates by shifting atomic partial 
charge from Cα to Cγ, resulting in a slightly stronger, shorter, Cβ-Cγ bond. The electron-
donating potential of the cyclopropyl donor is also a factor in controlling E/Z selectivity. 
In the case of substrates II-1a and II-1b, as the electron-donating ability of the phenyl 
ring increases (R = H vs. R = Me), the Cβ-Cγ bond is more polarized, and thus longer. As 
the Cβ-Cγ bond lengthens, the energy gap between the E and Z isomer transition states 
decreases, leading to lower E/Z selectivities (Figure II.3). 
 

























= decreasing E/Z transition
state energy gap
= decreasing E/Z selectivity
Increasing electron-donating ability 
= decreasing β-γ length 
= increasing E/Z selectivity
Increasing electron-donating ability
= increasing β-γ length
= decreasing E/Z selectivity
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II.3 Conclusion 
In summary, a Bi(OTf)3-catalyzed, dehydrative, ring-opening cyclization of 
(hetero)aryl cyclopropyl carbinols toward the synthesis of ABL frameworks has been 
developed. This represents a chemodivergent strategy from France’s previous Lewis 
acid-catalyzed protocol toward the synthesis of functionalized dihydronaphthalene using 
the same (hetero)aryl cyclopropyl carbinol precursors. It was determined that Bi(OTf)3 
likely serves as an easy-to-handle surrogate to TfOH, which catalyzes the reaction and 
gives ABL products in up to 89% yield and up to >99:1 E/Z selectivity. The electron-
donating ability of cyclopropane donors has a drastic effect on the chemoselectivity of 
the reaction, with more electron-deficient donors favoring ABLs over 
dihydronaphthalenes. Also as a part of this study, a comprehensive predictive model for 
E/Z selectivity was developed using computational methods. Using these methods, it was 
determined that the electronics of the (hetero)aryl substituent and the cyclopropyl donor 
group can greatly influence the cyclopropyl carbinyl cation Cβ-Cγ bond length which 
correlated with the overall E/Z selectivity of the reactions. Future efforts will focus on the 
synthesis of ABL natural products utilizing this newly developed ring-opening strategy. 
II.4 Experimental Section 
For all experimental data, including detailed experimental procedures, 
optimization tables, characterization data, and spectra, see Sandridge, M. J.; McLarney, 
B. D.; Williams, C. W.; France, S. “α-Alkylidene-γ-butyrolactone Formation via 
Bi(OTf)3-Catalyzed, Dehydrative, Ring-Opening Cyclizations of Cyclopropyl Carbinols: 
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Understanding Substituent Effects and Predicting E/Z Selectivity.” J. Org. Chem. 2017, 
82, 10883-10897. 
II.5 References 
1. Kunzmann, M. H.; Sieber, S. A. Mol. Biosyst. 2012, 8, 3061-3067. 
2. Ghantous, A.; Gali-Muhtasib, H.; Vuorela, H.; Saliba, N. A.; Darwiche, N. Drug. 
Discov. Today 2010, 15, 668-678. 
3. Lepoittevin, J. P.; Berl, V.; GiménezArnau, E. Chem. Rec. 2009, 9, 258-270. 
4. Hoffmann, H. M. R.; Rabe, J. Angew. Chem. Int. Ed. 1985, 24, 94-110. 
5. Kitson, R. R. A.; Millemaggi, A.; Taylor, R. J. K. Angew. Chem. Int. Ed. 2009, 
48, 9426-9451. 
6. Ohta, T.; Miyake, T.; Seido, N.; Kumobayashi, H.; Akutagawa, S.; Takaya, H. 
Tetrahedron Lett. 1992, 33, 635-638. 
7. Murray, A. W.; Reid, R. G. Synthesis 1985, 1985, 35-38. 
8. Miyata, O.; Shinada, T.; Naito, T.; Ninomiya, I. Chem. Pharm. Bull. 1989, 37, 
3158-3160. 
9. Artman, G. D.; Weinreb, S. M. Org. Lett. 2003, 5, 1523-1526. 
10. Nakamura, T.; Tsuboi, K.; Oshida, M.; Nomura, T.; Nakazaki, A.; Kobayashi, S. 
Tetrahedron Lett. 2009, 50, 2835-2839. 
11. Hirose, T.; Miyakoshi, N.; Mukai, C. J. Org. Chem. 2008, 73, 1061-1066. 
12. Dai, M.; Danishefsky, S. J. J. Am. Chem. Soc. 2007, 129, 3498-3499. 
13. Merten, J.; Fröhlich, R.; Metz, P. Angew. Chem. Int. Ed. 2004, 43, 5991-5994. 
14. Azarken, R.; Guerra, F. M.; Moreno-Dorado, F. J.; Jorge, Z. D.; Massanet, G. M. 
Tetrahedron 2008, 64, 10896-10905. 
 246 
15. Bandyopadhyay, S.; Dutta, S.; Spilling, C. D.; Dupureur, C. M.; Rath, N. P. J. 
Org. Chem. 2008, 73, 8386-8391. 
16. Hilt, G.; Paul, A.; Harms, K. J. Org. Chem. 2008, 73, 5187-5190. 
17. Ramachandran, P. V.; Pratihar, D. Org. Lett. 2007, 9, 2087-2090. 
18. Elford, T. G.; Arimura, Y.; Yu, S. H.; Hall, D. G. J. Org. Chem. 2007, 72, 1276-
1284. 
19. Mitra, S.; Gurrala, S. R.; Coleman, R. S. J. Org. Chem. 2007, 72, 8724-8736. 
20. Lloyd, M. G.; D'Acunto, M.; Taylor, R. J. K.; Unsworth, W. P. Tetrahedron 2015, 
71, 7107-7123. 
21. Lloyd, M. G.; Taylor, R. J. K.; Unsworth, W. P. Org. Lett. 2014, 16, 2772-2775. 
22. Shie, J.-Y.; Zhu, J.-L. Tetrahedron 2016, 72, 1590-1601. 
23. Moïse, J.; Arseniyadis, S.; Cossy, J. Org. Lett. 2007, 9, 1695-1698. 
24. Raju, R.; Allen, L. J.; Le, T.; Taylor, C. D.; Howell, A. R. Org. Lett. 2007, 9, 
1699-1701. 
25. Csuk, R.; Schröder, C.; Hutter, S.; Mohr, K. Tetrahedron: Asymmetry 1997, 8, 
1411-1429. 
26. Gagnier, S. V.; Larock, R. C. J. Org. Chem. 2000, 65, 1525-1529. 
27. Charruault, L.; Michelet, V.; Genêt, J.-P. Tetrahedron Lett. 2002, 43, 4757-4760. 
28. Lebel, H.; Parmentier, M. Org. Lett. 2007, 9, 3563-3566. 
29. Lertvorachon, J.; Thebtaranonth, Y.; Thongpanchang, T.; Thongyoo, P. J. Org. 
Chem. 2001, 66, 4692-4694. 
30. Dulcere, J. P.; Mihoubi, M. N.; Rodriguez, J. J. Org. Chem. 1993, 58, 5709-5716. 
31. Bachi, M. D.; Bosch, E. J. Org. Chem. 1992, 57, 4696-4705. 
 247 
32. Wakamatsu, T.; Miyachi, N.; Ozaki, F.; Shibasaki, M.; Ban, Y. Tetrahedron Lett. 
1988, 29, 3829-3832. 
33. Sandridge, M. J.; France, S. Org. Lett. 2016, 18, 4218-4221. 
34. Takada, S.; Takaki, N.; Yamada, K.; Nishii, Y. Org. Biomol. Chem. 2017, 15, 
2443-2449. 
35. Eri, Y.; Kazufumi, N.; Kei, T.; Ryouta, T.; Jiro, M.; Yoshinori, N. Chem. Lett. 
2010, 39, 194-195. 
36. Du, D.; Wang, Z. Tetrahedron Lett. 2008, 49, 956-959. 
37. Sakuma, D.; Yamada, K.; Sasazawa, K.; Nishii, Y. Chem. Lett. 2015, 44, 818-
820. 
 
